col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


875 Ergebisse       Seite 1

 [1] 
Elsevier: Value in Health
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Mai―10 Growing evidence base on condition-specific patient-reported outcomes measures for Long Covid Adam B. Smith, Darren Greenwood, Manoj Sivan
2 [GO] 2025―Mrz―05 A systematic review and meta-analysis of health state utility values for infectious diseases with pandemic potential and associated vaccine adverse reactions Taito Kitano, Daniel A. Salmon, Matthew Z. Dudley, Ian J. Saldanha, David A. Thompson, Lilly Engineer
3 [GO] 2025―Feb―07 Are Updated COVID-19 Vaccines Still Relevant for all Adult Age Groups? An Economic Evaluation of the Monovalent XBB.1.5 Vaccine in Australia. Charles Ebuka Okafor, Syed Afroz Keramat, Namal N. Balasooriya, Echezona H. Dioji
4 [GO] 2024―Dez―25 EE799 COVID-19 Vaccination of Individuals Aged 65 Years and Over in France: Clinical and Economic Impact of Vaccine Choice N El Mouaddin, M Uhart, C Demont, K Joshi, E Beck, A Lee, et al. (+3)
5 [GO] 2024―Dez―25 MSR133 The Impact of Crosswalk Algorithm Choice on COVID-19 Utility Values Derived From a Vignette Study V Coles, S Barton, A Puenpatom, H Goswami, D Ntais
6 [GO] 2024―Dez―25 EPH6 Understanding Mortality Risk Among COVID-19 Vaccinated Individuals in the US: A Literature Review A Jain, S Gogna, P Kondaparthi, R Pandey, R Bergemann
7 [GO] 2024―Dez―25 EE634 Impact of Patient's Financial Burden of COVID-19 Treatment on Antiviral Prescription Rates, and Clinical and Economic Outcomes in Japan M Nagano, S Hyokai, K Togo, T Mugwagwa, A Yuasa
8 [GO] 2024―Dez―25 EE146 To Pay or Not to Pay? Using the Health Belief Model to Explore Willingness to Pay for COVID-19 Vaccine Among High-Risk Ugandans R Olum, F Bongomin, DR Nassozi, I. Andia-Biraro
9 [GO] 2024―Dez―25 EE393 Economic Impact of COVID-19 Vaccination Programs on Healthcare Workers: A Comparative Model-Based Analysis in the US, UK, Japan, and the Netherlands O. Sebestyén-Balogh, Van de Velde N, Y Hagiwara, TA Westra, K Joshi, C Boersma, et al. (+3)
10 [GO] 2024―Dez―25 EE106 Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model C Pritchard, L Kutikova, R Pitman, K Lai, H Beyhaghi, I Gibbons, et al. (+4)
11 [GO] 2024―Dez―25 CO156 Incidence of Tinnitus After COVID-19 Vaccination Compared to Other Vaccines: A Propensity-Score Matched Analysis of a Large Real-World Claims Database R Argoubi, M Furegato, E Berliner, P Medina
12 [GO] 2024―Dez―25 EPH241 Impact of COVID-19's Cancer Screenings in the United States of America, Canada, and Brazil: An International Comparative Study B Tibet, G Kockaya, S Okcun, EB Ozdemir, M Kurnaz
13 [GO] 2024―Dez―25 SA49 Drug Approval Under Uncertainty Across the COVID-19 Timeline: Cumulative Evidence Versus Value of Information Analyses S. Dijk, E. Krijkamp, N. Kunst, C.P. Gross, J. Labrecque, A. Pandit, et al. (+4)
14 [GO] 2024―Dez―25 EE63 Implications of COVID-19 Treatment Post-Pandemic: The Bulgarian Perspective G Slavchev, J Vlaeva, V Todorova, A Dacheva, S Djambazov
15 [GO] 2024―Dez―25 MT60 Artificial Intelligence-Based Tools Designed to Predict Future Mechanical Ventilation and/or Mortality in Hospitalised COVID-19 Patients: A Systematic Literature Review H Dickinson, L Liu, A Rubino, A Chokkalingam
16 [GO] 2024―Dez―25 HPR108 Exploring Health Crisis in Developing Nations: A Study of COVID-19's Impacts on Healthcare Access and Resilience B Tibet, EB Ozdemir, S Okcun, M Kurnaz, G Kockaya
17 [GO] 2024―Dez―25 EPH44 Evaluating the COVID-19 Responses of Belgium, Denmark, Germany, the Netherlands, Sweden and the United Kingdom, February-June 2020: A Counterfactual Modelling Study P.T. de Boer, F Miura, G Lagerweij, J Wallinga
18 [GO] 2024―Dez―25 EE377 Cost-Effectiveness of Nirmatrelvir/Ritonavir in COVID-19 Patients at High-Risk for Progression in Spain C Peral, JR Azanza, JM Gonzalez del Castillo, R Ferrando, JM Molero Garcia, A Soriano, et al. (+4)
19 [GO] 2024―Dez―25 RWD180 Impact of the COVID-19 Pandemic on Mortality Associated With Surgical Interventions in the Gheorgheni Municipal Hospital (TRANSYLVANIA) in the Period Between 2019-2022 C. Könczei, E. Fülöp, I. Boncz, D. Elmer, L. Kajos, Z. Kívés
20 [GO] 2024―Dez―25 EPH80 Impact of the COVID-19 Pandemic on Arterial Hypertension Monitoring and Control in Portugal D Mendes, D Figueiredo, C Alves, R Amaral, B Costa, A Penedones, F Batel Marques
21 [GO] 2024―Dez―25 PCR298 COVID-19 Vaccines Relative Attribute Importance: Insights on Preference Heterogeneity Identified Through Latent Class Modeling J. Lazarus, N. Waite, D. Salisbury, C. Lehmann, S. Sri Bhashyam, M. d la Cruz, et al. (+4)
22 [GO] 2024―Dez―25 EPH31 Incidence of Pulmonary Nodules (PNs) During the Coronavirus Disease (COVID-19) Pandemic in the United States (US) J Kurman, K Le, M Jerry, M Richards
23 [GO] 2024―Dez―25 RWD29 Hospitalization for Acute Heart Failure and In-Hospital Mortality Before, During, and After the COVID-19 Pandemic Period in France: A Nationwide Open Cohort Study from 2013 to 2023 P. Moulaire, T. Delory, S. Oghina, M. Espagnacq, M. Khlat, S. Le Coeur, et al. (+2)
24 [GO] 2024―Dez―25 SA23 The Impact of the COVID-19 Pandemic on Psychotropic Medication Initiation Among Adolescents and Young Adults: A Time Series Analysis T. Hujanen, H. Koskinen, F. Nurminen, H. Rättö, L. Saastamoinen, H. Kari
25 [GO] 2024―Dez―25 EPH79 Impact of the COVID-19 Pandemic on Diabetes Mellitus Care in Portugal D Mendes, D Figueiredo, C Alves, A Penedones, B Costa, F Batel Marques
26 [GO] 2024―Dez―25 EPH93 Prevalence of Pulmonary Nodules (PNs) in 2020 During the Coronavirus Disease (COVID-19) Pandemic in the United States (US) J Kurman, K Le, M Jerry, M Richards
27 [GO] 2024―Dez―25 EPH230 Geographic Variation in Routine Childhood Vaccination Using Real-World Evidence: Pre- and Post- COVID-19 Pandemic AC Garduno, J Lloyd, T Schwartz
28 [GO] 2024―Dez―25 EE822 Willingness to Pay in Japan After the COVID-19 Pandemic S Tsuzuki, T Kitano
29 [GO] 2024―Dez―25 RWD28 Social Determinants of COVID-19 Outcomes in Latin America During Vaccine Rollout: A Real-World Study M. Diaz Puentes, N. Caballero, D. Buitrago, G. Silva Julian, J. Spinardi, V. Goularte, M.H. Kyaw
30 [GO] 2024―Dez―25 CO27 Comparative Effectiveness of the mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Canadians: A Systematic Literature Review and Meta-Analysis Using the Grade Framework X Wang, A Pahwa, P Sharma, A Chitkara, N Mishra, M Malmenas, et al. (+6)
31 [GO] 2024―Dez―25 EE573 Cost-Effectiveness of Older Adult COVID-19 mRNA-1273 and BNT162B2 Vaccination in Italy F Rumi, M Basile, K Joshi, E Beck, E Di Brino, A Ponzianelli
32 [GO] 2024―Dez―25 EPH175 Baseline Risk of Hospitalization and Death in a Nirmatrelvir/Ritonavir Treatment-Eligible Population With Mild-to-Moderate COVID-19 in the United States: A Systematic Literature Review K. Migliaccio-Walle, T Mugwagwa, A. Cha-Silva, CL Gong, D Campbell, JL Nguyen, et al. (+5)
33 [GO] 2024―Dez―25 EPH280 Direct Consequences of Social Distancing Policies on Mobility During COVID-19 in South Korea E Bae, SE Choi, D Kang
34 [GO] 2024―Dez―25 EPH27 Medical Costs of Adults With COVID-19 in Dominican Republic (DR) During the Endemic Phase: A Micro-Costing Study E Vásquez, P Lasalvia, J.J. Baldi-Castro, L.A. Barrantes-Aragon, A Villafranca, M. Marcano-Lozada, et al. (+4)
35 [GO] 2024―Dez―25 EPH89 Medical Costs of Adults With COVID-19 in Costa Rica During the Endemic Phase: A Micro-Costing Study P Lasalvia, E Vásquez, J.J. Baldi-Castro, L.A. Barrantes-Aragon, A Villafranca, M. Marcano-Lozada, et al. (+4)
36 [GO] 2024―Dez―25 EE70 Cost-Utility of Behavioral Activation (BA) for Mitigating Psychological Impacts of COVID-19 on Socially Isolated Older Adults With Depression and Multiple Long-Term Conditions Compared With Usual Care HI Wang, S Gilbody, E Littlewood, K Baird, D Ekers, D McMillan, et al. (+6)
37 [GO] 2024―Dez―25 EE151 Assessing the Impact of COVID-19 on National Productivity in Korea: A Fall 2023 Analysis S Joung, Y Kang, E Beck, K Joshi, H Lee
38 [GO] 2024―Dez―25 EE280 Impact of COVID-19 on Healthcare Utilization and Costs: A Detailed Analysis From Inpatient and Outpatient Perspectives M Steinmann, S Gruhn, B Jahn, A Kuhlmann, B Lange, W Greiner
39 [GO] 2024―Dez―25 PCR165 Compliance With Inhaled Corticosteroid Therapy in Asthma Patients Who Have COVID-19 Leads to Better Outcomes V. Sedlák, A. Tichopád, M. Jesenak, I. Solovič, K. Breciková, J. Žigmond, et al. (+2)
40 [GO] 2024―Dez―25 EPH128 COVID-19 Is Here to Stay: Seasonal Endemic SARS-CoV-2 Infection Patterns Indicate Recurring Waves Adding to Respiratory and Cardiovascular Disease Burden in Germany A Schmetz, J Knaul, S Müller, T Wilke, J Yang, S Dornig
41 [GO] 2024―Dez―25 PT38 Is There an Increased Risk of Developing Hypertension After a COVID-19 Infection? C. Eteve-Pitsaer, C. De Palma, C. Renaudat, C. Billinghurst, J.S. Chandan, K. Gokhale
42 [GO] 2024―Dez―25 EPH149 COVID-19 Cases and Deaths by Social Vulnerability in Chicago Community Areas K Shah, S Kim, S.M. Walton
43 [GO] 2024―Dez―25 EE197 The Acute and Long-Term Healthcare Costs Attributable to COVID-19 in Ontario, Canada: A Population-Based Matched Cohort Study B Sander, S Mishra, S Swayze, Y Sahakyan, R Duchen, K Quinn, J Kwong
44 [GO] 2024―Dez―25 EPH123 Characterization of Trabeculectomy Use and the Impact of COVID-19 in Medicare Beneficiaries With Primary Glaucoma by US Region A Nair, H Buser, M Gowda, B Delise, JF Ricci
45 [GO] 2024―Dez―25 EE180 Cost-effectiveness Analysis of Nirmatrelvir/Ritonavir Compared With Molnupiravir in Patients at High Risk for Progression to Severe COVID-19 in Japan A Yuasa, H Matsuda, Y Fujii, Y Kado, K Murata, M Yoshida, et al. (+2)
46 [GO] 2024―Dez―25 CO6 Projected Public Health Benefits of Increasing Vaccine Coverage for COVID-19 Among Adults ≥ 50 Years of Age in the United States K Joshi, E Beck, Van de Velde N, D Mehta
47 [GO] 2024―Dez―25 EPH148 Medical Costs of Adults With COVID-19 in Guatemala During the Endemic Phase: A Micro-Costing Study E Vásquez, P Lasalvia, J.J. Baldi-Castro, L.A. Barrantes-Aragon, A Villafranca, M. Marcano-Lozada, et al. (+3)
48 [GO] 2024―Dez―25 RWD82 Economic Burden of Influenza and COVID-19 in French Hospitals: Analysis of PMSI Data From 2018 to 2022 C. Demont, N. El Mouaddin, L. Chillotti, M. Uhart, A. Chéret
49 [GO] 2024―Dez―25 EE709 Cost-Effectiveness Analysis of Paxlovid® (Nirmatrelvir+Ritonavir) in Adults at High-Risk of Progression to Severe COVID-19 Disease in Portugal C Mota, L Silva Miguel, M Soares, A. Cha-Silva, T Mugwagwa
50 [GO] 2024―Dez―25 HTA405 Taxonomy of the Full Value of mRNA Influenza and COVID-19 Combination Vaccines J Sevilla, J Knee, G Meier, J Yang, M Di Fusco, T Hu, DE Bloom
51 [GO] 2024―Dez―25 EE257 Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162B2 COVID-19 Booster Vaccination in Mexico J Huerta, CF Mendoza, MH Kyaw, RA Becerra, D Abreu, I Chirila, B Yarnoff
52 [GO] 2024―Dez―25 HPR213 Inequalities in the COVID-19 Case Fatality Rate at a Hospital Institution in Armenia, Colombia, 2020-2021 G.M. Castillo-Valencia, E. Villazon-Gutierrez, D Jervis Jalabe, T. Beltran-Venegas
53 [GO] 2024―Dez―25 EE638 Long COVID: A Costly Condition Imposing Substantial Burden on Society J Knight, CF Mendoza, A. Cha-Silva, I Chopra, M Gavaghan, H Burnett, et al. (+3)
54 [GO] 2024―Dez―25 RWD143 Caregiver Burden Among Patients With COVID-19: A Systematic Literature Review of Real-World Evidence M. Di Fusco, V.L. Welch, A. Sinh, S. Vaghela
55 [GO] 2024―Dez―25 EPH258 Impact of SARS-CoV-2 on Child and Adolescent Mental, Behavioral, and Neurodevelopmental Disorders: A MarketScan by Merative Bayesian Structural Time-Series Analysis J Janak, R Ross, B Brady, LA Palmer
56 [GO] 2024―Dez―25 CO38 Burden and Trends of COPD Exacerbations in France Before and During the Pandemic S Perrier, N Pages, A Panes, J Tavi, M Gouysse, A Schmidt, AL Vataire
57 [GO] 2024―Dez―25 EE485 Exploring the Impact of Changes in Health Valuation Post-COVID-19 Pandemic on an Existing Cost-Effectiveness Analysis R Grindley, L Ruff, J Mckendrick
58 [GO] 2024―Dez―25 EPH86 Increased Healthcare Resources Utilization and Costs of Long COVID in Community-Managed Adult Patients in France J Yang, C Tamberou, E Arnee, A Boukhlal, P.A. Squara, M. Lepoutre-Bourguet, et al. (+5)
59 [GO] 2024―Dez―25 PCR55 The Burden of Long COVID on Quality of Life and Daily Functioning N. Stapleton, I. Chopra, C.F. Mendoza, A. Cha-Silva, M. Gavaghan, H. Burnett, et al. (+3)
60 [GO] 2024―Jun―15 PCR170 Mental Health Status, Symptoms and Sleep Quality of Patients Hospitalized for Infection with COVID-19 I Viczli, L Kajos, B Kovács, I Boncz, Z Kívés
61 [GO] 2024―Jun―15 EE283 Cost-Effectiveness Analysis of NRICM101 Compared to Usual Care for Treating COVID-19 PJ Chen, HC Lang
62 [GO] 2024―Jun―15 EE229 Characterizing the Clinical and Economic Burden of COVID-19 Among Individuals with Immunocompromising Conditions in Ontario, Canada - A Matched, Population-Based Observational Study C Qian, A Nam, K Johnston, M Tinajero, M.A. Hamilton
63 [GO] 2024―Jun―15 CO179 The Association Between Social Determinants of Health, COVID-19, and Incidence of De Novo Depression Following Traumatic Brain Injury C. Edalat, F.. Moehring-Moskal, W. Jiao, L. Hu, K. Lodaya, HO. Yapici, F. D'Souza
64 [GO] 2024―Jun―15 EPH159 Burden of COVID-19 and Its Associated Clinical Characteristics in Colombia: A Retrospective Database Analysis J Arciniegas, J Bolaños-López, Sanchez JM Reyes, C Mendoza, J Spinardi, J Yang, et al. (+10)
65 [GO] 2024―Jun―15 HSD77 Prescription Patterns for COVID-19 before the Availability of Antiviral Drugs Using the National Database of Health Insurance Claims in Japan T Takeshima, K Iwasaki
66 [GO] 2024―Jun―15 SA44 Association between Facilities of First COVID-19 Diagnosis and Previous Outpatient Visits Based on a Claims Database Analysis T Takeshima, K Iwasaki
67 [GO] 2024―Jun―15 EE187 Remdesivir Reduced Healthcare Resource Utilization in Patients Hospitalized With COVID-19 During the Omicron-Dominant Period R Gupta, A. Papadakis-Sali, X Li, G Leung, J Jarrett
68 [GO] 2024―Jun―15 EPH107 Characteristics of the COVID-19 Epidemic in Three Hungarian Disctricts R Kokos, R Vajda, L Kajos, B Kovács, I Boncz, Z Kívés
69 [GO] 2024―Jun―15 EE261 Costs and Outcomes Associated with COVID-19 Hospitalisation in the South African Public-Sector during the First-Wave K Govender, K Modiba, S Madlala, L Matsela, T Maotoe, J Nel, et al. (+3)
70 [GO] 2024―Jun―15 RWD91 Healthcare Resource Utilization and Costs Associated with COVID-19 in Colombia: A Retrospective Database Study J Arciniegas, Sanchez JM Reyes, J Bolaños-López, C Mendoza, J Spinardi, J Yang, et al. (+11)
71 [GO] 2024―Jun―15 SA48 Methods to Account for the Impact of COVID-19 in Real-World Retrospective Studies of Economic Outcomes: A Targeted Literature Review K Coyle, J Multani, CB McGuiness, NF Shaikh, V Divino
72 [GO] 2024―Jun―15 EE333 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the U.S.: An Updated Analysis D Campbell, D Veenstra, K. Migliaccio-Walle, M Dzingina, S Sullivan, F Draica, et al. (+3)
73 [GO] 2024―Jun―15 EE197 The Impact of Funding Tocilizumab for the Inpatient Treatment of COVID-19 in the United States: A Distributional Cost-Effectiveness Analysis KL Rosettie, J Best, S Kowal
74 [GO] 2024―Jun―15 EPH40 Changing Role of Comorbidities in Risk of Mortality Among Elderly Patients Diagnosed with COVID-19 in the United States: Examining Pre- and Post-Vaccine Clinical Risk Factors R Doshi, D Tian, K Grant
75 [GO] 2024―Jun―15 EPH145 Feasibility of a Network Meta-Analysis Assessing Relative Effectiveness and Safety of Remdesivir Versus Other Treatments for COVID-19 Inpatients A Papadakis-Sali, R Thaliffdeen, T Curteis, H Luedke, C Michaels, Z Jafry, J Jarrett
76 [GO] 2024―Jun―15 CO63 Real-World Comparative Effectiveness of the First COVID-19 mRNA Booster, mRNA-1273 Versus BNT162b2, Among US Medicare Fee-for-Service Non-Immunocompromised Beneficiaries Aged 65 and Older J. Zurovac, M. Barna, M. Georgieva, T. Lu, M.A.. Marks, D. Esposito, et al. (+5)
77 [GO] 2024―Jun―15 EPH208 Prevalence and Average Annual Percent Change of Potentially Inappropriate Medication Use in Older Adults before and during the COVID-19 National Emergency J DeShazo, DA Djibo, D Harris, K Hayes, V Mor, C Walraven
78 [GO] 2024―Jun―15 PCR73 Health Care for People with Autism in the COVID-19 Pandemic B Trixler, I Boncz, L Szabó, KJ Dinnyés, H Pusztafalvi
79 [GO] 2024―Jun―15 EPH105 Obesity Continues to be Associated With Poor Health-Related Quality of Life During the Third Year of the COVID-19 Pandemic S Madhavan, A Roy, S Chhetri, R Rasu, S Roy, U Sambamoorthi
80 [GO] 2024―Jun―15 EE354 Economic Burden of ICU Diseases and Injuries in Brazil During the COVID-19 Pandemic I Bezerra, Malheiro D Tavares, Junior AP Nassar, AJ Pereira
81 [GO] 2024―Jun―15 HPR73 Breast Cancer-Related Healthcare Resource Utilization and Staging before and after the COVID-19 Pandemic Among White and Black Patients with Newly Diagnosed Breast Cancer F Devine, E Yung, C Kim, L Popadic
82 [GO] 2024―Jun―15 SA67 Demographic and Clinical Characteristics of Patients Who Delayed, Skipped, or Continued Care During the First Year of the COVID-19 Pandemic and the Study Design Implications T Marlin, J Cheng, C Pack, N Coenen, A Bogdanov, L Kallenbach, J Winer-Jones
83 [GO] 2024―Jun―15 EPH38 Antimicrobial Susceptibility of Klebsiella Pneumoniae Clinical Isolates From the Lower Respiratory Tract Infection During the COVID-19 Pandemic in Brazil (SMART 2020-2021) AA Bittencourt, V Faustino, P de Mendonça Batista, MDND Paula, TJ Polis
84 [GO] 2024―Jun―15 EPH223 Excess of Mortality By Asthma during COVID-19 Pandemic in Colombia N Alvis-Guzman, Sierra J Zakzuk
85 [GO] 2024―Jun―15 HSD86 Health Care Utilization before and during the COVID-19 Pandemic in Patients with Epithelial Ovarian Cancer A Mukherjee, N Shammas, L Xu, K Cannavale, AD Gilfillan, E Szamreta, et al. (+3)
86 [GO] 2024―Jun―15 HSD95 Utilization of Prescription Acquisition by Drive-Thru and Mail Before and During the COVID-19 Pandemic in the United States O Adekunle, AW Olson, JC Schommer, LM Brown
87 [GO] 2024―Jun―15 EE486 Impact of COVID-19 Pandemic on IV Iron (IVI) Cost and Utilization in Commercially-Insured Patients With Iron Deficiency Anemia (IDA) M Polson, B Winegar, S Kidd
88 [GO] 2024―Jun―15 EPH235 Impact of Real-Time Containment Measures on COVID-19 Pandemic Outcomes in African Countries O Mgbere, T Temedie-Asogwa, O Adepoju, W Liaw, C Darkoh, EJ Essien
89 [GO] 2024―Jun―15 EE491 Modeling Costs of Variations in Healthcare Utilization Following the COVID-19 Pandemic: Exploring How Model Choices and Fit Impact Interpretation C Pack, J Cheng, T Marlin, J. Winer-Jones, N Coenen, A Bogdanov, L Kallenbach
90 [GO] 2024―Jun―15 CO79 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States: How Did It Change in 2022 and 2023? R. Moon, N. Rosenthal
91 [GO] 2024―Jun―15 EPH157 Does COVID-19 Related Lockdown Restrictions Impact People With Musculoskeletal Disorders? A Systematic Review F Fatoye, T Gebrye, C Fatoye, J Lawoe, C Mbada
92 [GO] 2024―Jun―15 EPH154 Impact of COVID-19 Response on Primary Care Utilization C Chen, V Tan, G Ang, KB Tan
93 [GO] 2024―Jun―15 RWD116 Navigating the Currents of the Pandemic: A Comprehensive Analysis of Medicare Data Reflecting COVID-19's Impact on Cardiovascular Disease Healthcare Utilization Z Liu, I Varghese, J Celli, P Kardel, C Sheetz
94 [GO] 2024―Jun―15 HSD74 COVID-19's Impact on Healthcare Access for Arthritis Patients: Insights From the 2020 Medical Expenditure Panel Survey RA Alharbi, LT Wingate, S Weaver, EE Ameyaw, AS Adebayo
95 [GO] 2024―Jun―15 EPH95 Leveraging Data Aggregators to Annotate Deidentified Genomic Data Derived from Commercial Laboratory Specimens to Study COVID-19 Severity S Dandiker, A Latham, P Tanpaiboon, AM Ratajski, L Bare, S Chanock, et al. (+3)
96 [GO] 2024―Jun―15 EE57 Missed Opportunities? Gaps in Capturing the Full Value of Vaccination Across Health Economic Studies of COVID-19 Vaccination D Bem, M Nassim, X Wang, de Velde N Van, E Beck, C Pritchard, K Joshi
97 [GO] 2024―Jun―15 PCR35 Impact of COVID-19 Vaccination with BNT162b2 on the Frequency of Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy Fusco M Di, J Cappelleri, A Berk, A Yehoshua, KE Allen, TM Porter, et al. (+4)
98 [GO] 2024―Jun―15 EPH37 Determinants of COVID-19 Vaccine Acceptance Among Nigerian Adults OK Afolayan, OA Olateju, YA Adekunle
99 [GO] 2024―Jun―15 EPH5 COVID-19 Vaccine Acceptance Disparities Among Foreign-Born and US-Born Individuals in California: A 2021 Cross-Sectional Analysis A Sepassi, S Garcia, S Lee, SP Tanjasiri, N Entsuah, M Bounthavong
100 [GO] 2024―Jun―15 EE476 Cost of COVID-19 Vaccine Delivery Integration into Routine Immunization and Service Delivery in South Africa L Matsela, K Modiba, Y Luther, G. Meyer-Rath, I Edoka, J Miot
101 [GO] 2024―Jun―15 EPH171 A Qualitative Survey Analysis for Understanding COVID-19 Vaccine Hesitancy in the United States M Pathan, S Dangpiaei, KJ Jeun, T Dhumal, N Dwibedi, ZA Siddiqui
102 [GO] 2024―Jun―15 PCR181 Predicting COVID-19 Vaccine Hesitancy through Integrated Protection Motivation Theory Constructs B Presson, G Adunlin
103 [GO] 2024―Jun―15 EPH104 Public Health Impact of Pediatric BNT162b2 XBB1.5-Adapted COVID-19 Vaccine in the United States A Yehoshua, B Yarnoff, Di Fusco M, S Lopez, A Rudolph, E Thoburn, K Marczell
104 [GO] 2024―Jun―15 EPH123 Incorporating Social Determinants of Health Into Transmission Modeling of COVID-19 Vaccine in the US: A Scoping Review K Duong, DT Nguyen, W Kategaew, X Liang, W Khaing, LD Visnovsky, et al. (+16)
105 [GO] 2024―Jun―15 PCR176 Preferences for a Combination Influenza and COVID-19 Vaccine: Results from a Threshold Technique Study with Consumers in the United Kingdom C Poulos, A McMichael, C Kent, D Rudin, P Buck, P Ghaswalla, D Mehta
106 [GO] 2024―Jun―15 EPH224 Effectiveness of COVID-19 Vaccines in Colombia: Findings from Two Highly Specialized Healthcare Centers Luna JA Cortés, A Paternina-Caicedo, Tamara L Moyano, España R Navarro, Zakzuk NR Alvis, Guzman N Alvis, la Hoz Restrepo F De
107 [GO] 2024―Jun―15 MSR6 Machine Learning Insights Into COVID-19 Variant Spread Across US Regions L Hu, X Zhang, I Weimer, HO Yapici, A Shenoy, K Lodaya, F D'Souza
108 [GO] 2024―Jun―15 EPH149 Regional Dynamics and Prevalence of COVID-19 Variants in US Health and Human Services Regions L Hu, X Zhang, I Weimer, HO Yapici, A Shenoy, K Lodaya, F D'Souza
109 [GO] 2024―Jun―15 RWD187 The Use of a Large Epidemiological Surveillance Dataset (SIVEP-Gripe) for the Generation of Scientific Evidence in Brazil on COVID-19: A Literature Review Zakzuk NJ Alvis, FA Diaz-Quijano
110 [GO] 2024―Jun―15 MT10 Higher SARS-CoV-2 Spike Antibody Levels Are Associated With Reduced Risk of Subsequent Symptomatic and Severe COVID-19: A Real-World Data Study Y Jin, F Yang, CM Rank, S Letovsky, P Ramge, S Jochum
111 [GO] 2024―Jun―15 HTA40 Nirmatrelvir/Ritonavir for Non-Hospitalized Adults With Mild/Moderately Severe COVID-19: A Systematic Evidence Review of Randomized Controlled Trials and Real-World Studies With Meta-Analysis and Trial Sequential Analysis GN Okoli, N Askin, R Rabbani
112 [GO] 2024―Jun―15 HTA72 Molnupiravir for Treatment of Non-Hospitalized Adults With Laboratory-Confirmed, Mild/Moderately Severe COVID-19: A Systematic Evidence Review With Meta-Analysis and Trial Sequential Analysis GN Okoli, N Askin, R Rabbani
113 [GO] 2024―Jun―15 PCR154 Health State Utility Values in COVID-19: A Vignette Study in Japan S Noto, K Shimozuma, T Iwatani, Y Suzukamo, M Sakai, K Moriwaki
114 [GO] 2024―Jun―15 HSD13 Missed Opportunities for Respiratory Disease Diagnosis in the United States During Endemic Spread of SARS-CoV-2 J Chase
115 [GO] 2024―Jun―15 EE236 Healthcare Resource Utilization (HCRU) and Direct Medical Costs Following Acute SARS-Cov-2 Infection: Findings From a Literature Review E Łukomska, K Kloc, M Kowalska, A Matjaszek, K Joshi, S Scholz, et al. (+2)
116 [GO] 2024―Jun―15 PCR194 Examination of the Subjective Assessment of General Physical and Mental Health, Social Relationships, and Exercise Regularity Among Hungarian Football Players and Professionals during the Pandemic E Derkács, O Dózsa-Juhász, V Keresztesy, P Tardi, I Boncz, B Molics, et al. (+3)
117 [GO] 2024―Jun―15 HSD100 Effectiveness of Data-to-Care Proactive Adherence Interventions on Retention and Relinkage to HIV Care Amid COVID Pandemic TY Lee, A Johnson, H. Cassidy-Stewart, E Onukwugha, N Pandit
118 [GO] 2024―Jun―15 EE332 Cost-Effectiveness Analysis of Implementing a Field Hospital during a Pandemic Malheiro D Tavares, S Pereira, KCJ Parreira, JGD Pagliuso, A.M. Codeco, GDPP Schettino, V Teich
119 [GO] 2024―Jun―15 EPH131 Adolescent Pregnancy Before and During the SARS Cov-2 Pandemic in Cartagena De Indias, Colombia 2015 - 2021 Zakzuk NR Alvis, Arnedo CA Marrugo, de La Rosa F Gomez, Carrillo E Polo, Zakzuk NJ Alvis, Sierra J Zakzuk
120 [GO] 2024―Jun―15 PCR178 Use of Patient Reported Outcomes in Registered Drug Studies for Long COVID E Kairis, J Raad, P McCracken, J Hanmer
121 [GO] 2024―Jun―15 HPR3 Exploring the Inequity of HRQoL in Individuals With Long COVID Symptoms A McCullough, P Lorgelly, D Exeter, J Crossan
122 [GO] 2024―Jun―15 EE422 “This Isn’t a Life”: An Analysis of EQ-5D in a Cohort of Individuals with Long COVID Symptoms A McCullough, P Lorgelly, D Exeter, J Crossan
123 [GO] 2024―Mai―06 Navigating Public Policy Responses to A Pandemic: The Balancing Act Between Physical Health, Mental Health and Household Income Eric Andrew Finkelstein, Semra Ozdemir, Vinh Anh Huynh, Junxing Chay, Axel Mühlbacher, Hiang Khoon Tan
124 [GO] 2024―Apr―17 The Long Coronavirus Disease (COVID) Symptom and Severity Score: Development, Validation, and Application Gengchen Ye, Yanan Zhu, Wenrui Bao, Heping Zhou, Jiandong Lai, Yuchen Zhang, et al. (+8)
125 [GO] 2023―Dez―23 EE488 Budget Impact Analysis of Oral Treatment With Nirmaltrevir+Ritonavir for COVID-19 in Argentina L. Rey-Ares, M.F. Viozzi, C. Vega, J. Elgart, M.L. Glancszpigel
126 [GO] 2023―Dez―23 EE640 The Impact of Blue-Light Emitting Device on the Loss of Productivity From COVID-19 in North Carolina M. Caterino, U. Silas, R. Saunders
127 [GO] 2023―Dez―23 PT11 Overall Survival of Patients with Lung Cancer Newly Diagnosed in the Period of the COVID-19 Pandemic Compared to Patients with an Incident Diagnosis Before the Pandemic: A Retrospective Analysis of German Claims Data J. Krieger, S. Mueller, P. Hahn, A. Fuchs
128 [GO] 2023―Dez―23 EPH179 Ibuprofen, Other Nsaids, & COVID-19: A Narrative Review W. Laughey
129 [GO] 2023―Dez―23 EPH121 Contraindicated Remdesivir Use Among Individuals Hospitalized Due to COVID-19: According to the Danish Treatment Guidelines J. Hoe, K. Blond, M. Berry, M. Chiang, E. Lee, T. Studsgaard, et al. (+3)
130 [GO] 2023―Dez―23 EE643 Cost-Effectiveness of Universal Asymptomatic Preoperative SARS-CoV-2 PCR Screening: A Cost-Utility Analysis S. Uno, R. Goto, K. Honda, S. Uchida, Y. Uwamino, H. Namkoong, et al. (+6)
131 [GO] 2023―Dez―23 HTA295 Insights From Economic Evaluations in Emerging Infection Diseases in France: Focus on COVID-19 L. Vacherot, C. Sambuc, S. Arnetorp, L. Majed, C. Fradet
132 [GO] 2023―Dez―23 EPH45 Exploring the Pandemic's Impact: An Examination of Adolescent and Adult Vaccination Rates in Different Countries During COVID-19 C. Masseria, A. Guyenet, L. Mody, C. Roeder, V. Schliep
133 [GO] 2023―Dez―23 PCR172 Physical Distancing to Avoid COVID-19 and the Association With Humanistic Burden in Immunocompromised Adults - The Eagle Study P.A. Powell, P. Williams, T.A. Herring, S. Venkatesan, S. Arnetorp, A. Lloyd, et al. (+9)
134 [GO] 2023―Dez―23 HPR130 Analysis of Extemporaneous Compounding of Medicines During COVID-19 and Wartime in Ukraine O. Zaliska, Y. Kacheray, Z. Zabolotnya, O. Semenov, O. Barchuk, S. Bilous
135 [GO] 2023―Dez―23 EE750 Budget Impact Analysis (BIA) of Increased COVID-19 Booster Vaccinations in Austria M. Traunfellner, F. Meyer, E. Walter
136 [GO] 2023―Dez―23 EE490 Analysis of Access and Avalibility of Low Molecular Heparins for the Treatment of COVID-19 during Wartime in Ukraine O. Zaliska, O. Semenov, O. Barchuk, O. Brezden, E. Bryharda
137 [GO] 2023―Dez―23 HPR97 Healthcare Systems Resilience and the COVID-19 Emergency: How Care Can Be Improved Within the Current Budget and Resources Constraint by Increasing the Efficiency of Healthcare Delivery H. Ahir, M. Pistollato
138 [GO] 2023―Dez―23 EPH209 Incidence Rates for an Extensive List of Adverse Events of Special Interest in the Pre-COVID-19 and Active COVID-19 Eras: A Comprehensive Source for Representative Historical Background Rates in the US General Population C. Wang, J. Citronberg, S. Reynolds, I. Estevez, R. Sajedian, U. Dave, et al. (+2)
139 [GO] 2023―Dez―23 EPH178 Burden of the Disease and Management in COVID-19 Hospitalized Patients in MSO and Home Care in France: COVID-Hosp Study (2020-2022) M. Pozzar, N. Petrica, H. Ben Romdhane, S. Fiévez, P. Crépey, M. Mongazon-Cazavet
140 [GO] 2023―Dez―23 PCR26 Testing the Psychometric Properties of Several Euroqol Instruments for Measuring the Impact of COVID-19 in a Large Sample of Chinese Children and Their Parent Carers W. Zhou, J.V. Busschbach, M. Herdman, Z. Yang
141 [GO] 2023―Dez―23 PCR118 Cross-Sectional Measurement Properties of the Physical Distancing Scale - COVID-19 (PDS-C19) Self- and Observer-Reported Measure of Physical Distancing Behaviors to Avoid COVID-19 in Adults, Children, and Caregivers P. Powell, J. Marcus, S. Venkatesan, P. Williams, S. Arnetorp, T.A. Herring, et al. (+8)
142 [GO] 2023―Dez―23 EE291 Budget Impact Analysis of Mrna-1273 (Spikevax) in Patients with COVID-19 in Bulgaria A. Dacheva, M. Boyan Likomanov, G. Slavchev, Y. Vutova, S. Djambazov
143 [GO] 2023―Dez―23 EPH176 Comorbidities Among Individuals at Risk to Develop Severe Form of COVID-19 in Case of Sars-Cov-2 Infection E. Guyot, G. Béraud, A. Ausset-Moraillon, M. Belhassen, F. Jacoud, C. Mackosso, et al. (+2)
144 [GO] 2023―Dez―23 HTA149 Handling Uncertainty in Health-Economic Assessments: Experience From COVID-19 in France E. Autin, M. Pozzar, A.L. Couillerot
145 [GO] 2023―Dez―23 PCR226 Health Related Quality of Life and Health Utility Values Across Different Levels of Physically Distancing Behaviors to Avoid COVID-19 in Immunocompromised Adults - The Eagle Study A. Lloyd, S. Arnetorp, J. Marcus, R.T.C. Yokota, T.A. Herring, P.A. Powell, et al. (+8)
146 [GO] 2023―Dez―23 RWD27 Opportunities and Challenges in Linkage of Early Access Databases With the French National Claims Database: A RWE Effectiveness Study of AZD7442 for Pre-Exposure Prophylaxis Against COVID-19 in Immunocompromised Patients L. Luong, A.S. Jannot, C. Burdet, L. Majed, C. Fabry-Vendrand, T. Cerceau, et al. (+5)
147 [GO] 2023―Dez―23 MSR133 What Factors Influence the Prescription of Oral Antivirals for COVID-19 in Japan? - a State Transitional Agent-Based Model Analysis N. Itsumura, K. Kurazono, S. Hiroi, C. Ha, K. Iwasaki
148 [GO] 2023―Dez―23 PCR96 Long Term Consequences of COVID-19 in Quality of Life in Patients Discharged From Hospital: Systematic Review C. Casas, M.F. Nogueira, R.D.C. de Albuquerque, R. Santos-de-Souza, C.C. Oliveira, M. Ribeiro Alves
149 [GO] 2023―Dez―23 EE644 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the US R. Sandin, D. Veenstra, M. Dzingina, M. Vankelegom, S. Sullivan, D. Campbell, et al. (+5)
150 [GO] 2023―Dez―23 EE340 Cost-Effectiveness Analysis of Molnupiravir Against Standard Care for Treating Mild to Moderate COVID-19 Infection in Singapore. Z. Junyang, M.I. Abdul Aziz, S.K.B. Ong, K.H. Ng
151 [GO] 2023―Dez―23 EE486 Municipality Costs Due to COVID-19 Infections in Denmark: A Cost-of-Illness Study T. Mølbach, P.B. Poulsen, T. Pilgaard
152 [GO] 2023―Dez―23 EE289 Comparison of the Clinical and Economic Impact of Two COVID-19 mRNA Vaccines in High Risk Individuals in the Tokyo Prefecture M. Kohli, Y. Hagiwara, A. Igarashi, K. Joshi, A. Lee, M. Maschio, et al. (+2)
153 [GO] 2023―Dez―23 SA69 Impact of COVID-19 on Health Care Resource Utilization and Costs in Patients With Chronic Obstructive Pulmonary Disease and Asthma in the United States (2018-2022): A Population-Based Study L.Y. Lee, A. Steffens, T. Bancroft, G. Requena, K. Rothnie, S. Gelwicks, et al. (+6)
154 [GO] 2023―Dez―23 EPH183 The Effects of COVID-19 on Mental Health A. Kim
155 [GO] 2023―Dez―23 EPH231 The Impact of COVID-19 on National Disease Dynamics: Population-Based Interrupted Time Series Study in South Korea K. Choi, S. Kim, M. Jang, S.J. Park, H.S. Suh
156 [GO] 2023―Dez―23 EPH177 The Impact of COVID-19 on National Mortality: Population-Based Interrupted Time Series Study in South Korea H.S. Suh, K. Choi, S. Kim, M. Jang, S.J. Park
157 [GO] 2023―Dez―23 CO147 Impact of COVID-19 on Patients With Asthma in US Routine Care S.G. Noorduyn, R. Paczkowski, L.Y. Lee, A. Steffens, T. Bancroft, K. Rothnie, et al. (+6)
158 [GO] 2023―Dez―23 RWD123 The Impact of COVID-19 on Treatment of Patients With Ovarian Cancer in England J. Wallis, F. Picariello, L. Carpenter
159 [GO] 2023―Dez―23 HSD107 Descriptive Analysis of Changes to Cardiovascular Healthcare Resource Use Recorded in Malaysian Real World Data from the Syntium Database before, during and after the COVID-19 Pandemic S. Beecroft, N.D. Franco-Sierra, S. Kadiman, G. Sundararaman, G. Zarkadakis, G.C. Hall
160 [GO] 2023―Dez―23 EPH254 Changes in Asthma-Related Healthcare Resource Use in Asthma Patients in the United States During the COVID-19 Pandemic E. Packnett, T. Lillehaugen, L. Palmer
161 [GO] 2023―Dez―23 EPH120 Explaining the Differences in Social Distancing Behavior in the EU During the COVID-19 Pandemic G. Brådvik, P.Y. Geoffard, J. Moller, U. Persson
162 [GO] 2023―Dez―23 EE332 Evaluation of Hospital Pandemic Control Strategies of a Chinese Tertiary Care Hospital During the Late Phase of COVID-19 Pandemic D. Wang, T. Dong, D. Yu, Y. Chen, L. Yuan, Y. Tang, et al. (+3)
163 [GO] 2023―Dez―23 EPH134 Prevalence of and Associated Factors for Therapy Delay Due to COVID-19 Pandemic Among Breast Cancer Patients in Europe N. Gremke, S. Alymova, K. Kostev, M. Kalder, I. Klein
164 [GO] 2023―Dez―23 HSD64 Breast Cancer in the COVID-19 Pandemic Era: An Old Tool with Modern Innovations S. Gioia, J. Pachnicki, E. Tanaka, A.P. Rodrigues, L.E.B. Leal da Rocha, L.B. Santos, et al. (+3)
165 [GO] 2023―Dez―23 EPH40 Evolving Impact of the COVID-19 Pandemic in Chronic Dialysis Recipients According to Wave Sub-Periods E. Leye, K. El Karaoui, T. Delory, N. Lapidus, G. Hejblum
166 [GO] 2023―Dez―23 HTA151 Subjective Well-Being and Mental Health During the COVID-19 Pandemic in Hungary F. Xu, V. Brodszky
167 [GO] 2023―Dez―23 HSD82 Impact of the COVID-19 Pandemic in the Netherlands on Primary Healthcare Use and Clinical Outcomes in People with Type 2 Diabetes J. van den Berg, M.T. Blom, K.M.A. Swart-Polinder, J. Overbeek, S. Remmelzwaal, P.J.M. Elders, R.M.C. Herings
168 [GO] 2023―Dez―23 CO70 COPD Exacerbations Pre, During, and Post COVID-19 Pandemic in the US G. Requena, S.G. Noorduyn, L. Lee, A. Steffens, T. Bancroft, K. Rothnie, et al. (+6)
169 [GO] 2023―Dez―23 P10 Impact of the COVID-19 Pandemic on Cancer Screenings in Portugal and Years of Life Lost Due to Delayed Diagnoses D. Mendes, D. Figueiredo, C. Alves, A. Penedones, B. Costa, F. Batel Marques
170 [GO] 2023―Dez―23 EPH56 The Impact of the COVID-19 Pandemic on Cardiovascular Disease Prevention and Corresponding Geographical Inequalities in England: Interrupted Time Series Analysis A. Castanon, K. Grasic, S. Chen, F. Ma, G. Oboli, B.D. Bray, et al. (+4)
171 [GO] 2023―Dez―23 EPH128 Evaluation of the Effects of the COVID-19 Pandemic on Depression Among the Under 20-Year-Old Population in Japan, the US, and Germany Before and During the COVID-19 Pandemic: A Retrospective Observational Study Using Real-World Data S. Takeno, S.W. Kim, R. Filomeno, S. Nakamatsu, Y. Sakai, T. Taylor, H. Lin
172 [GO] 2023―Dez―23 HSD127 Impact of the COVID-19 Pandemic on Frequency of Surgeries in Germany Based on Hospital Data S. Schnaidt, J. Röhrkaste, K. Borchert, C. Jacob
173 [GO] 2023―Dez―23 HSD77 The Impact of the COVID-19 Pandemic on Patient Flow and Key Performance Indicators (KPIS) of Hippocration General Hospital of Athens N. Chatzinikolaou, M. Hatzikou
174 [GO] 2023―Dez―23 EE205 The Impact of the COVID-19 Pandemic on Physician Visits Among Patients Diagnosed with Breast Cancer and Heart Failure in the United States C.Y. Hsu, D. Seo, E. Onukwugha
175 [GO] 2023―Dez―23 EPH16 Exploring the Effects of the COVID-19 Pandemic on Pneumococcal Disease in France: A Comprehensive Analysis of Public Health Impact and Economic Burden J. Carette, M. Massetti, H. Leleu
176 [GO] 2023―Dez―23 HTA36 Monitoring of the Long-Term Impact of the COVID-19 Pandemic on the Decision Process of the Italian Medicine Agency B. Canali, M. Caimmi, L. Candelora, A. Ciarlo, F. Fiorentino, I. Mattu, et al. (+2)
177 [GO] 2023―Dez―23 HSD53 Effect of COVID-19 Pandemic on the Delivery Time and the Point of Re-Order of Pharmaceuticals at the Logistics Services in a Governmental Hospital in Riyadh Saudi Arabia N. Alshehri, B. Balkhi
178 [GO] 2023―Dez―23 EE135 Efficiency Management of Immunization Programs in Peru, in the Context of the COVID-19 Pandemic: The Fully Liquid Acellular Hexavalent Vaccine M.A. Mendoza, A. Gutiérrez-Aguado, A. Upegui, T. Sarazu, S. Londono
179 [GO] 2023―Dez―23 EPH123 A Machine Augmented Systematic Literature Review: Prevalence of Coinfections in COVID-19 Patients During Early and Late Pandemic Periods D. Patel, V. Chhaya, R. Patel, K. Khambholja
180 [GO] 2023―Dez―23 CO162 More Serbia: Molnupiravir Real World Utilization Among COVID-19 Patients in Serbia N. Nađvinski, J. Liu, G. Liu, G. Stevanović, A. Cvetković, V. Bojat, et al. (+7)
181 [GO] 2023―Dez―23 PCR173 Identifying Behaviors Practiced By Individuals to Avoid COVID-19: Development of the Content of the Physical Distancing Scale - COVID-19 (PDS-C19) P. Powell, T. Maia, S. Arnetorp, R.T.C. Yokota, T.A. Herring, A. Lloyd, et al. (+7)
182 [GO] 2023―Dez―23 EPH17 The Impact of COVID-19 Preventive Restrictions on the Development of Diseases of Despair: A Multi-Group Time Series Analysis F. Wolde, C. Hayes, L. Gressler, B. Martin
183 [GO] 2023―Dez―23 EE28 Cost-Effectiveness Formulation of PCR-Test Screening for COVID-19 Regarding Multiple Factors in Epidemic I. Kamae, M. Kobayashi, R. Watanabe
184 [GO] 2023―Dez―23 EE335 Burden of COVID-19 Related Hospitalization in Adults at High Risk for Severe Disease Progression in Germany-A Retrospective Claims Data Analysis S. Schnaidt, N. Bihrer, E. Fröling, T. Stremel
185 [GO] 2023―Dez―23 EE181 COVID-19 Related Work Absenteeism and Its Associated Lost Productivity Cost in Germany: A Population-Based Study J. Yang, K.K. Rai, M. Seif, H. Volkman, J. Ren, H. Gowman, et al. (+2)
186 [GO] 2023―Dez―23 HPR78 From Submission to Reimbursement: Navigating the COVID-19 Ripple Effect on Therapy Access in Canada P. Purkayastha, R. Gautam, T. Srivastava
187 [GO] 2023―Dez―23 RWD24 Decision Making and the Questions Raised When Real World Evidence From a Federated Data Network Conflicts With RCT Data: A Use Case on COVID-19 Treatments C. Read, R. Claire, J. Elvidge, J. Dietz, T. Debray, M.A. Mayer, et al. (+3)
188 [GO] 2023―Dez―23 EE184 Lessons Learned from Model-Based Economic Evaluations of COVID-19 Treatments Under Pandemic Circumstances: Results from a Systematic Review C. Veijer, M. van Hulst, M.J. Postma, A.D.I. van Asselt
189 [GO] 2023―Dez―23 EE287 Epidemiologic and Economic Impact of COVID-19 Vaccination Among at-Risk Individuals and Individuals Aged ≥60 Years in Germany K. Joshi, M. Kohli, M. Maschio, A. Lee, K. Fust, E. Beck, et al. (+3)
190 [GO] 2023―Dez―23 EE593 Cost-Effectiveness Model of COVID-19 Vaccination: The United Kingdom Perspective MŽ Gojović, R. Pitman, C. Pritchard, K.Z.H. Lai, J. Lundkvist, L. Kutikova, et al. (+3)
191 [GO] 2023―Dez―23 MSR21 Methodological Aspects of a COVID-19 Vaccine Discrete Choice Experiment Survey in Canada, Germany, UK, and US General Populations S. Sri Bhashyam, H.B. Lewis, M. Rousculp, L.G. Shane, M. d la Cruz, J. Galinsky, et al. (+6)
192 [GO] 2023―Dez―23 CO38 Real-World Comparative COVID-19 Vaccine Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 Among Immunocompromised Adults in the US E. Beck, T. Sun, L. Li, M. Georgieva, N. Van de Velde
193 [GO] 2023―Dez―23 EE140 Comparison of the Clinical and Economic Impact of Two MRNA COVID-19 Vaccines in High Risk Individuals in Japan M. Kohli, Y. Hagiwara, A. Igarashi, K. Joshi, A. Lee, M. Maschio, et al. (+2)
194 [GO] 2023―Dez―23 EE295 Willingness to Pay for COVID-19 Vaccines in Hungary Z. Beretzky, M. Thema, V. Brodszky
195 [GO] 2023―Dez―23 EE594 Comparison of the Clinical and Economic Impact of Two COVID-19 Vaccines in Immunocompromised Patients in France M. Uhart, A. Cheret, N. Van de Velde, A. Lee, M. Kohli
196 [GO] 2023―Dez―23 HPR201 Lessons from the COVID-19 Vaccines Taskforce E. Bell, J. Van-Tam, R. Todd, S. Carroll
197 [GO] 2023―Dez―23 EE516 Cost-Utility Analysis (CUA) in Chronic Lymphocytic Leukemia (CLL): Is COVID-19’s Impact on National Life Tables Important to Consider? L. Mohseninejad, S. Rivolo, A. Rudas, B. Peter, A. Prieto, N. Bahar, K. Yang
198 [GO] 2023―Dez―23 PCR63 Health-Related Quality of Life in COVID-19: A Vignette Study D. Ntais, V. Ntim, S. Barton, A. Porteous, A. Ng, J. Page, et al. (+2)
199 [GO] 2023―Dez―23 MSR54 COVID-19: Do All Patients Who Meet the EMA High-Risk Definition Receive Prescription? M. Aiyaz, M. Hollis, J. Godfrey, S. Kanal, Q. Khalid, E. Martyn, et al. (+3)
200 [GO] 2023―Dez―23 EPH53 Leave or Stay? Influencing Factors of Intention to Leave or Stay in Healthcare Profession After Coronavirus Pandemic Among Frontline Nurses P. Bogdán, M. Zrínyi, Z. Verzár, K. Haitham, K. Kozmann, I. Boncz, et al. (+2)
201 [GO] 2023―Dez―23 HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece M. Kalogeropoulou, M. Barmpouni, V. Grammelis, A. Rousakis, A. Livieratos, D. Paraskevis, O. Zisimopoulou
202 [GO] 2023―Dez―23 HTA249 The Use of Preprints in Health Technology Assessment during Sars-Cov-2 Pandemic E. García Carpintero, G. Loroño Ortiz, I. Imaz-Iglesia, B. Granadino Goenechea, M. Carmona, L.M. Sánchez-Gómez
203 [GO] 2023―Dez―23 EPH270 Impacts of Different SARS-CoV-2 Variants on Hospital Usage and Performance in the United Arab Emirates: A Comparison Among Alpha, Delta, and Omicron L.L. Dai-Woodys
204 [GO] 2023―Dez―23 EE149 Surge Capacity for Preserving Accessibility to Primary Healthcare Services during the COVID19 Pandemic in a Middle Income Country N. Singweratham, T. Phodha, O. Rochanathimoke, W. Techakehakij, A. Bunpean, S. Chotchoungchatchai, V. Vongmongkol
205 [GO] 2023―Dez―23 PCR9 Rise of Undiagnosed Major Depressive Disorder Post-COVID-19 Pandemic in Europe K. Annunziata, K. Krupsky, L. Lee
206 [GO] 2023―Dez―23 OP7 Coverage and Equity of a Patient Support Program for Diabetes During the Pandemic Period in a Middle-Income Country I. Rico, E. Carpio, A. Retana
207 [GO] 2023―Dez―23 HSD50 Infantile Vaccination Coverage in Brazil From 2016-2022 - Effects of Pandemic Period in Non-COVID-19 Vaccination G.S. Julian, H.W. Santos, O.C. Mellone, A. Polycarpo Ribeiro
208 [GO] 2023―Dez―23 MSR116 Unsupervised Clustering and Binary Classification Analysis for Predicting Long COVID Among Adults in EU4 and UK K. Finlayson, V. Li, R. Argoubi, M. Furegato
209 [GO] 2023―Dez―23 CO123 Long COVID Symptom Diary: Development of a PRO Instrument to Support Drug Development and Regulatory Submissions in Europe K. Rudell, J. Mueller, C. Nick
210 [GO] 2023―Dez―23 EPH11 Prevalence, Risk Factors, and Characterization of Individuals with Long COVID Using Electronic Health Records in Over 1.5 Million COVID Cases in England H.I. Wang, T. Doran, M. Crooks, K. Khunti, M. Heightman, A. gonzalez-Izquierdo, et al. (+3)
211 [GO] 2023―Dez―23 PCR91 Patients’ Needs in Assessing Long COVID: A Review of Relevant Concepts and Patient-Reported Outcomes N. Kraft, S. Carvalho, T. Brooks, A. West, R. Kinuthia, B. Capella, S. Bothorel
212 [GO] 2023―Dez―23 HSD32 Long COVID: Clinical Characteristics and Management in the Real-World Setting A. Althoff, L. Rasouliyan, V. Kumar, S. Chang, S. Long, A. Mummert
213 [GO] 2023―Dez―23 EPH68 What Are the Main Symptoms of Long COVID? Real World Medical Data Cross-Referenced with Social Network Content C. Paris, T. Marty, M. Dahoumane, C. Eteve-Pitsaer, M. Le Floch, A. Mebarki, et al. (+3)
214 [GO] 2023―Dez―02 Cost-effectiveness of oral nirmatrelvir/ritonavir in patients at high risk for progression to severe COVID-19 in the United States Josh Carlson, Volker Foos, Adam Kasle, Tendai Mugwagwa, Florin Draica, Timothy Lee Wiemken, et al. (+4)
215 [GO] 2023―Nov―01 A scoping review & taxonomy of epidemiological-macroeconomic models of COVID-19 Gabrielle Bonnet, Carl A.B. Pearson, Sergio Torres-Rueda, Francis Ruiz, Jo Lines, Mark Jit, et al. (+2)
216 [GO] 2023―Jun―10 OP17 Pilot Study Evaluating the Trends in Utilization of Compounded Products Pre- and Post- COVID-19 Pandemic D. Seo, T.J. Mattingly
217 [GO] 2023―Jun―10 OP16 The Importance of Clinical Research Organizations (CRO) in Clinical Research and Impact of COVID-19 Pandemic M. Dehlinger-Kremer, H. Lüning, Yaşaroğulları Ş, D. Rolando, L. Mahi
218 [GO] 2023―Jun―10 HSD111 Prescription Opioid Use Among Cancer Patients before and after the Onset of COVID-19: Evidence from Real-World Data B. Zhou, M. Pathak, R. Rasu, U. Sambamoorthi
219 [GO] 2023―Jun―10 HSD103 Impact of COVID-19 on Delivery of Cancer Care: Real-World Insights from Community Oncology Research Evaluations (CORE) R. Manimaran, S. Bhardwaj, I. Manigault, G. Wright, E. Vissers
220 [GO] 2023―Jun―10 EPH262 Preventing COVID-19 Outbreaks Using Wastewater Surveillance at Long-Term Care Facilities: A Pilot Modelling Study J. Wen, M.Y. Li, X.L. Pang, B.E. Lee, A. Ohinmaa
221 [GO] 2023―Jun―10 EPH257 Public Health Impact of UK COVID-19 Booster Vaccination during Omicron Predominance D. Mendes, R. Chapman, E. Aruffo, P. Gal, J.L. Nguyen, E. Hamson, et al. (+3)
222 [GO] 2023―Jun―10 EPH252 Contributions and Challenges of Pharmacists during a Public Health Crisis Such As COVID-19 A. Barseghyan, L. Nazaryan, M.H. Simonyan
223 [GO] 2023―Jun―10 EPH221 Persons Diagnosed with COVID-19 in the Clinical Practice Research Datalink (CPRD) Primary Care Dataset: A Cohort Description K. Andersen, M. Reimbaeva, L.J. McGrath, D. Mendes, T. Mugwagwa, J.L. Nguyen, et al. (+4)
224 [GO] 2023―Jun―10 EPH219 Digital Contact Tracing for COVID-19: Overview of Existing Systems and Framework for Future Innovation C. Mack, K. Rough, C. Tai, G. Farkas, E. Wasserman
225 [GO] 2023―Jun―10 EPH218 Cardiac Manifestations Including Heart Failure and Myocardial Infarction Post COVID-19 Recovery: A Systematic Review and Meta-Analysis M.K. Siddiqui, M. Siroula, S. Mathur, J. Gupta, K. Choudhry
226 [GO] 2023―Jun―10 EPH207 Factors Associated with COVID-19 Infections and Deaths in the Gulf Cooperation Council (GCC) Countries: A Time Series Cross-Section Analysis M. Alam, F. Alkhowar, M Al-mansoori, S Al-mohannadi
227 [GO] 2023―Jun―10 EPH208 Impacts of COVID-19 on Career Choices in Health Professionals and Medical Students L. Doan
228 [GO] 2023―Jun―10 EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis Y. Fu, J. Zhao, P. Han, L. Yang, T. Ren, S. Zhan, L. Li
229 [GO] 2023―Jun―10 CO181 Clinical Characteristics of Patients with Sars-Cov-2 Omicron Variant and COVID-19 Vaccination with Clinical Outcome Findings in Shanghai, China: A Single Center, Retrospective, Observational Study D. Yang, J. Li, H. Weng, X. Lu, W. Yang, J. Qiang, et al. (+3)
230 [GO] 2023―Jun―10 SA12 Use of Living Systematic Reviews (LSRS) Beyond COVID-19 V. Patel, P. Dabirvaziri, J. Tran, M.E Richard, S. Grieve, D. Thakur
231 [GO] 2023―Jun―10 RWD156 The Impact of the Sars-Cov-2 Pandemic (COVID-19) on the Incidence of Newly Diagnosed Multiple Myeloma Patients Using a Federated Network of Real-World Evidence in US and Germany S. Schilling, K. Strobel, L. Kellermann, S. Wischlen, S. Luciano, J. Stacey, et al. (+4)
232 [GO] 2023―Jun―10 RWD152 Real-World Evidence on the Use of Ecmo in Hospitalized COVID-19 Patients: Results from a Linked Closed and Open Claims Database in the US S. Kuranz, D. Neilson
233 [GO] 2023―Jun―10 RWD144 The Short Run and Long Run Behavioral Effects of COVID-19 Vaccination Enforcement I. Baser, N. Rodriguez, Y. Azmoudeh
234 [GO] 2023―Jun―10 RWD142 Prospective Monitoring of Patients with COVID-19 Vaccination for Outcomes of Hospitalization Using Electronic Medical Record Network K. Nikolli
235 [GO] 2023―Jun―10 RWD118 Long-Term Neurologic Sequelae Among Patients with Varying COVID-19 Severity: An Administrative Claims Database Analysis I. Dhangar, R. Ahlawat, P. Veeranki, A. Anderson, J.T McPheeters, K.P Singh
236 [GO] 2023―Jun―10 RWD82 To Study the Impact of Long COVID-19 in the US - A 9-Month Retrospective Study A. Roy, A. Gupta, A. Nayyar, S. Bhargava, V. Dawar, V. Verma, et al. (+4)
237 [GO] 2023―Jun―10 RWD81 Long-Term Metabolic Sequelae of COVID-19, By Severity Levels I. Dhangar, P. Veeranki, A. Anderson, J.T McPheeters, K.P Singh, R. Ahlawat
238 [GO] 2023―Jun―10 RWD70 Comprehensive Code List Associated with CDC-Defined High-Risk Underlying Medical Conditions Leading to Potential Progression to Severe COVID-19 Outcomes A. Scott, F. Draica, J. Atkinson, R. Chambers, M. Reimbaeva, R. Stanford, et al. (+2)
239 [GO] 2023―Jun―10 RWD46 Reclassification of COVID-19 Related ICD-10 Codes in Mexico: A Real-World Data Analysis of 1,937,360 Hospital Discharges from the Ministry of Health D. Rodriguez, M. Osorio, I.C. Garcia-Appendini, J. Larrosa
240 [GO] 2023―Jun―10 RWD26 Variation in Demographic Characteristics, Socioeconomic Status, Clinical Presentation and Selected Treatments in Mortality Among Patients with a Diagnosis of COVID-19 in the United States R. Wade, R. Doshi, D. Tian
241 [GO] 2023―Jun―10 PCR184 Impact of COVID-19 Symptoms on Patients' Health-Related Quality of Life V. Li, K. Finlayson, H. Costantino
242 [GO] 2023―Jun―10 PCR157 Sociopsychological Factors Related to Information Seeking during the COVID-19 Pandemic T. Park, J. Muzumdar
243 [GO] 2023―Jun―10 PCR144 Evaluation of the Association between Self-Perceptions of Aging and Care Deferrals Among US Adults Aged ≥50 Years during the COVID-19 Pandemic S. Korgaonkar, P. Prajapati, M. Barnard, S. Goswami
244 [GO] 2023―Jun―10 PCR99 Regular COVID-19 Booster Shot Preference and Willingness to Pay in the Vietnamese Population: A Theory-Driven Discrete Choice Experiment B. Tran, Le Vu M, L. Doan
245 [GO] 2023―Jun―10 PCR62 Post-Lockdown Behaviors and Impacts of Avoiding COVID-19 in Individuals and Caregivers of Individuals at High-Risk of Severe COVID-19: A Qualitative Study T. Maia, R. Yokota, S. Arnetorp, J. Spiler, G. Settergren, P. Williams
246 [GO] 2023―Jun―10 PCR12 Delayed Care Among Low-Income Adults during the COVID-19 Pandemic: A US Population-Based Study J. Han
247 [GO] 2023―Jun―10 MT27 Comparison of High-Flow Nasal Canula and Non-Invasive Mechanical Ventilation in Treating COVID-19 Patients Q. Gu, Y. Dai, A. Harvey
248 [GO] 2023―Jun―10 MT3 Delphi Panel on the Recommended Use of the Cue COVID-19 at Home Diagnostic Test D. Tsay, L. Pastor, S. Whitney, M. Bourque, N. Duggal
249 [GO] 2023―Jun―10 HSD99 Telemedicine and the Utilization of Outpatient Mental Health Services By Patients with Incident Major Depressive Disorder during the COVID-19 Pandemic S. Axeen, S. Jin, O. Lubarsky, B. Kenou, R. Chapman, R. Xie, S. Seabury
250 [GO] 2023―Jun―10 HSD97 Treatment Utilization and Key Characteristics of COVID-19 Patients Treated with Monoclonal Antibody Therapy in the Outpatient Setting F. Devine, A. Clary, J.H. Liu, Y.C. Wu, J. Park, A. Bhat
251 [GO] 2023―Jun―10 HSD73 Characteristics of Type 2 Diabetes Patients That Used Virtual Care Since COVID-19 Pandemic: Evidence from a Large Commercial Healthcare Claims Database in the US H. Ahn, V. Thao, B. Borah
252 [GO] 2023―Jun―10 HSD58 Impact of the COVID-19 Pandemic on Cervical Cancer Screening Rates in Colombia: An Interrupted Time Series Analysis, Stratified By Region R. Thomas, D. Guarin
253 [GO] 2023―Jun―10 HSD51 Differences in Disease Burden and Treatment Utilization By Socioeconomic Status Among a Large Cohort of Patients with COVID-19 Diagnosis in the United States R. Wade, D. Tian, R. Doshi
254 [GO] 2023―Jun―10 HSD25 Study of Pharmacists' Awareness Regarding Coronavirus Disease (COVID-19) in Ukraine O. Zaliska, O. Semenov, Z. Zabolotnya, N. Maksymovych
255 [GO] 2023―Jun―10 HSD16 Impact of Provider Nudges on Herpes Zoster Vaccine Series Completion during the COVID-19 Pandemic in the United States J. Gatwood, A. Brookhart, O. Kinney, T.M. Hagemann, C.Y. Chiu, S. Ramachandran, et al. (+2)
256 [GO] 2023―Jun―10 HSD18 Patient Experience of Using Telehealth Services during COVID-19 in Dubai Health Authority: A Retrospective Cross-Sectional Electronic Survey W. Alnakhi, N. Alzarouni
257 [GO] 2023―Jun―10 HSD9 Impact of Participation in Colorectal Cancer Screening during the COVID-19 Pandemic in Japan C. Hamashima, H. Sano
258 [GO] 2023―Jun―10 HPR89 Trends in Remote Patient Monitoring Among Medicare Beneficiaries during COVID-19: A Comparative Interrupted Time Series Analysis R. Mahashabde, A. Pandit, M. Acharya, M.M. Ali, C. Bogulski, H. Eswaran, C. Hayes
259 [GO] 2023―Jun―10 EPH205 A Global Analysis of COVID-19 Infection Fatality Rate and Its Associated Factors during the Delta and Omicron Variant Periods Nhi N Thi Hong
260 [GO] 2023―Jun―10 EPH203 Patients Characteristics, Vaccine Uptake, Healthcare Resource Utilization and Costs Associated with Acute COVID-19 during the Omicron Predominant Period in Brazil: A Nationwide Database Study J. Yang, G. Cordeiro, M. Longato, M.H. Kyaw, A. Dantas, T. Senna, et al. (+2)
261 [GO] 2023―Jun―10 EPH204 COVID-19 Vaccination during Pregnancy: A Structured Electronic Medical Record Data Study B. Levy, C.D. Mullins, S. Haider, A. Elfman, G. Poorman, G.R. Saade
262 [GO] 2023―Jun―10 EPH198 The Sustained Impact of COVID-19 on Opioid Dispensing in California J. Zheng, C. Rakovski, T. Varisco, H. Chen, M. Fleming, Y. Wang
263 [GO] 2023―Jun―10 EPH189 Assessment of Burden of COVID-19 Infection and the Dynamics in African Union Member States O. Mgbere, O.C. Nwabuko, O. Olateju, O. Adepoju, W. Liaw, C. Darkoh, E.J. Essien
264 [GO] 2023―Jun―10 EPH174 Trends in Postpartum Depression before and during the COVID-19 Pandemic and Correlates of Treatment Choices: A Population-Based Retrospective Cohort Study D. Do, T. Lee, U. Patel
265 [GO] 2023―Jun―10 EPH169 Persons Diagnosed with COVID-19 in Linked Clinical Practice Research Datalink (CPRD) - Hospital Episode Statistics (HES) Data: A Cohort Description K. Andersen, M. Reimbaeva, L.J. McGrath, D. Mendes, T. Mugwagwa, J.L. Nguyen, et al. (+4)
266 [GO] 2023―Jun―10 EPH166 The Effect of COVID-19 on Maternal and Neonatal Outcomes in a Large Tertiary Health System in Saudi Arabia A. Almutairi, N. Al-Fadel, M Al Ammari, N. Al Makhlafi, S. Al Mahmoud, M Al Shammari, et al. (+2)
267 [GO] 2023―Jun―10 EPH168 Regional Variation in Patient Characteristics and Treatment Patterns for over 17 Million COVID-19 Patients in the United States R. Doshi, D. Tian, R. Wade
268 [GO] 2023―Jun―10 EPH155 Relative Effectiveness of Vaccination and Non-Pharmaceutical Interventions on COVID-19 Infection and Deaths in the US A.P. Khatiwada, A.G. Gebremariam, M. Genie, T.C. Lai, N. Poudel, S. Ngorsuraches
269 [GO] 2023―Jun―10 EPH113 Healthcare Utilization Remains Elevated Among People Living with Post-COVID-19 Condition More Than One Year after Acute COVID-19 Illness M. Binka, B. Klaver, G. Cua, B. Sander, H. Sbihi, N.Z. Janjua
270 [GO] 2023―Jun―10 EPH99 Janssen COVID-19 Vaccine Safety in a Real-World Setting: A Pharmacovigilance Study A. Braga, Q.C. Morais, M. Da Costa, M. Santos
271 [GO] 2023―Jun―10 EPH98 Cutaneous Adverse Drug Reactions of COVID-19 Vaccines: A Cross-Sectional Study of the Largest Healthcare System in Taiwan S.L. Tan, Y.H. Chen, H.Y. Chen, S.C. Shao
272 [GO] 2023―Jun―10 EPH100 Evaluation of COVID-19 Vaccines in Primary Prevention Against Infections and Reduction in Severity of Illness Following the Outbreak of Sars-Cov-2 Omicron Variant in Shanghai D. Yang, H. Weng, Y. Song, J. Li, X. Lu, W. Yang, et al. (+4)
273 [GO] 2023―Jun―10 EPH97 Application of Self-Protective Behaviors in Balancing Objective and Subjective COVID-19 Risk Assessments Among Residents in an Urban Setting O. Mgbere, S. Iloanusi, I. Yunusa, N.J.R. Iloanusi, S. Gohil, E.J. Essien
274 [GO] 2023―Jun―10 EPH85 A Cross- Sectional Assessment of Impact of COVID-19 Vaccine on Menstrual Cycle of Pharmacy and Medical Students of Qassim University, Saudi Arabia K. Alrobaian, M. Farooqi, G. Alwanin, R. Alzain, S. Almutairi, M. Alsaeed
275 [GO] 2023―Jun―10 EPH65 The Analysis of Dynamic Processes of Virus Transmission: How Could Diagnostic Tests and Vaccinations Can Stop COVID-19 Pandemic? I. Kamae
276 [GO] 2023―Jun―10 EPH61 Uptake of the Post COVID-19 Condition ICD-10-CM Diagnosis Code By Social Factors A.D. Lee, C. Prener, A. Scott, T. Alfred, D. Oliveri, D. Malhotra, L.J. McGrath
277 [GO] 2023―Jun―10 EPH50 Impact of COVID-19 on the Change in Work Conditions and Career Choices in General Vietnamese Population L. Doan, VA Trong Dam, H.T. Nguyen, T.T. Nguyen
278 [GO] 2023―Jun―10 EPH47 Active Surveillance for Safety Monitoring of COVID-19 Vaccines in Saudi Arabia S. Alhabardi, L. Alhusayni, M. Aljebreen, A. Alzamil, M. AlSwead, M. Alrohaimi, F. Al-Harbi
279 [GO] 2023―Jun―10 EPH44 On the Frontline Against COVID-19: Provision of Community Pharmacy Services during a Public Health Crises L. Nazaryan, A. Barseghyan, M.H. Simonyan
280 [GO] 2023―Jun―10 EPH26 Barriers to in-Person Focus Group Participation during the Third-Year of COVID-19 Pandemic: A Case Study of Colorectal Cancer (CRC) Screening in Underrepresented Groups R. Rasu, L.A. Miller-Wilson, S. Kamt, A. White, S. Chhetri, R. Hittson-Smith, et al. (+2)
281 [GO] 2023―Jun―10 EPH9 Characterization of Demographics and Concomittant Symptoms in Patients with Post COVID-19 Conditions or Long COVID S. Srinivasan, J. Morgan
282 [GO] 2023―Jun―10 EE335 A Multicenter Microcosting Study for COVID-19 in Brazil R. Bertoglio Cardoso, M. Marcolino, M.S. Marcolino, L. Moreira, F. Anschau, L. Kopittke, et al. (+5)
283 [GO] 2023―Jun―10 EE333 Assessment of Medically-Attended COVID-19 Patient Risk Profiles and Health Care Resource Utilization (HCRU) and Costs in the U.S. M. Chacon-Araya, J. Tkacz, M. Zagari, T. Bello, B. Lewing, S. Brusky
284 [GO] 2023―Jun―10 EE329 The Value-Based Price for a Bivalent COVID-19 Booster Vaccine in the United Kingdom M. Kohli, M. Maschio, A. Lee, S. Carroll, N. Van de Velde, M. Drummond
285 [GO] 2023―Jun―10 EE326 Malnutrition Prevalence and Economic Burden Among US Hospitalized Older Adult Patients with and without COVID-19 T. Zhang, S. Sulo, S. Drawert
286 [GO] 2023―Jun―10 EE319 Healthcare Resource Utilization and Direct Medical Costs Associated with Post COVID-19 Condition in Colombia, 2020-2021 F. Salcedo Mejía, N.J. Alvis Zakzuk, A. Lozano, L. Moyano, N.R. Alvis Zakzuk, J.C. Fernandez Mercado, et al. (+4)
287 [GO] 2023―Jun―10 EE299 Cost Analysis of High-Flow Oxygen Therapy Compared with Conventional Oxygen Therapy in Severe COVID-19 in Colombia: Data from a Randomized Clinical Trial S. Prada, M.P. Garcia-Garcia, G.A. Ospina-Tascón, D. Rosselli
288 [GO] 2023―Jun―10 EE240 Beyond Symptoms Alleviation: Population-Level Benefits of COVID-19 Oral Direct-Acting Antiviral (DAA) Treatment and Resulting Decreases in Infectivity and Transmission M. Chacon-Araya, J.D. Ortendahl, J. Lee, M. Broder, S. Brusky
289 [GO] 2023―Jun―10 EE229 The Effect of COVID-19 on Care for Chronic Wounds Among Medicare Beneficiaries Using Medicare Claims - 2019, 2020, and 2021 M. Carter, J. DaVanzo, R. Haught, M. Nusgart, D. Cartwright, C. Fife
290 [GO] 2023―Jun―10 EE213 Long COVID-19 Associated with 5-Fold Increase in Total Medical Costs and Greater Use of Inpatient and Outpatient Services Compared to Non-Long COVID-19: An Analysis of Real-World Data M. Chacon-Araya, J. Tkacz, M. Zagari, T. Bello, B. Lewing, S. Brusky
291 [GO] 2023―Jun―10 EE122 The Economic Impact of a Psychosocial Utility Benefit Associated with Pre-Exposure Prophylaxis (PrEP) for COVID-19, in Immunocompromised (IC) Individuals - a Case Study for Future PrEP Evaluations T. Henry, M. Fisher, T. Holland, M. Watt, S. Arnetorp, A. Jańska, D. Squirrell
292 [GO] 2023―Jun―10 EE123 Cost Evaluation of COVID-19 Remote Home Monitoring Services' Patients in England during Wave 2 from October 2020-April 2021 S. Tomini
293 [GO] 2023―Jun―10 EE98 Health Economic Evaluation of COVID-19 Vaccines: A Systematic Literature Review Y. Li, I. Guerra, K. Rtveladze, J. Leite, M. Vandoulakis, L. Eggendorfer, M. D'Alessandro
294 [GO] 2023―Jun―10 EE21 COVID-19 Premature Mortality Productivity Losses: Real World Information Analysis E. Tanaka, G.K. Tanaka, R. Kuabara, E.M. Massuda, L. Assunção-Costa, C. Tafla, et al. (+2)
295 [GO] 2023―Jun―10 CO149 Prevalence of Chain-of-Event and Contributing Conditions Among Treated COVID-19 Patients in the United States: Identifying Risk Factors Associated with Deaths R. Doshi, D. Tian, R. Wade
296 [GO] 2023―Jun―10 CO142 Evaluating the Impact of the COVID-19 Pandemic on Acute Ischemic Stroke Outcomes in the Stroke Belt E. Stitzlein, F. Pathan, I. Weimer, K. Lodaya, F. D'Souza, A. Shenoy
297 [GO] 2023―Jun―10 CO134 The Future of COVID-19: What Is Next in the Drug Pipeline A. Carey
298 [GO] 2023―Jun―10 CO130 Dyspnea and Health-Related Quality of Life in Patients with Persistent Symptoms after at Least Six Months of Hospital Discharge Due to COVID-19 A. Lozano, F. Salcedo Mejía, N.R. Alvis Zakzuk, L. Moyano, M. Jerez Arias, J. Paz Wilches, et al. (+4)
299 [GO] 2023―Jun―10 CO103 Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the National COVID Cohort Collaborative (N3C) C. Bell, P. Bobbili, R. Desai, D. Gibbons, V. Patel, M. DerSarkissian, et al. (+5)
300 [GO] 2023―Jun―10 CO56 Real-World Effectiveness of Early Treatments for COVID-19: Evidence from Administrative Claims Data C. Bell, T. Lokhandwala, D. Gibbons, V. Patel, M. Drysdale, J. Wang, E. Lloyd
301 [GO] 2023―Jun―10 CO14 Disparities in COVID-19 Related Outcomes in the United States By Race and Ethnicity: An Umbrella Review of Meta-Analyses K. Duong, L. Le, S.K. Veettil, P. Saidoung, W. Wannaadisai, R.E. Nelson, et al. (+7)
302 [GO] 2023―Jun―10 P55 Budget Impact Analysis of COVID-19 Vaccines on U.S. Medicare and Commercial Health Plans after Depletion of the Federally-Purchased Supply H. Vu, K. Nguyen, J. Hendricks
303 [GO] 2023―Jun―10 P11 Depression Severity Among Patients with Psychiatric Disorders during the COVID-19 Pandemic E. Yung, J. Yin, J. Park, U. Periyanayagam
304 [GO] 2023―Jun―10 P10 The Public's COVID-19 Fatigue and Mental Health Towards COVID-19 Public Health and Social Measures (PHSMS) and Mental Health in China: A Discrete Choice Experiment T. Liu, Z. He, W.K. Ming
305 [GO] 2023―Jun―10 EPH66 Epidemiological Population Study of Sars-Cov-2 in Lake County, Illinois: Contact: Health-Related Quality of Life Assessment O. Sanchez-Solino, R.D. Kilpatrick, C. Johnson, Y. Fang, K. Zarish, Y. Ye, et al. (+2)
306 [GO] 2023―Jun―10 CO105 The Association of Sars-Cov-2 Infection and Tuberculosis Disease with Unfavorable Treatment Outcomes: A Systematic Review N. Vadlamudi, C.A. Basham, J.C. Johnston, F.A. Khan, G.B. Migliori, R. Centis, et al. (+5)
307 [GO] 2023―Jun―10 CO93 A Qualitative Investigation of the Impact of the Sars-Cov-2 Pandemic on Goal Attainment Scaling in a Clinical Research Setting S. Nesto, J. Stanley, S.E. Howlett, C.A. Chapman
308 [GO] 2023―Jun―10 HPR47 Access to Prenatal Care and Poverty in Colombian Regions: Before and in the Pandemic N. Alvis-Guzman, F. De La Hoz
309 [GO] 2023―Jun―10 EE14 Cost-Effectiveness of Non-Pharmaceutical Interventions (NPI), Vaccines and the Combination of NPI and Vaccines in Managing the COVID Pandemic J. Lou, C.G.X. Cai, H. Clapham, Y. Teerawattananon, H.L. Wee
310 [GO] 2023―Jun―10 EPH62 Annual Burden of Non-COVID-19 Respiratory Tract Infections in the Pre- to Post- Pandemic Eras: Analysis from the Anlitiks’ All Payor Claims Database K. Rajagopalan, A. Grossman, E. Zwick
311 [GO] 2023―Jun―10 EPH109 Excess Mortality from Diabetes Mellitus in the First Year of the Pandemic in Colombia N. Alvis-Guzman, N.J. Alvis Zakzuk, F. De La Hoz
312 [GO] 2023―Jun―10 HSD10 Efficiency of the Cervical Cancer Program on the Budget Execution Processes during COVID 19 Pandemic Years 2020 - 2021 in Peru FM Perez Garcia, A. Gutierrez-Aguado, D. Guarin
313 [GO] 2023―Jun―10 EPH49 Did Gender Healthcare Disparity Against Women Exist in Chile during the First Two Years of the Pandemic? S. Arenillas, A. Rada, S. Avila, C. Valdes
314 [GO] 2023―Jun―10 EPH170 Diagnoses of Long COVID in the United States: Analysis of a Large Claims Database B. Buysse, C. Coombs, J. Albano
315 [GO] 2023―Jun―10 P12 Unsupervised Clustering and Binary Classification Analysis for Predicting COVID Syndrome (LONG COVID) in US Adults K. Finlayson, V. Li
316 [GO] 2023―Jun―10 EPH192 Association of Long COVID with Seeing Difficulties Among Adults in the United States M. Pathak, S. Mitra, C. Shen, H. Wang, P. Findley, R.C. Wiener, U. Sambamoorthi
317 [GO] 2023―Jun―10 PCR61 Persistent Work Limitations in Long COVID: A Cross-Sectional Analysis of Employed US Respondents to the 2022 National Health and Wellness Survey A. Martin, K. Thomson, A. LePrade, J. Bertolli, S.D. Grosse
318 [GO] 2023―Jun―10 MSR37 Identifying Clinical Subtypes of Long COVID: An Unsupervised Machine Learning Approach M. Munsell, M. Friedman, J. Menzin
319 [GO] 2023―Jun―10 P9 Characteristics of Patients Diagnosed with Long COVID: Early Findings from Real-World Data M. Munsell, M. Friedman, J. Menzin
320 [GO] 2022―Dez―14 EPH69 Health Inequity in Viral Infections in a Medicaid Population: Lessons From Influenza and COVID-19 B Brady, LA Palmer
321 [GO] 2022―Dez―14 HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19 S Warttig, C Ling
322 [GO] 2022―Dez―14 EPH104 Valuing the Impact of Incorporating an Acellular Hexavalent Vaccine in the National Vaccination Scheme of Peru in the Context of COVID-19 J Seinfeld, A Sobrevilla, ML Rosales, M Ibañez, C Munayco, S Londono
323 [GO] 2022―Dez―14 HTA257 MOVe-OUT: A Trial of Two Halves - The Impact of Heterogeneity on Cost-Effectiveness Outcomes for COVID-19 D McConnell, L Mccullagh, C Usher, C Walsh, M Barry, R Adams
324 [GO] 2022―Dez―14 PCR46 Assessing the Mental Health of Secondary School Students in the Light of COVID-19 R Vajda, E Karamán, T Csákvári, K Fusz, H Khatatbeh, E Miszory, et al. (+2)
325 [GO] 2022―Dez―14 RWD68 Characteristics/Comorbidities of Vaccinated and Unvaccinated Patients With COVID-19 A Roy, R Markan, S Kumar, V Verma, I Kukreja, A Gaur, et al. (+6)
326 [GO] 2022―Dez―14 PCR168 The Changing Face of Qualitative Interviewing in Clinical Outcome Assessments Research: Conducting Qualitative Interviews Post COVID-19 J Randall, S Keith, J Clegg
327 [GO] 2022―Dez―14 CO50 Efficacy and Safety of Itolizumab for the Treatment of Coronavirus Disease (COVID-19): A Systematic Literature Review NS Gurram, RB Vagicharla, G Rayapureddy, P Kummari, K Pulleddula, J Mir, et al. (+6)
328 [GO] 2022―Dez―14 CO178 Cardiovascular, Neurological, and Ocular Complications of COVID-19 Among Indian Patients - A Targeted Literature Review A Krishna, A Vhanakalas, MK Rai, R Gautam
329 [GO] 2022―Dez―14 HSD18 Access to Healthcare Services During COVID-19 Restrictions in Kazakhstan: A Nationwide Survey on COVID-19 and Lifestyle Changes B Iskakova, B Zhussupov, A Izekenova, A Izekenova, A Myrkassymova, A Bukharbayeva, et al. (+4)
330 [GO] 2022―Dez―14 EE110 Psychological Impact of COVID-19 and the Economic Burden of Rheumatic and Musculoskeletal Diseases V Lorenzoni, I Palla, G Andreozzi, G Fulvio, C Tani, F Trentin, et al. (+4)
331 [GO] 2022―Dez―14 HPR63 Estimates of the Global Burden of COVID-19 and the Value of Broad and Equitable Access to COVID-19 Vaccines E Bell, S Brassel, H Schirrmacher, E Oliver, S Arnetorp, K Berg, et al. (+6)
332 [GO] 2022―Dez―14 HTA161 A Systematic Review of the Safety of COVID-19 Anti-Interleukin Therapy J Gomon, A Kolbin, FM Sultanova, Y Balykina
333 [GO] 2022―Dez―14 MSR32 COVID-19 Beds’ Occupancy and Hospital Complaints: A Predictive Model E Foglia, LB Ferrario, D Bellavia, F Schettini, E Falletti, C Gallese, et al. (+2)
334 [GO] 2022―Dez―14 EPH124 Prediction Model to Evaluate the Impact of a Next Generation Bivalent Omicron-Containing COVID-19 Booster (MRNA.1273.214) on Hospitalizations in Adults in Germany A Müller, B Ultsch, A Nasir, T Certejan, P Buck, A Ben, et al. (+3)
335 [GO] 2022―Dez―14 EE540 Cost-Effectiveness of Vaccines Targeting Infectious Diseases - Has COVID-19 Changed the Landscape? R Pitman, P Khurana
336 [GO] 2022―Dez―14 RWD111 Influenza Vaccine Sales During the COVID-19 Era A Ngami, T Christie, F Guelfucci, F Bianic, P Net
337 [GO] 2022―Dez―14 SA43 Rapid Evidence Publication in the COVID-19 Era: Impact on Study Quality and Study Identification C Wright, K Misso, R Green, Z Marjenberg
338 [GO] 2022―Dez―14 HPR43 Differences in Inequalities of Uterine Cancer Treatment Before and After COVID-19 in England H Brewer, CT Rice, C Winton, S Jarvis, M Hamlyn, J Davidson
339 [GO] 2022―Dez―14 EPH4 Burden and Characteristics of COVID-19 in France During 2020 Based on National Hospital Database C Leboucher, C Blein, V Machuron, K Le Lay, K Benyounes, A Millier, F Raffi
340 [GO] 2022―Dez―14 EPH64 Public Health Impact of COVID-19 in French Ambulatory Patients With at Least One Risk Factor for Severe Disease R Supiot, A Millier, K Benyounes, V Machuron, K Le Lay, M Sivignon, et al. (+3)
341 [GO] 2022―Dez―14 EE527 Cost-Effectiveness and Budget Impact Analysis of Remdesivir for the Treatment of COVID-19 in Greece K Athanasakis, N Nomikos, C Tsoulas, K Zisis
342 [GO] 2022―Dez―14 HTA17 Cost-Effectiveness Analysis of Tocilizumab for The Treatment of COVID-19 in Hospitalised Patients on Corticosteroids, From the Italian NHS Perspective N Jovanoski, A Dario
343 [GO] 2022―Dez―14 EPH7 A Survey of the Occurrence and Transmission of COVID-19 in Outdoor Education Settings in Canada S Szabo, S Walker, T Edgar, J Kretnzel, K Johnston, B Stone
344 [GO] 2022―Dez―14 EE465 Cost-Effectiveness of Sotrovimab for the Treatment of Mild-to-Moderate COVID-19 in Patients at High Risk of Disease Progression in Italy F Piccolo, J Tosh, S De Boisvilliers, S Patel, V Patel
345 [GO] 2022―Dez―14 EE572 Cost-Effectiveness of AZD7442 (Tixagevimab and Cilgavimab) for Pre-exposure Prophylaxis Against COVID-19 in the Immunocompromised Population K Sutton, P Miller, N Branscombe, M Mittal, C Browne, S Arnetorp, et al. (+5)
346 [GO] 2022―Dez―14 RWD129 A Comparison of ICU Admission Rate and Related Cost Among Patients Taking Nirmatrelvir and Ritonavir Combination Versus Molnupiravir for Treatment of Mild to Moderate COVID-19 in the US I Kukreja, A Gaur, N Upadhyay, S Bhalani, A Gupta, V Verma, et al. (+6)
347 [GO] 2022―Dez―14 CO43 The Role of Different Biomarkers in the Prognosis of COVID-19 Infection B Horváthné Galántai, Z Ujszászi, S Tímea, K Takács, I Boncz, B Varga, et al. (+2)
348 [GO] 2022―Dez―14 RWD98 Variation in COVID-19 Length of Stay Due to Social Factors in the US - Estimation Using Integration of CDC/ATSDR's Social Vulnerability Index (SVI) and Healthcare Claims Data A Nayyar, U Raj, M Rastogi, S Daral, V Verma, A Gaur, et al. (+6)
349 [GO] 2022―Dez―14 P67 Cumulative Effect of Depression on Health Worsening During The COVID-19 Lockdown Among Diabetic Patients in Europe T Laurent, L Bonnal, P Favard
350 [GO] 2022―Dez―14 PCR257 Humanistic Burden Pre and Post COVID-19 on Caregivers of Cancer Patients in Japan and China: A NHWS Survey WH Tan, A Grillo, Y Chen, A Woo
351 [GO] 2022―Dez―14 RWD57 Epidemiological Study of the Burden of COVID-19 on Depression in Men (DIM) in Pre- and During COVID-19 Pandemic Using Real-World Data A Sharma, V Verma, S Pandey, A Nayyar, S Daral, I Kukreja, et al. (+6)
352 [GO] 2022―Dez―14 RWD60 Exploring the Burden of COVID-19 on Eating Disorders Spectrum (Types of Eating Disorders) in Pre- and During-COVID-19 Pandemic Using Real-World Data V Verma, N Verma, A Gaur, K Paul, A Chopra, S Daral, et al. (+7)
353 [GO] 2022―Dez―14 HSD93 Investigating the Impact of COVID-19 on Haemodialysis CT Rice, GA Unal, S João Carvalho, J Davidson
354 [GO] 2022―Dez―14 P65 Impact of COVID-19 on Hospital Screening, Diagnosis and Treatment Activities Among Prostate and Colorectal Cancer Patients in Canada FSH Lee, M Halat, N Bleibdrey, S Zhang, R Chalmers, D Zimskind
355 [GO] 2022―Dez―14 PCR150 Physicians’ Perceptions of the Impact of COVID-19 on Patient Access and Adherence J Cook, S Donde, K Gilchrist, M Pittaoulis, M Sapia
356 [GO] 2022―Dez―14 RWD128 Exploring the Burden of COVID-19 on Post-Traumatic Stress Disorder (PTSD) in Pre- and During-COVID-19 Pandemic Using Real-World Data I Kukreja, A Sharma, V Verma, A Nayyar, S Daral, A Gaur, et al. (+7)
357 [GO] 2022―Dez―14 RWD95 Exploring the Burden of COVID-19 on Suicides and Suicidal Attempts (SSA) in Pre- and During-COVID-19 Pandemic Using Real-World Data A Gaur, K Paul, A Sharma, V Verma, A Chopra, A Roy, et al. (+4)
358 [GO] 2022―Dez―14 EPH91 Association Between Mental Disorders and COVID-19 Outcomes in Hospitalized Patients in France: A Retrospective Nationwide Population-Based Study A Descamps, J Frenkiel, K Zarca, C Laïdi, O Godin, O Launay, et al. (+2)
359 [GO] 2022―Dez―14 PCR221 Health-Related Quality of Life Among Working Nurses in Hong Kong: The Role of Resilience Under the COVID-19 Pandemic E Wong, AWL Cheung, AYK Wong, JCH Ma, TKS Sun, CHK Yam, et al. (+3)
360 [GO] 2022―Dez―14 HSD99 Analysis of the Balanced Scorecard's Customer Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
361 [GO] 2022―Dez―14 HSD76 Analysis of the Balanced Scorecard's External Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
362 [GO] 2022―Dez―14 HSD53 Analysis of the Balanced Scorecard's Internal Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
363 [GO] 2022―Dez―14 HSD30 Analysis of the Balanced Scorecard's Financial Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
364 [GO] 2022―Dez―14 HSD31 Analysis of the Balanced Scorecard's Managerial Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
365 [GO] 2022―Dez―14 HSD7 Analysis of the Balanced Scorecard's Knowledge and Growth Subdimensions in Health Care Organizations During the COVID-19 Pandemic F Amer, S Hammoud, H Khatatbeh, S Lohner, I Boncz, D Endrei
366 [GO] 2022―Dez―14 EPH180 Acute Coronary Heart Syndrom (ACS): Hospitalizations in Germany Before and During COVID-19 Pandemic S Wahler, A Ben, A Müller
367 [GO] 2022―Dez―14 EPH171 Delivery Outcomes in the United States Among Women With Commercial or Medicaid Insurance During the COVID-19 Pandemic B Brady, E Packnett, LA Palmer
368 [GO] 2022―Dez―14 EPH67 Sleep Disorders, Depression, Anxiety, and Stress During the COVID-19 Pandemic L Kovács, I Boncz, T Csákvári, Z Kívés
369 [GO] 2022―Dez―14 EPH66 Underground Economy - A Parameter of Social Influence During the COVID-19 Pandemic I Yfantopoulos, A Efstathiou, G Stefanakos, I Kehris, P Efstathiou, F Zora
370 [GO] 2022―Dez―14 EE610 Economic Investment for Saving a Year of Life Following the Israeli Government's Actions in the First Year of the COVID-19 Pandemic N Khoury Nakhoul, S Brammli-Greenberg
371 [GO] 2022―Dez―14 EE267 Evolution of Country Gross Domestic Product Following the COVID-19 Pandemic A Ngami, P Net
372 [GO] 2022―Dez―14 CO153 Mind-Body Modalities for Healthcare Workers in the COVID-19 Pandemic CY Kwon, B Lee
373 [GO] 2022―Dez―14 SA14 Clinical Evidence on Corticosteroid Treatment Reported in the First Year of the COVID-19 Pandemic - Comparison of Clinical Trial Publications and Treatment Recommendation S Wüstner, S Hogger, D Gartner-Freyer, A Friederich, K Schley, F Leverkus
374 [GO] 2022―Dez―14 HPR205 Future-Proofing European Regulatory and Market Access Practices Based on Learnings From the COVID-19 Pandemic - Stakeholder Perspectives Z Claessens, G Beirne, C Decouttere, N Vandaele, I Huys, L Barbier
375 [GO] 2022―Dez―14 EPH157 Physical Activity Level in Association with Mental Health Before and During the Restrictions of the First Three Waves of COVID-19 Pandemic Among Hungarian Adults P Ács, I Boncz, B Molics, V Prémusz, D Paár, K Morvay-Sey, et al. (+3)
376 [GO] 2022―Dez―14 HTA250 Health Technology Assessment Policy and Guideline Changes in the EU-5 During the COVID-19 Pandemic Era: An Insight Into Trends and Drivers S Ghosh, M Chatterjee
377 [GO] 2022―Dez―14 HPR118 An Updated Estimate of the Direct Cost of the COVID-19 Pandemic for the Greek Healthcare System K Athanasakis, N Nomikos, I Kyriopoulos, K Souliotis
378 [GO] 2022―Dez―14 EE197 Efficacy and Economic Impact of Metformin Plus Glibenclamide Treatment During the COVID-19 Pandemic in Ecuadorian Outpatients With Type II Diabetes Mellitus R Zambrano, M Cabezas, G Loor, N Aguirre, C Miño
379 [GO] 2022―Dez―14 HSD49 Improving Influenza Vaccination Rates: Evaluation of Pharmacy Vaccination Model Project During COVID-19 Pandemic in Germany U May, C Bauer, C Giulini-Limbach, TK Pham, A Schneider-Ziebe
380 [GO] 2022―Dez―14 SA54 Physical and Mental Health Among Frontline Healthcare Workers During COVID-19 Pandemic in Hungary K Kósa, I Boncz, B Molics, P Tardi
381 [GO] 2022―Dez―14 HTA65 Socio-Economic Determinants of Health Status During COVID-19 Pandemic in Hungary FF Xu, V Brodszky
382 [GO] 2022―Dez―14 HPR37 Comparing Reimbursement of New Drugs During the COVID-19 Pandemic in Ireland and Scotland D McLoughlin, B Dooley, C Copeland
383 [GO] 2022―Dez―14 PCR23 Humanistic Burden and Mental Conditions Among Cancer Patients Before and During the COVID-19 Pandemic in Japan and China WH Tan, Y Chen, M Gao, A Woo
384 [GO] 2022―Dez―14 RWD142 General Vaccine Dispensing Patterns During the First Year of the COVID-19 Pandemic in South Africa I Truter
385 [GO] 2022―Dez―14 RWD130 The Effect of the COVID-19 Pandemic in the Prevalence of Diabetes Mellitus Type 1 and 2 in Children and Young Adults in Greece: Real World Data from Greece L Daflla, K-A Poulia, J Doupis, N Kotsopoulos, I Yfantopoulos
386 [GO] 2022―Dez―14 EPH5 Impact of the COVID-19 Pandemic on Cervical and Breast Cancer Screening B Brady, LA Palmer
387 [GO] 2022―Dez―14 SA13 The Impact of the COVID-19 Pandemic on Collaboration and Innovation in Antiviral Drug Development: A Multi-Stakeholder Systems Dynamics Analysis G Beirne, C Decouttere, N Vandaele, C Van Riet, L Boey, Z Claessens, et al. (+2)
388 [GO] 2022―Dez―14 RWD139 Impact of the COVID-19 Pandemic on Diagnosis and Cancer-Related Medical Procedures in Brazil JP Reis Neto, J Busch, S Stefani
389 [GO] 2022―Dez―14 PCR131 Resilience, and Positive Parenting in Parents of Children With Autism and Intellectual Disability: Evidence From the Impacts of the COVID-19 Pandemic on Family's Quality of Life and Parent-Child Relationships C Bolbocean, K Rhidenour, M McCormack, B Suter, J Holder
390 [GO] 2022―Dez―14 EPH203 Estimating the Impact of COVID-19 Pandemic on Gynaecology Treatment in England R Sloan, E Morris, R Walworth, R King, A Marsland, BD Bray, J Pearson-Stuttard
391 [GO] 2022―Dez―14 SA62 Impact of the COVID-19 Pandemic on Health Care Resource Utilisation and Costs in Asthma in England: A Population-Based Study KJ Rothnie, T Tritton, X Han, T Holbrook, B Numbere, AF Ford, et al. (+8)
392 [GO] 2022―Dez―14 SA8 Impact of the COVID-19 Pandemic on Health Care Resource Utilisation and Costs in COPD in England: A Population-Based Study AS Ismaila, T Tritton, X Han, T Holbrook, B Numbere, AF Ford, et al. (+8)
393 [GO] 2022―Dez―14 HTA253 Payer Perspectives on the Impact of the COVID-19 Pandemic on Health Technology Assessments (HTA) in Europe R Hutcheson, M Agrawal, S Singh, R Vishwakarma, A Chaupin
394 [GO] 2022―Dez―14 CO88 The Impact of COVID-19 Pandemic on Health-Related Quality of Life Outcomes: Evidence From a Longitudinal Study on Children With Rare Disorders C Bolbocean, J Holder
395 [GO] 2022―Dez―14 EPH114 Impact of the COVID-19 Pandemic on HPV Vaccinations in Switzerland and Greece: Road to Recovery I Gountas, A Favre-Bulle, K Saxena, A Skroumpelos, U Sabale
396 [GO] 2022―Dez―14 EPH109 Impact of COVID-19 Pandemic on HPV Vaccine Initiation Rates in Adolescent Girls: Projected Time to Reverse Dose Deficits in France C Mamane, G Farge, L Bensimon, E Morais, K Saxena
397 [GO] 2022―Dez―14 EPH24 The Impact of COVID-19 Pandemic on Paediatric Vaccination Coverage Rates H Collings, A Karakusevic, R Newman
398 [GO] 2022―Dez―14 RWD82 Influence of the COVID-19 Pandemic on Patients Receiving Oral Anticoagulants for the Treatment of Non-Valvular Atrial Fibrillation J Comin-Colet, A Sicras-Mainar, I Pérez Román, J Salazar, MI del Campo Alonso, A Echeto, et al. (+2)
399 [GO] 2022―Dez―14 RWD164 The Impact of the COVID-19 Pandemic on Patients With Type 2 Diabetes in Greece: Results From a Real-World Study L- Daflla, K-A Poulia, J Doupis, N Kotsopoulos, I Yfantopoulos
400 [GO] 2022―Dez―14 HPR108 Impact of COVID-19 Pandemic on the Decision Process of the Italian Medicine Agency: A Quantitative Assessment F Fiorentino, B Canali, L Candelora, T Halmos, P La Malfa, F Massara, et al. (+2)
401 [GO] 2022―Dez―14 EPH144 The Impact of COVID-19 Pandemic on the Detection and Management of Cancer: A German Claims Data Analysis A Mevius, S Müller, T Wilke, U Maywald
402 [GO] 2022―Dez―14 EE391 Impact of the COVID-19 Pandemic on the Healthcare Resource Use of People With Newly Diagnosed Mood/Affective Disorder S Junker, R Knapp, P Hahn, U Maywald, F Hardtstock
403 [GO] 2022―Dez―14 EPH178 Impact Assessment of the COVID-19 Pandemic on Varicella Incidence Across Europe Using Digital Epidemiology Methods U Sabale, L Jarmale, J Murtagh, G Bencina
404 [GO] 2022―Dez―14 EPH14 Prevalence of Depression in Japan and the US Populations Before and During the COVID-19 Pandemic: A Retrospective Observational Study Using Real-World Data S Demiya, S Takeno, SW Kim, WS Lee, Y Sakai
405 [GO] 2022―Dez―14 EPH121 Future Trends of the COVID-19 Pandemics: What Should We Expect? H Leleu, M Blachier
406 [GO] 2022―Dez―14 RWD34 Comparison of ICU/Ventilator Usage Among Vaccinated and Unvaccinated COVID-19 Patients A Roy, A Gupta, M Rastogi, V Verma, I Kukreja, A Gaur, et al. (+7)
407 [GO] 2022―Dez―14 EE468 Healthcare Resource Utilisation and Costs Associated With the Management of Hospitalised COVID-19 Patients in England V Patel, S Beecroft, HJ Birch, D Gibbons, G Hall, D Heaton, et al. (+4)
408 [GO] 2022―Dez―14 EPH35 Post-COVID Conditions in Hospitalized COVID-19 Patients in Germany S Pacis, U Maywald, T Wilke, M Ghiani
409 [GO] 2022―Dez―14 EPH117 Coinfections in COVID-19 Patients in India: A Systematic Review K Khambholja, D Patel, V Chhaya, S Sekhar
410 [GO] 2022―Dez―14 PCR256 Humanistic Burden and Prevalence of Mental Conditions Among COVID-19 Patients in Japan and China WH Tan, Y Chen, HC Lin, V Grillo, A Woo
411 [GO] 2022―Dez―14 RWD101 Impact of COVID-19 Vaccination in Reducing Standard Hospitalization Cost Among COVID-19 Patients in the US - A Retrospective Study A Roy, A Gupta, M Rastogi, A Sharma, V Verma, I Kukreja, et al. (+7)
412 [GO] 2022―Dez―14 EE419 Economic Evaluation of Extracorporeal Membrane Oxygenation (ECMO) vs Invasive Ventilation for COVID-19 Patients with Severe Acute Respiratory Distress Syndrome (ARDS) K R.M., G Gopalan, K Kachroo, N Pudi, J Sharma
413 [GO] 2022―Dez―14 EE383 The Economic Burden of COVID-19 Prevention and Cases Management in Egypt from Governmental Perspective I Anan
414 [GO] 2022―Dez―14 P3 How Much Did the COVID-19 Shielding Policy Cost in Wales? Results of a Cost Analysis Within the EVITE Immunity Evaluation B. Sewell, A. Farr, A. Akbari, J. Morgan, V. Williams, A. Carson-Stevens, et al. (+6)
415 [GO] 2022―Dez―14 MT15 Obvio-19 App Ease of Use of Cancer Patients for Reporting COVID-19 Symptomology (ONCOVID Study) M Heidman, M Culbreth-Notaro, S Dallabrida, E Raymond, C Bartels
416 [GO] 2022―Dez―14 EPH99 Determinants of COVID-19 Vaccination in Hungary, Results of a Large Cross-Sectional Online Survey Z Beretzky, FF Xu, V Brodszky
417 [GO] 2022―Dez―14 EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States K Paret, H Beyhaghi, W Herring, M Rousculp, S Toback, J Mauskopf
418 [GO] 2022―Dez―14 EE632 Winning the COVID-19 Vaccine Race: How to Launch a Premium Priced COVID-19 Vaccine in a Competitive and Saturated Cost-Effectiveness Market R Folorunso, H Vyas, L Perez, M O'Brien
419 [GO] 2022―Dez―14 EPH53 The Role of Incentives- Parents’ Intention to Vaccinate Their 5- to 11-Year-Old Children with the COVID-19 Vaccine in Israel L Shmueli
420 [GO] 2022―Dez―14 RWD33 Analysis of COVID-19 Vaccine-Related Adverse Events in Adults, Geriatrics and Pediatrics - A Retrospective Study A Roy, H Khandelwal, A Gupta, M Rastogi, V Verma, S Pandey, et al. (+7)
421 [GO] 2022―Dez―14 P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 J. Mar, O. Ibarrondo, I. Larrañaga, M. Aguiar, N. Stollenverk, J. Bidaurrazaga, et al. (+2)
422 [GO] 2022―Dez―14 RWD67 Association of COVID-19 With Venous Thrombosis and Arterial Thrombosis S Pandey, R Markan, S Kumar, A Sharma, A Roy, V Verma, et al. (+5)
423 [GO] 2022―Dez―14 EPH106 Evaluating Changes in the Diagnostic Setting and Treatment of Bacterial Sexually Transmitted Infections in Germany During COVID-19: A Descriptive Analysis of German Claims Data From 2018-2021 RF Rios Chavarria, R Knapp, F Hardtstock, T Wilke, U Maywald
424 [GO] 2022―Dez―14 RWD161 Pharmacological Treatment Disruption in Women With Post-Partum Depression (PPD) During COVID-19: A Retrospective Cohort Study Using Claim Data K Paul, V Verma, A Sharma, A Roy, S Pandey, I Kukreja, et al. (+6)
425 [GO] 2022―Dez―14 EPH185 Increased Influenza Vaccine Coverage Rate Following COVID-19: Durable Trend or Epiphenomenon? A Ngami, T Christie, F Guelfucci, F Bianic, P Net
426 [GO] 2022―Dez―14 HPR86 Sustainability of Healthcare Systems in the Wake of COVID-19: The UK VPAS Case Study R Macaulay
427 [GO] 2022―Dez―14 SA59 Is There Life for Pre-Prints After COVID-19? P Wittkopf, R Raorane, C Casañas i Comabella, I Iheanacho
428 [GO] 2022―Dez―14 EPH153 Increased Prevalence of Post-Traumatic Stress Syndrome Among Healthcare Workers During the Coronavirus Epidemic P Bogdán, L Szabó, Z Verzár, H Khatatbeh, M Zrínyi, K Kozmann, et al. (+2)
429 [GO] 2022―Dez―14 HPR45 Medical Quality Indicators Trends During the Coronavirus Pandemic in Israel: Meuhedet Health Services Real Data Analysis and Future Conclusions S Klang, S Merling, S Regev-Rosenberg, M Pugatch
430 [GO] 2022―Dez―14 PCR272 Attitudes Towards Coronavirus Vaccination Among the Hungarian Population B Bernáth, L Szabó, M Zrínyi, R Ábrahám, G Kelemen, H Khatatbeh, et al. (+2)
431 [GO] 2022―Dez―14 PCR19 SARS-COV-1 Omicron BA.1 Associated Impact on Quality of Life and Medication Adherence of Multiple Myeloma Patients Treated With Thalidomide or Its Analogues Plus Dexamethasone 1JAN-31MAR2022 R Burruss, V Kim, V Arikian
432 [GO] 2022―Dez―14 EPH187 Effects of Non-Pharmaceutical Interventions (NPIS) Aimed at Limiting the Spread of SARS-COV-2 R Pentz, R Felder-Puig, I Soede, H Stürzlinger, L Teufl, R Winkler
433 [GO] 2022―Dez―14 EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance M Maschio, B Schweikert, B Ultsch, R Cai, K Fust, A Lee, et al. (+4)
434 [GO] 2022―Dez―14 HPR200 The Impact of Community Pharmacies on Regional Equity in Access to Professional Rapid Antigen Testing for SARS-COV-2 in Portugal J Guerreiro, I Teixeira, S Romano, J Mansinho, R Pereira, A Teixeira Rodrigues
435 [GO] 2022―Dez―14 PCR138 Association of SARS-CoV-2 Omicron Ba.1 on Adherence to Oral Tetrabenazine Congener and Quality of Life of Patients Diagnosed With Huntington's Disease With Chorea or Tardive Dyskinesia on the Service of a USA Specialty Pharmacy R Burruss, R Alhabashi, V Arikian
436 [GO] 2022―Dez―14 EPH68 Epidemiological Impact of Generalized SARS-COV-2 Vaccination of Children Aged 5 to 11 H Leleu, M Blachier
437 [GO] 2022―Dez―14 EPH150 The Psychological Impacts of COVID -19 as a Social Influence Parameter During the Pandemic I Yfantopoulos, A Efstathiou, G Stefanakos, I Kehris, P Efstathiou, F Zora
438 [GO] 2022―Dez―14 EE464 Is the Willingness to Pay for Years of Life in an Extreme Situation of the COVID Pandemic Closures Similar to the Willingness to Pay in Situations of Ordinary Basis? Comparison by Population Groups N Khoury Nakhoul, S Brammli-Greenberg
439 [GO] 2022―Dez―14 MSR141 Building Bridges: What Pandemic Preparedness Can Learn From Real-Option Value Analyses of Water Infrastructure in the Netherlands M Schöttler, S Van der Pol, S van der Schans, C Boersma
440 [GO] 2022―Dez―14 HPR30 Too Ultra-Rare for Care? Orphan Drug Availability for People Living With Ultra-Rare Respiratory Diseases in the Pre, Present and Post Pandemic Worlds H Matthews, N Lipunova, S Beecroft, G Jones
441 [GO] 2022―Dez―14 SA25 Evolution of the Number of Metastatic Lung Cancer Patients before and during the COVID 19 Pandemic: A French National Hospital Database Analysis B Sano, N Petrica, R Finas, M Rosé
442 [GO] 2022―Dez―14 EPH155 A Systematic Review of the Impact of Vaccination on Long COVID JY Thompson, DA Nnate, M Mussad, S Carroll, P Buck, WD Strain, et al. (+2)
443 [GO] 2022―Dez―14 EPH34 Long COVID Symptoms and Diagnosis in Primary Care: A Cohort Study Using the Thin Database Including Unstructured Text A Shah, S Dhalla, A Subramanian, E Ford, S Haroon, V Kuan, K Nirantharakumar
444 [GO] 2022―Nov―25 Disability-Adjusted Life Years for Drug Overdose Crisis and COVID-19 Are Comparable During the Two Years of Pandemic in the United States Qiushi Chen, Paul M. Griffin, Sarah S. Kawasaki
445 [GO] 2022―Nov―25 One-year temporal changes in long COVID prevalence and characteristics: a systematic review and meta-analysis Qiangru Huang, Mengmeng Jia, Yanxia Sun, Binshan Jiang, Dan Cui, Luzhao Feng, Weizhong Yang
446 [GO] 2022―Okt―01 The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis Stacey Kowal, Carmen D. Ng, Robert Schuldt, Daniel Sheinson, Richard Cookson
447 [GO] 2022―Aug―11 Modeling the Recovery of Elective Waiting Lists Following COVID-19: Scenario Projections for England Nicholas C. Howlett, Richard M. Wood
448 [GO] 2022―Jul―20 Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: Correspondence Pathum Sookarodee, Viroj Wiwanitkit
449 [GO] 2022―Jun―25 PCR80 Informing a Conceptual Framework for a Patient-Centered Value Assessment of Emerging Therapies for Mild/Moderate COVID-19 C Ali, TJ Mattingly, JF Slejko, S Dosreis
450 [GO] 2022―Jun―25 OP6 Measuring and Quantifying Lost Productivity Due to Priority Diseases: A Review of the Past 10 Years and Reflections on the Unprecedented Changes and Implications Emerging with COVID-19 S Rojanasarot, NC Edwards, SK Bhattacharyya
451 [GO] 2022―Jun―25 MSR10 An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19 M Broder, SN Gibbs, I Yermilov
452 [GO] 2022―Jun―25 HSD54 Adherence to Expert Recommendations: Evidence from Oral vs. Infusion Substitution during COVID-19 Y Civelek, D Cullen, D Debono, MJ Fisch, J Barron, G Sylwestrzak
453 [GO] 2022―Jun―25 HSD49 Variability in Incidence of Circulatory and Endocrinal Complications Post COVID-19 S Choudhary, A Sethi, V Verma, L Brooks, M Sulzicki, S Pandey, et al. (+7)
454 [GO] 2022―Jun―25 CO67 Predictors of Long COVID in Patients with Severe COVID-19 - a US Healthcare Database Analysis C Holy, B Patterson, J Ruppenkamp, F Richards, R Debnath, JK DeMartino, et al. (+3)
455 [GO] 2022―Jun―25 EE422 Healthcare Costs Associated with Severe VS Moderate and Mild COVID-19 - a US Payer Perspective C Holy, B Patterson, J Ruppenkamp, F Richards, R Debnath, JK DeMartino, et al. (+3)
456 [GO] 2022―Jun―25 EE468 Economic Impact of Sequential Testing for COVID-19 and Influenza with Molecular Point of Care in 3 European Countries J Shafrin, A Mubayi, K Birch, N Land, M Sotak, M Venkatachalam, et al. (+2)
457 [GO] 2022―Jun―25 EPH32 Perceived Risk of COVID-19 and Its Association with Preparedness and Preventive Practices: A Latent Class Segmentation Analysis O Mgbere, S Iloanusi, I Yunusa, NJR Iloanusi, S Gohil, EJ Essien
458 [GO] 2022―Jun―25 EE20 An Overview of Optimisation Studies on COVID-19 and Its Economic Benefits in India E Harika, M Roy
459 [GO] 2022―Jun―25 CO132 Duration of COVID-19 and Long COVID - a US Healthcare Database Analysis B Patterson, J Ruppenkamp, F Richards, R Debnath, AC El Khoury, JK DeMartino, et al. (+3)
460 [GO] 2022―Jun―25 EPH174 Adverse Events Associated with COVID-19 and Seasonal Influenza Vaccines: A Retrospective and Descriptive Analysis of CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Reports Z Alqahtani, JJ Guo, PR Wigle
461 [GO] 2022―Jun―25 HPR2 COVID-19 and the Use of Antenatal Care Services in Côte d'Ivoire, an Africa South of the Sahara's Country AR Attia-Konan, DFR Meless, K Koffi, J Kouame, MF Male, AS Pongathie
462 [GO] 2022―Jun―25 EPH172 When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China D Zhou, T Shao, H Shao, Y Tu, Y Tang, J Zhou, et al. (+2)
463 [GO] 2022―Jun―25 CO146 Readmission and Mortality Following Discharge from Inpatient Treatment for COVID-19 By Mechanical Ventilation Status in Early and Late Phases of the Pandemic J Best, SV Mohan, J Jonas, L Arader, J Yeh, MJ Butler
464 [GO] 2022―Jun―25 EPH22 Prevalence and Risk Factors of Post COVID-19 Condition in Previously Hospitalized Patients in Bolivar, Colombia: An Observational Study A Lozano, F Salcedo Mejía, N Alvis Zakzuk, JC Fernandez Mercado, M Jerez Arias, J Zakzuk Sierra, et al. (+2)
465 [GO] 2022―Jun―25 EE471 Valuing the Fear of COVID-19 Contagion N Poudel, S AlMahasis, S Simpson, S Ngorsuraches
466 [GO] 2022―Jun―25 EE240 Estimating the COVID-19 Cost-of-Illness Associated with Comorbidities in a Brazilian Public Hospital LA Oliveira, R Lucchetta, F Tonin, AF Bonetti, HH Borba, A Matoso Mendes, et al. (+3)
467 [GO] 2022―Jun―25 EPH58 The Experiences of Healthcare Workers during the Second Wave of COVID-19 Crisis in the South Indian State of Kerala J Kochuparambil, A Issac
468 [GO] 2022―Jun―25 PCR93 Comprehensibility and Usability of an Electronic COVID-19 Daily Symptom Diary K Baranov, C Casstevens, P McLeroth, E Merikle
469 [GO] 2022―Jun―25 EPH134 Sex-Gender Differences in COVID-19 Diagnosis, Hospitalization and Mortality S Kharroubi, M El Harakeh
470 [GO] 2022―Jun―25 P36 The Impact of COVID-19 Diagnosis on Healthcare Costs C. Morrow, RM. McKenna, L. Palmer
471 [GO] 2022―Jun―25 PCR158 Hungarians' Attitudes Toward the COVID-19 Disease and Vaccination: An Online Survey H Khatatbeh, M Zrínyi, R Vajda, Z Verzár, J Turcsán, K Takács, et al. (+3)
472 [GO] 2022―Jun―25 EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic A Tebaibia, A Mammeri, H Brahimi, M Ammi, N AitSaid, M Lebdjiri, et al. (+14)
473 [GO] 2022―Jun―25 EPH31 Disparities and Trends of COVID-19 Epidemiology in EU-5 Countries across Pandemic Waves: A Targeted Literature Review (TLR) S Kamra, J Venkateswara Rao, R Mandlik, S Dabral, R Pagidigummula, R Hyderboini, et al. (+3)
474 [GO] 2022―Jun―25 CO31 Health Equity Considerations in Minority Groups with Type 1 and 2 Diabetes in the COVID-19 Era: Care Utilizations and Costs Y Ionova, L Zhong, Y Ma, L Wilson
475 [GO] 2022―Jun―25 PCR100 COVID-19 Experiences of Pregnant and Postpartum Persons and Their Impact on Health-Related Quality-of-Life P Aytha Swathi, A Regan, NY Gu, M Nosek
476 [GO] 2022―Jun―25 MT30 Learnings from DTC Launch of a Digital Therapeutic for ADHD in Response to the COVID-19 FDA Policy for Digital Health Devices for the Treatment of Psychiatric Disorders L Palko
477 [GO] 2022―Jun―25 HTA56 COVID-19 from the Perspective of Intellectual Property CR Pereira da Veiga, C Da Veiga, R Arcaro
478 [GO] 2022―Jun―25 EE410 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Three Countries of LATAM: Argentina, Chile, and Colombia R Montejano, F Riera, C Falistocco, L Espinoza, A Azamar-Alonso
479 [GO] 2022―Jun―25 EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network K Moll, S Hobbi, CK Zhou, K Fingar, T Burrell, V Hernandez-Medina, et al. (+5)
480 [GO] 2022―Jun―25 EPH135 The Effect of Lockdown on Reducing Hospitalisations Associated with COVID-19 in Australia S Choi, H Kim
481 [GO] 2022―Jun―25 HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil R Arcaro, C Da Veiga, CR Pereira da Veiga
482 [GO] 2022―Jun―25 RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD) A Kolbin, GI Syraeva, SA Mishinova
483 [GO] 2022―Jun―25 EE495 Threshold Price in the US to Achieve Cost-Effective Use of Molnupiravir and PF-07321332/Ritonavir for the Prevention of Severe COVID-19 in High-Risk Adults T Majda, D Veenstra
484 [GO] 2022―Jun―25 EPH51 Associations between Psychiatric Disorders and COVID-19 in Japan: Results from the Life Study F Murata, M Maeda, H Fukuda
485 [GO] 2022―Jun―25 EE99 Economic Burden of COVID-19 in Mexico AE Frias Gasga, VU Delgadillo Hernández, H Soto Molina, S Guzman Vazquez
486 [GO] 2022―Jun―25 EE335 The Hospitalization Burden of COVID-19 in Patients with NSCLC: Differential Impact of Vaccination F Richy, D Kumar, D Kulkarni
487 [GO] 2022―Jun―25 EE467 Recovid Study. Cost-Effectivness Analysis of Using Nutridrink 200 ML in the Treatment of COVID-19 in the Hospital M Frolov
488 [GO] 2022―Jun―25 PCR77 Using Twitter to Examine Public Perceptions about COVID-19 in the United States: A Sentiment Analysis AA Ali, K Adjei, S Fatimah, K Ezendu, M Taeb, H Chi, et al. (+2)
489 [GO] 2022―Jun―25 EE225 Economic and Clinical Impact of a Novel, Antiviral Therapy on COVID-19 in the US S Gibson, R Saunders, N Stasko, C Brown-Bickerstaff, J Oakley, M Osterman, et al. (+4)
490 [GO] 2022―Jun―25 P60 The Association between Statin Use and Severe Outcomes in COVID-19 Infected Beneficiaries Enrolled in Mississippi Medicaid Y. Rong, E. Pittman, S. Ramachandran, J. Bentley, B. Banahan, T. Kirby, et al. (+2)
491 [GO] 2022―Jun―25 EE330 Spill-over of Medical Cost for Blue Cross and Blue Shield of Louisiana Members with Differing Severity of COVID-19 Infection E Lucas, S Palanki, M Liu, D Barfield, Y Zhang, B Vicidomina, et al. (+2)
492 [GO] 2022―Jun―25 EPH20 Does a Mother's Previous Experience with COVID-19 Infection Change Her Intention to Vaccinate Her Children M Zakeri, J Li, EJ Essien, SS Sansgiry
493 [GO] 2022―Jun―25 P35 Risk of Psychiatric and Neurological Sequelae after the COVID-19 Infection: A Retrospective Cohort Study Using Claim Data A. Gaur, I. Kukreja, N. Mishra, A. Roy, A. Chopra, A. Gupta, et al. (+6)
494 [GO] 2022―Jun―25 P34 Identifying Interventions That Reduced COVID-19 Mortality in Long-Term Care Facilities: A Causal Inference Analysis R. Goldberg
495 [GO] 2022―Jun―25 CO139 Use of Remdesivir Among Hospitalized Patients with Severe COVID-19: Analysis of Electronic Health Records from Trinetx COVID-19 Network F Wolde, L Gressler
496 [GO] 2022―Jun―25 RWD69 The Impact of COVID-19 on Colorectal Cancer Screening in Northern Ireland Z Waller, E McFerran, F Lamrock, M Lawler, F Bannon
497 [GO] 2022―Jun―25 SA43 The Impact of COVID-19 on Managing Clinical Trials PP Gannavarapu, KV Mandello
498 [GO] 2022―Jun―25 SA34 Impact of COVID-19 on Telehealth Utilization: Analysis of Komodo Healthcare Map™ Claims Data A Silber, R Liu, M Mulrooney, M Salkar, K Francis, N Hadker
499 [GO] 2022―Jun―25 HSD64 The Influence of COVID-19 on Telemedicine Services Among Blue Cross and Blue Shield of Louisiana Members with Diabetes H Zhang, E Lucas, M Kiggans, Y Zhang, B Vicidomina, S Mills, S Nigam
500 [GO] 2022―Jun―25 MSR49 Assessing the Impact of COVID-19 on the Healthcare Resource Utilization and Treatment in High Incidence Oncological Conditions K Paul, V Verma, U Parashar, L Brooks, M Sulzicki, S Pandey, et al. (+7)
501 [GO] 2022―Jun―25 RWD70 Impact of COVID-19 on the Utilization of Behavioral Healthcare Services in the US I Kukreja, N Mishra, A Gaur, A Roy, A Chopra, A Gupta, et al. (+6)
502 [GO] 2022―Jun―25 RWD134 Impact of COVID-19 on the Utilization of Screening and Therapy Services for Children with Autism in the US N Mishra, M Rawat, A Gaur, I Kukreja, A Roy, A Chopra, et al. (+7)
503 [GO] 2022―Jun―25 EPH129 Blue Cross and Blue Shield of Louisiana's COVID-19 Outbreak Simulation- Deterministic SEIR Modeling M Cong, J Holloway, M Liu, E Lucas, Y Zhang, J Ouyang, et al. (+2)
504 [GO] 2022―Jun―25 EPH45 The Impact of Gingivitis and Periodontitis on COVID-19 Outcomes: A Case-Control Study C Morrow, RM McKenna, E Gebauer, L Palmer
505 [GO] 2022―Jun―25 HPR55 How Inequities and Disparities in Health & Healthcare Are Impacting COVID-19 Outcomes: A Scoping Review KJ Craig, TJ Bright, H Karunakaram, C VanHouten, Y Akdas, I Dankwa-Mullan
506 [GO] 2022―Jun―25 PCR103 A Digitally Enabled Care and Real World Evidence (RWE) Research Program Among Individuals with Asthma and COPD during the COVID-19 Pandemic R Willmon, O George, S Selvarajah, J Adams, G Soyao, M Hart, et al. (+2)
507 [GO] 2022―Jun―25 OP8 Trends in General Surgery Procedure Volumes By Modality during the COVID-19 Pandemic S Wing, A de Groot, Y Liu, Y Li
508 [GO] 2022―Jun―25 HSD47 Malignant Surgical Volumes and Length of Stay By Modality during the COVID-19 Pandemic S Wing, A de Groot, Y Liu, Y Li
509 [GO] 2022―Jun―25 EPH160 Burden of Frequent Mental Distress in the US Population during the COVID-19 Pandemic NHK Le
510 [GO] 2022―Jun―25 EPH117 Factors Associated with Receipt of Second Dose of mRNA-1273 Vaccine at Walgreens Pharmacies during the COVID-19 Pandemic E Roberts, A Shah, R Smith-Ray, P Buck, N Van de Velde, C Talarico, et al. (+2)
511 [GO] 2022―Jun―25 EPH35 Information Seeking and Preventive Behavior during the COVID-19 Pandemic T Park, I Ju, J Ohs, A Hinsley, J Muzumdar
512 [GO] 2022―Jun―25 PCR15 The Impact of the COVID-19 Pandemic and Lockdowns on the Health-Related Quality of Life of People Living with Multiple Sclerosis in Australia G Henson, I van der Mei, BV Taylor, P Blacklow, SB Claflin, AJ Palmer, et al. (+2)
513 [GO] 2022―Jun―25 EPH92 Investigating Undergraduate Students’ Perception on COVID-19 Pandemic and Social Distance and Its Influencing Factors By Association Analysis and Sentimental Analysis K Lee, S Han, L Osipenko, HS Suh
514 [GO] 2022―Jun―25 HPR18 The Missing Claimants of 2020: Who Went without Claims in Canada during the First Year of the COVID-19 Pandemic and What Does It Mean for Public and Private Insurers? É Gaudette, Y Zhang
515 [GO] 2022―Jun―25 PCR64 COVID-19 Pandemic Effect Estimation, in Medical Attention on Patients with Gynecological Cancer and Their Caregivers in Mexico F Morales, S Guzmán Vázquez, K Torres Méndez, H Soto
516 [GO] 2022―Jun―25 HSD88 Fruit and Vegetable Consumption in Hungary during the Fall of COVID-19 Pandemic in 2020 B Tisza, T Stromájer-Rácz, Z Verzár, I Boncz, A Pakai, A Gubicskóné Kisbenedek
517 [GO] 2022―Jun―25 HTA2 RAPID C-19: Achievements and Challenges of a Collaborative Response to the COVID-19 Pandemic in the UK A Greenwood, A Brett, N Umeweni, S Upadhyaya
518 [GO] 2022―Jun―25 MSR29 Predicting Panel Attrition in Longitudinal HRQoL Surveys during the COVID-19 Pandemic in the US T Yu, J Chen, NY Gu, JW Hay, CL Gong
519 [GO] 2022―Jun―25 CO136 COVID-19 Pandemic Indirect Impact on Mortality Rates D Araja
520 [GO] 2022―Jun―25 EPH43 Impact of COVID-19 Pandemic on Cancer Preventive Screening D Weeraratne, A Rajmane, M Patel, B Rosario
521 [GO] 2022―Jun―25 HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients Y Shao, L Shi, E Nauman, E Price-Haywood, C Stoecker
522 [GO] 2022―Jun―25 HSD98 Estimating the Impact of the COVID-19 Pandemic on Healthcare Waiting Lists in England R King, A Pijper, A Marsland, R Sloan, S Holloway, B Bray, J Pearson-Stuttard
523 [GO] 2022―Jun―25 HSD19 Impact of Coronavirus Disease (COVID-19) Pandemic on Non-COVID Healthcare Utilization in Saudi Arabia R Alameddine, Y Bassil, J Barhoun, K Asmar, C Maskineh, H Al-Omar
524 [GO] 2022―Jun―25 HSD26 Impact of the COVID-19 Pandemic on Real-World Antipsychotic Treatment Patterns in Patients with Schizophrenia Z Liu, CA Patel, A Campbell, A Fu, C Benson
525 [GO] 2022―Jun―25 P33 Evaluating the Impact of the COVID-19 Pandemic on the Diagnosis and Staging of New Breast Cancer Cases: A Retrospective Analysis of Medical Chart Data from the United States R. Knapp, F. Hardtstock, T. Wilke, B. Boner, C. Hurmiz, A. McCracken
526 [GO] 2022―Jun―25 RWD26 Real World Evidence for the Impact of COVID-19 Pandemic on the Incidence of Multiple Myeloma in Germany S Schilling, G Azarias, L Merker, K Strobel, S Wischlen, L Kellermann
527 [GO] 2022―Jun―25 RWD117 Impact of COVID-19 Pandemic on the Romanian Breast Cancer Burden: A County Population-Based Study A Turcu-Stiolica, MS Subtirelu, M Bogdan, VC Dinescu, V Gheorman, M Aldea, et al. (+2)
528 [GO] 2022―Jun―25 EPH86 Effect of the COVID-19 Pandemic on the Utilization of Hospice-Palliative Care Services in Hungary M Lukács, A Siket, M Zrínyi, I Karácsony, I Boncz, A Pakai
529 [GO] 2022―Jun―25 CO109 Increase in All-Cause Mortality Rate for Patients Admitted to the Emergency Department (ED) with Myocardial Infarcts during COVID-19 Pandemic Regardless of ST Elevation A Braendle, K Lodaya, X Zhang, J Lilley, S Munson, F D'Souza
530 [GO] 2022―Jun―25 PCR116 Exploring the Known-Group Validity between EQ-5D-5L and GAD-7 during Hong Kong COVID-19 Pandemic Situation CW Ng, E Wong, AWL Cheung
531 [GO] 2022―Jun―25 PCR16 Stroke Rehabilitation Treatment Preferences of Chinese Physicians and Patients during the COVID-19 Pandemic: A Discrete Choice Experiment G Feng, D Hao, T Liu, X Fang, N Yan, Q Chen, et al. (+6)
532 [GO] 2022―Jun―25 EPH100 Assessment of Psychological Responses of the Indian Population Due to COVID-19 Pandemic: A Web-Based Survey RV Rajesh, A Anand, J Sebastian, J Lucca
533 [GO] 2022―Jun―25 SA44 Trends in Medication Error Reporting during the COVID-19 Pandemic: An Analysis of Faers Data, 2016 to 2021 V Wysocki, DW Grabe, PD Meek
534 [GO] 2022―Jun―25 EPH6 Health-Related Quality of Life (HRQOL) Among Chinese Population during the COVID-19 Pandemic: The Role of Socio-Demographic Factors and Loneliness E Wong, J Li, S Yuen, AHY Lai, AWL Cheung, PSY Yau, EK Yeoh
535 [GO] 2022―Jun―25 RWD31 Comparison of Remdesivir As Monotherapy or in Combination with Steroids in Treating COVID-19 Patients M Rawat, S Choudhary, A Gaur, V Verma, I Kukreja, A Roy, et al. (+7)
536 [GO] 2022―Jun―25 EPH40 Characteristics of COVID-19 Patients Admitted to the University Hospital of El Biar in Algiers during the First 6 Months of the Epidemic in Algeria: Descriptive Study of 1008 Cases A Tebaibia, A Mammeri, H Brahimi, M Ammi, N AitSaid, M Lebdjiri, et al. (+14)
537 [GO] 2022―Jun―25 PCR55 Analyzing the Relationship between Social Determinants of Health (SDOH) on Hospital Capacity for COVID-19 Patients By Geographic Region K Watkins, S Strickland, K Prudyus, K Rademacher
538 [GO] 2022―Jun―25 HSD104 Antibiotics Dispensed at Drugstores for Mild Cases of COVID-19 Patients in Northern Punjab, Pakistan U Malik, F Hashmi, N Atif, F Khan, Y Fang
539 [GO] 2022―Jun―25 EE349 Remdesivir Use in Hospitalized COVID-19 Patients in the United Arab Emirates: A Cost-Effectiveness and Health Care Resource Use Model A Subhi, A Mohamed El Shamy, SA Hussein, J Jarrett, S Kozma, C Harfouche, MA Sara Ahmad
540 [GO] 2022―Jun―25 RWD16 Impact of COVID-19 Vaccination in Reducing Average Length of Stay in Hospitals Among COVID-19 Patients in the US - a Retrospective Study from De-Identified Administrative Claims Database N Pandey, V Verma, A Chopra, I Kukreja, A Gaur, M Sulzicki, et al. (+6)
541 [GO] 2022―Jun―25 EPH132 In-Hospital Mortality Among Hospitalized COVID-19 Patients in the US: How Did It Change in 2021 from ALPHA to DELTA Variant? R Moon, N Rosenthal
542 [GO] 2022―Jun―25 EE315 Economic Evaluation of Neutralising Monoclonal Antibodies for the Treatment of COVID-19 Positive People in the Community A Metry, R Rafia, A Wailoo
543 [GO] 2022―Jun―25 EE415 Spatial Cost-Efficiency Analysis on the Separability Condition of COVID-19 Potential Determinants T Nepomuceno, A De Lima
544 [GO] 2022―Jun―25 SA6 A Review of Economic Evaluation on Vaccination and Non-Pharmaceutical Interventions for COVID-19 Prevention and Control J Zhao, Y Fu, P Han, L Yang
545 [GO] 2022―Jun―25 EPH167 Recursive Partitioning Analysis of COVID-19 Risk and Behavioral Measures in an Urban Setting O Mgbere, S Iloanusi, I Yunusa, NJR Iloanusi, S Gohil, EJ Essien
546 [GO] 2022―Jun―25 RWD57 Emergency and Inpatient COVID-19 Service Utilization and Its Stratification Based on Comorbid Conditions S Choudhary, A Gaur, I Kukreja, A Roy, A Chopra, A Gupta, et al. (+6)
547 [GO] 2022―Jun―25 RWD2 Variation in COVID-19 Treatment Cost due to Social Factors in the US - Estimation Using Integration of CDC/ATSDR’s Social Vulnerability Index (SVI) and Healthcare Claims Data A Roy, A Gaur, A Gupta, N Upadhyay, I Kukreja, A Chopra, et al. (+7)
548 [GO] 2022―Jun―25 EE386 Cost-of-Illness Analysis of Coronavirus Disease 2019 (COVID-19) Treatment in the Philippine General Hospital RM Castillo, V Chuabio, CI Panelo, C Jimeno
549 [GO] 2022―Jun―25 HSD5 Changes in COVID-19 Treatment Patterns over the Course of 2020 BA Turner, J Winer-Jones, A Maresca
550 [GO] 2022―Jun―25 EPH103 COVID-19 Vaccination Among Pregnant Women in the US: A Systematic Review S Rawal, RL Tackett, RH Stone, HN Young
551 [GO] 2022―Jun―25 HSD60 Children's COVID-19 Vaccination and Race - a Nationwide Survey of Children's Vaccination Status and Trust in the U.S. General Population E Heidari, CM Brown, R Morlock, K Blakomer, A Morlock
552 [GO] 2022―Jun―25 EPH60 Real-World Data Dashboard Integrating Public Health & EHR Data for Identifying COVID-19 Vaccination Gaps in the US L Kallenbach, S Whipple, M Bonafede
553 [GO] 2022―Jun―25 HPR36 Using Best-Worst Scaling to Identify the Important Barriers to COVID-19 Vaccination in Black Belt Region: A Pilot Study H Yang, N Poudel, S Simpson, C Chou, S Ngorsuraches
554 [GO] 2022―Jun―25 EE71 Cost-Effectiveness of COVID-19 Vaccination in Colombia: A Micro-Simulation Modelling Analysis C Castañeda-Orjuela, N Alvis-Zakzuk, D Diaz-Jimenez, N Alvis-Guzman
555 [GO] 2022―Jun―25 P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study B. Jahn, G. Sroczynski, M. Bicher, C. Rippinger, N. Mühlberger, J. Santamaria, et al. (+3)
556 [GO] 2022―Jun―25 P10 Parental Vaccine Sentiment and Decision-Making Factors for Pediatric COVID-19 Vaccinations B. Wu, R. Almeida, N. Eslami, S. Garfield
557 [GO] 2022―Jun―25 HSD117 Sociodemographic Disparities in COVID-19 Vaccinations Still Exist 1 Year Following Vaccine Rollout J Rizk, FT Shaya
558 [GO] 2022―Jun―25 P13 Risk of COVID-19 Vaccine Breakthrough Infection in Fully Vaccinated Patients with Multiple Comorbid Conditions in the United States M. Liu, A.C. Wong, J.T. McPheeters, R. Dixon, V. Madge, G. Basra, et al. (+2)
559 [GO] 2022―Jun―25 EPH75 COVID-19 Vaccine Breakthrough Infections in the United States, By Race M Liu, AC Wong, JT McPheeters, R Dixon, V Madge, G Basra, et al. (+2)
560 [GO] 2022―Jun―25 P15 Drivers of Health Disparities and Consequences for COVID-19 Vaccine Choices: Modelling Health Preference Heterogeneity Among Underserved Populations E. Van Den Broek-Altenburg, J. Benson, A. Atherly, S. Hess
561 [GO] 2022―Jun―25 EE188 COVID-19 Vaccine Hesitancy Among Early Adaptors in Jordan S Muflih
562 [GO] 2022―Jun―25 P14 Identification of COVID-19 Vaccine Hesitancy Predictors E. Saldarriaga
563 [GO] 2022―Jun―25 EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England S Aballea, P Karwala, I Zerda, M Toumi, M Pochopien, B Borissov, E Clay
564 [GO] 2022―Jun―25 EPH139 COVID-19 Vaccine Related Adverse Events in a Population Aged 5-17 Years: A Study of Reports from the VAERS Database Y Lee, A Gómez-Lumbreras, MS Tan, DC Malone, L Villa Zapata
565 [GO] 2022―Jun―25 SA16 Technology-Assisted Adaptive Recruitment Strategy for a National Study of Immunogenicity of COVID-19 Vaccines and Levels of Sars-COV-2 Neutralising Antibody in the Bruneian Population CY Shim, H Ghani, L Ahmad, H Sharif, MF Alikhan, S Bagol, et al. (+11)
566 [GO] 2022―Jun―25 EE7 Economic Evaluation of COVID-19 Vaccines: A Targeted Literature Review A Addae, L Ramjee, G Tremblay
567 [GO] 2022―Jun―25 EPH106 Comparison of the Post-Marketing Safety Profile between Influenza and COVID-19 Vaccines: An Analysis of the Vaccine Adverse Event Reporting System (VAERS) AK Alahmari, Z Almalki, A Alshehri, AA Albassam, NJ Ahmed
568 [GO] 2022―Jun―25 EE238 Healthcare Costs of COVID-19 Versus Flu and Pneumonia - a Payer Perspective F Richards, B Patterson, J Ruppenkamp, R Debnath, AC El Khoury, JK DeMartino, et al. (+3)
569 [GO] 2022―Jun―25 RWD91 A Real-World Pharmacovigilance Study Using National Russian Database of Adverse Events of COVID-19-Related Drugs: Focus on Hydroxychloroquine A Kolbin, SA Mishinova, GI Syraeva, YS Polushin
570 [GO] 2022―Jun―25 EPH55 Association Between Prior Bisphosphonate Use and COVID-19-Related Outcomes J Thompson, Y Wang, T Dreischulte, O Barreiro, R Gonzalez, P Hanč, et al. (+6)
571 [GO] 2022―Jun―25 EE456 Healthcare Resource Utilization Among Patients with Glycogen Storage Disease Type Ia (GSDIa) in the United States and the Impact of COVID-19: A Claims Database Analysis J Nedzesky, E Kruger, RN Gupta, NA Thomas, V Valayannopoulos
572 [GO] 2022―Jun―25 EE450 Treatments and Diagnostics for COVID-19: A Living Systematic Review of Economic Evaluations J Elvidge, A Summerfield, D Nicholls, D Dawoud
573 [GO] 2022―Jun―25 RWD44 Post-COVID Syndrome in Hospitalized Patients with COVID-19: A Prospective Cohort Study from a Health Care Plan in Brazil J Busch, J DOS Reis Neto
574 [GO] 2022―Jun―25 SA5 The Effectiveness and Safety of Remdesivir for COVID-19: A Quantitative Meta-Analysis AF Mohamed, P Duong, T Shah, M Zhang, RA Mekary
575 [GO] 2022―Jun―25 HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites P Rojas, C Epp, L Gozzo, D Geba, M Epstein, S Michel
576 [GO] 2022―Jun―25 HPR62 Economic Evaluations of Public Health Interventions on COVID-19: A Systematic Review A Rayanakorn, SL Leong, P Chaiprom, S Lee
577 [GO] 2022―Jun―25 EE334 Healthcare Utilization and Charges Associated with US Hospitalized Adult Patients with Coronavirus Disease 2019 F Richards, B Munoz, MW Fried, HL Morris, AR Mospan, JM Crawford, et al. (+4)
578 [GO] 2022―Jun―25 EPH121 A Descriptive Study on Hospital-Related Coronavirus Disease 2019 (HRCOVID-19) Among Chronic Kidney Disease Patients during the Pandemic at a Tertiary Center in the Philippines IMD Cruz, M Mendoza
579 [GO] 2022―Jun―25 EE483 The Economic Impact of Coronavirus Pandemic on Stroke Care: Direct and Indirect Costs Estimations in Chile D Paredes, R Lenz, K Hernández, L Paez
580 [GO] 2022―Jun―25 EPH140 SARS-COV-2 Breakthrough Infections Among the Healthcare Workers Post-Vaccination with ChAdOx1 nCoV-19 Vaccine in the South Indian State of Kerala A Issac, J Kochuparambil
581 [GO] 2022―Jun―25 EPH137 Digital Health Solutions for Workers: Engagement with a Digital Tool for Management of SARS-COV-2 Exposure and Infection TB Gibson, L Schubel, V Assibey-Mensah, S Bloemers, C Pack, E Roemer, et al. (+4)
582 [GO] 2022―Jun―25 EPH120 Comparing the Effectiveness and Cost-Effectiveness of SARS-COV-2 Screening Strategies Using Rapid Antigen Tests in a Residential College Campus H Smolen, A Johnston, L Smolen, Y Yih
583 [GO] 2022―Jun―25 RWD72 SARS-COV-2 Vaccine Breakthrough Infection Rates Based Data from 3 EHRS J Overcash, N Nguyen
584 [GO] 2022―Jun―25 EE43 Budget Impact Analysis of Favipiravir (AVIGAN®) for the Treatment of Patients with Confirmed Infection with SARS-COV2 in Mexico JÁ Paladio Hernández, BA Godina-Ortiz, A Lara-Terrazas
585 [GO] 2022―Jun―25 MT29 Optimal Strategies for Diabetic Foot Care in Times of Pandemic V Riquelme-Hidalgo, C Huiriqueo-Carrizo, K Reynaldos-Grandón
586 [GO] 2022―Jun―25 HSD16 Trends in Rheumatology Patient Care and Practice Operations Pre- and Post-COVID-19 Pandemic K Savill, A Klink, C Brown-Bickerstaff, Y Jeune-Smith, B Feinberg
587 [GO] 2022―Jun―25 PCR113 Depression Fallout from the Pandemic in a Sample of the Middle Eastern and North African (MENA) Community in Houston Texas, USA B Fatima, Z Majd, S Zeidat, F Atrooz, G Alrousan, S Abughosh, S Salim
588 [GO] 2022―Jun―25 HSD42 Trends in Non-COVID Healthcare Utilization during the Pandemic in Lebanon R Alameddine, Y Bassil, J Barhoun, K Asmar, C Maskineh
589 [GO] 2022―Jun―25 EE211 Cost of Long COVID Following Severe Disease - a US Healthcare Database Analysis B Patterson, J Ruppenkamp, F Richards, R Debnath, AC El Khoury, JK DeMartino, et al. (+3)
590 [GO] 2022―Jun―02 A Simulation-Based Cost-Effectiveness Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Prevention Strategies for Visitors of Healthcare Institutions Christina C. Bartenschlager, Selin Temizel, Alanna Ebigbo, Vivian Gruenherz, Petra Gastmeier, Helmut Messmann, et al. (+2)
591 [GO] 2022―Mai―06 “Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs Douglas C. Cheung, Karen E. Bremner, Teresa C.O. Tsui, Ruth Croxford, Lauren Lapointe-Shaw, Lisa Del Giudice, et al. (+11)
592 [GO] 2022―Mai―05 Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands Niek Mouter, Sander Boxebeld, Roselinde Kessels, Maarten van Wijhe, Ardine de Wit, Mattijs Lambooij, Job van Exel
593 [GO] 2022―Apr―28 Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials Stijntje W. Dijk, Eline M. Krijkamp, Natalia Kunst, Cary P. Gross, John B. Wong, M.G. Myriam Hunink
594 [GO] 2022―Apr―27 Brief Cost Analysis of Surgical Personal Protective Equipment During the COVID-19 Pandemic Kandice A. Kapinos, Jordan R. Salley, Andrew Day
595 [GO] 2022―Apr―26 Americans’ Health Priorities During the COVID-19 Pandemic Joseph Cook, Melissa Pittaoulis, Kim Gilchrist, Justine Alderfer, Molly Sapia
596 [GO] 2022―Apr―12 Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic Rodrigo Murteira, Sónia Romano, Inês Teixeira, Carolina Bulhosa, Sérgio Sousa, Maria Inês Conceição, et al. (+3)
597 [GO] 2022―Apr―06 A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-health Impacts and Distributional Issues Meghan I. Podolsky, Isabel Present, Peter J. Neumann, David D. Kim
598 [GO] 2022―Apr―04 COVID-19 Health Economics: Looking Back and Scoping the Future Maarten J. Postma, Jagpreet Chhatwal
599 [GO] 2022―Mrz―30 Update on a Model to Minimize Population Health Loss in Times of Scarce Surgical Capacity During the COVID-19 Crisis and Beyond Benjamin Gravesteijn, Eline Krijkamp, Anouk van Alphen, Jan Busschbach, Geert Geleijnse, Isabel Retel Helmrich, et al. (+8)
600 [GO] 2022―Mrz―23 Electronic Patient Symptom Management Program to Support Patients Receiving Cancer Treatment at Home During the COVID-19 Pandemic Debra Wujcik, William N. Dudley, Matthew Dudley, Vibha Gupta, Jeannine Brant
601 [GO] 2022―Mrz―19 Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing? Jagpreet Chhatwal, Anirban Basu
602 [GO] 2022―Feb―24 Effectiveness of Systemic Corticosteroids Therapy for Nonsevere Patients With COVID-19: A Multicenter, Retrospective, Longitudinal Cohort Study Zhenyuan Chen, Xiaoxv Yin, Xiangping Tan, Jing Wang, Nan Jiang, Mengge Tian, et al. (+4)
603 [GO] 2022―Feb―20 A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales Rachid Rafia, Marrissa Martyn-St James, Sue Harnan, Andrew Metry, Jean Hamilton, Allan Wailoo
604 [GO] 2022―Feb―19 The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19 Melanie D. Whittington, Steven D. Pearson, David M. Rind, Jonathan D. Campbell
605 [GO] 2022―Feb―17 Healthcare Resource Utilization of Patients With COVID-19 Visiting US Hospitals Rena C. Moon, Harold Brown, Ning Rosenthal
606 [GO] 2022―Feb―16 Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations Jamie Elvidge, Ashley Summerfield, David Nicholls, Dalia Dawoud
607 [GO] 2022―Feb―05 Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real World Rafael Dal-Ré, Magí Farré, M. Isabel Lucena
608 [GO] 2022―Feb―03 Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands Bram Wouterse, Frederique Ram, Pieter van Baal
609 [GO] 2022―Jan―20 P26 The Practice of Face Masking Among Young Adults in South India: An Online Cross-Sectional Survey During Second Wave of COVID-19 J Kochuparambil, A Issac
610 [GO] 2022―Jan―20 POSB33 Comorbidities, Oxygen Therapy Use and Rehospitalization in US Patients with Severe COVID-19 S Jhamb, S Khan, H Taneja, A Sachdev, D Mazumder, A Buikema
611 [GO] 2022―Jan―20 POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19 E Mozaffari, Z Zhang, M Thrun, RL Gottlieb, DR Kuritzkes, PE Sax, et al. (+5)
612 [GO] 2022―Jan―20 POSB255 Enough with the Madness! Hydroxychloroquine Is NOT a Treatment for COVID-19. A Santos, ÉSD Gonçalves, AJF Oliveira, DB Lima, KVMDS Noronha, MV Andrade
613 [GO] 2022―Jan―20 POSA424 Challenges of COVID-19 Research: Results from a Systematic Literature Review on COVID-19 and Asthma or COPD S Grieve, P Daniele, AP Rabe, A Forsythe
614 [GO] 2022―Jan―20 POSB398 Kaplan-Meier Survival Curves Analysis of Hospitalized COVID-19 Beneficiaires of a Health Care Plan in Brazil JP Reis Neto, J Busch
615 [GO] 2022―Jan―20 POSC419 Examining the Rate of COVID-19 Breakthrough Infections in Individuals Who Received mRNA Vaccine in the United States V Madge, N Bhardwaj, D Mazumder
616 [GO] 2022―Jan―20 P61 COVID-19 Concerns Experienced by Pregnant and Postpartum Women and Their Influence on Health-Related Quality-of-Life Swathi P Aytha, A Regan, E Grinshteyn, M Nosek, NY Gu
617 [GO] 2022―Jan―20 POSB266 NICE Published Oncology Recommendations: What Progress Has Been Made During the COVID-19 Era? E Samuels, M Tang
618 [GO] 2022―Jan―20 POSB425 Methodological Challenges to Coronavirus Disease (COVID-19) Evidence Generation to Inform Health Technology Assessment (HTA) K Rtveladze, J Gaultney, CJ Crossman-Barnes, S Kamra, D Wright
619 [GO] 2022―Jan―20 POSA383 Identification of Risk Factors Associated with COVID-19 Hospitalization A Chopra, A Arora, I Kukreja, A Gupta, V Verma, A Shukla
620 [GO] 2022―Jan―20 P6 Projecting COVID-19 Hospitalizations and Deaths Under Scenarios of Vaccination in Jefferson County, Kentucky N Patel
621 [GO] 2022―Jan―20 POSA394 Mortality Curves Analysis of COVID-19 Hospitalizations in Oncologic Patients of a Private Health Care Plan in Brazil JP Reis Neto, J Busch, S Stefani
622 [GO] 2022―Jan―20 POSC41 Cost-Effectiveness Analysis of Remdesivir for the Treatment of COVID-19 Hospitalized Adults in Mexico A Ponce-de-León, A Azamar-Alonso, F Silva-Sanchez, R Chirino-Sprung, V Dominguez-Esquivel, S Rajme-López
623 [GO] 2022―Jan―20 POSC172 The Long-Term Acceptability of COVID-19 Hygiene Measures, for the UK General Population G Roberts, B English, J Mumford, A Mumford
624 [GO] 2022―Jan―20 POSA21 An In-Hospital Study to Trace the Risk Factors Associated with Adverse Drug Reactions during the Second Wave of COVID-19 in a Secondary Care Hospital in India J Kochuparambil, A Issac
625 [GO] 2022―Jan―20 POSA420 Trends in Thrombotic and Cardiovascular Events Among Hospitalized Patients with COVID-19 in the US: Findings from a Large Electronic Health Records Database Z Icten, M Friedman, J Menzin
626 [GO] 2022―Jan―20 POSA190 Socio-Economic Influences on County-Level Differences in COVID-19 Incidence During the Second Wave in Germany JA Gossmann, C Meier, RA Greiner, J Otto, E Shlaen, A Batscheider
627 [GO] 2022―Jan―20 POSA393 Online Risk Calculator Using Machine Learning for Prediction of Survival After Hospital Discharge from COVID-19 Infection JP Reis Neto, J Busch, FN Barcellos Filho, EMJDM Farina, MCM Ferreira
628 [GO] 2022―Jan―20 POSC324 Clinical Pharmacist Intervention to Improve the Administration of Injectable Antiviral Agents By Nurses in the Treatment of COVID-19 Infection. A Nidha, J Kochuparambil, A Issac
629 [GO] 2022―Jan―20 POSA384 Identification of Complications Associated with COVID-19 Infection from Claims Data A Arora, A Chopra, I Kukreja, V Verma, A Shukla
630 [GO] 2022―Jan―20 POSB240 The Effects of COVID-19 Infection on Medication Adherence with Chronic Therapies in Italy: The Fail-to-Refill Project Esposti L Degli, A Ghigi, DD Ancona, M Andretta, A Barbieri, F Bartolini, et al. (+16)
631 [GO] 2022―Jan―20 POSA173 Onset of Stroke in Patients with Post-COVID-19 Syndrome Following Hospitalisation for Severe COVID-19 Infection: A Systematic Literature Review C Fleming, A Chakraborty, T Jaiswal, P Patel, S Nair
632 [GO] 2022―Jan―20 POSC374 Association of COVID-19 on Adherence to Oral Specialty Pharmacy Oncology Medications and Quality of Life of Multiple Myeloma Patients R Burruss, V Arikian, K Oleru, T Traurig, M Stranz, J Lindhorst
633 [GO] 2022―Jan―20 POSC254 The Impact of COVID-19 on European HTA Decisions C Watson, JL Petrie, JA Toomey, C Shaw
634 [GO] 2022―Jan―20 P63 Impact of COVID-19 on Health-Related Quality-of-Life in the United States, Sweden and Norway: A Cross-Country Comparison Using a Panel Survey J Chen, CL Gong, X Jiao, NK Zawadzki, U Persson, JW Hay, NY Gu
635 [GO] 2022―Jan―20 P31 Impact of COVID-19 on HTA/PRMA of Medicinal Products in Europe: A Payer Perspective J Mycka, R Dellamano, W Lobb, N Dalal, L Dellamano, E Pereira
636 [GO] 2022―Jan―20 POSC185 Healthcare Utilisation, Health Inequality and the Impact of COVID-19 on Idiopathic Pulmonary Fibrosis (IPF) Care in England: A Retrospective Cohort Study J Bevan
637 [GO] 2022―Jan―20 POSC198 Impact of COVID-19 on Influenza Vaccine Coverage Rate During the 2020/2021 Season A Ngami, F Guelfucci, F Bianic, P Net
638 [GO] 2022―Jan―20 POSC402 Impact of COVID-19 on Influenza Vaccine Sales in France, United Kingdom and United States A Ngami, T Christie, G Ménin, F Guelfucci, F Bianic, P Net
639 [GO] 2022―Jan―20 P28 Impact of COVID-19 on Mental Health in Young Adults in the United States T Intermill, CL Gong, NY Gu
640 [GO] 2022―Jan―20 POSA249 Diagnostic Pathways, Genetic Testing, and Impact of COVID-19 on Patients in Europe with X-Linked Retinitis Pigmentosa: Results from the Cross-Sectional Explore XLRP 1 Physician Survey T Denee, K Pungor, Y Kambarov, R Nissinen, J Lee, K Ampeh, F Parmeggiani
641 [GO] 2022―Jan―20 POSA401 Impact of COVID-19 on Surgical Activity: Experience from a French University Teaching Hospital L Cazin, A Ngami, L Parrenne, F le Mercier, F Guelfucci, F Bianic, et al. (+2)
642 [GO] 2022―Jan―20 P25 Impact of COVID-19 on the Health-Related Quality-of-Life of Pregnant and Postpartum Persons A Regan, P Aytha Swathi, M Nosek, NY Gu
643 [GO] 2022―Jan―20 P21 Social Distancing and Trends in Influenza Hospitalization during the COVID-19 Outbreak: A Difference-in-Difference Analysis of German Claims Data S Pacis, U Maywald, T Wilke, M Ghiani
644 [GO] 2022―Jan―20 POSB278 Modernising the Clinical Trial: A Shift to Decentralised Trials Driven By Advances in Technology and Catalysed By the COVID-19 Pandemic N Cross, N Kipentzoglou, J Whitehouse, A Satherley
645 [GO] 2022―Jan―20 P27 Vaccination Coverage Trends for Hepatitis B in Infants from the Brazilian and Colombian Expanded Immunization Program: A Real-World Analysis of COVID-19 Pandemic Impact P Lima, A Abreu, F Hernández, J Martins, B Kano, D Kashiura, G Julian
646 [GO] 2022―Jan―20 P22 COVID-19 Pandemic Impacts Volume of Evaluation & Management (E&M) Telehealth Visits within Community Oncology Practices M Karhade, N Mohammad, N Robert, N Wu, B Heller, S Alwardt, et al. (+3)
647 [GO] 2022―Jan―20 POSA32 Early COVID-19 Pandemic in Germany: Patient Characteristics and Clinical Outcomes S Pacis, U Maywald, T Wilke, M Ghiani
648 [GO] 2022―Jan―20 POSB242 Telemedicine Use During Year 2020 of the COVID-19 Pandemic in Older US Medicare Beneficiaries ML Davis-Ajami, ZK Lu, J Wu
649 [GO] 2022―Jan―20 POSC218 Study of Antibiotic Consumption Trends in Public Pharmacies during the COVID-19 Pandemic in Ukraine O Zaliska, O Semenov, Z Zabolotnya, N Maksymovych, O Brezden, B Zaliskyy, I Mudrak
650 [GO] 2022―Jan―20 POSA233 The Indirect Health Economic Consequences of the COVID-19 Pandemic on English Hospitals: A Scoping Review D Jones, L Barham
651 [GO] 2022―Jan―20 POSB223 Impact of the COVID-19 Pandemic on Influenza Vaccination Policies P Net, J de Renteria, F Bianic
652 [GO] 2022―Jan―20 P64 Evaluating the Impact of the COVID-19 Pandemic on Mortality after Myocardial Infarctions Hospitalization in Germany J Krieger, F Hardtstock, T Wilke, U Maywald
653 [GO] 2022―Jan―20 POSA363 Lasting Impacts of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe B Halioua, A Astruc, M Gourdon, A Bombezin--Domino, L Radoszycki
654 [GO] 2022―Jan―20 POSA279 The Impact of the COVID-19 Pandemic on the MHRA’s Early Access to Medicines Scheme P Ruane, R Brown, LE Francis, L Sam
655 [GO] 2022―Jan―20 P62 The Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Melanoma - Findings from a UK Melanoma Registry M Heinrich, D Mulgina, A Kudlac, C Ouyang, M Larkin, A Ofori
656 [GO] 2022―Jan―20 POSB174 Clinical and Economic Impact of Non-Pharmacological Interventions on the COVID-19 Pandemic: A Predictive Model Based on the Spanish Case E Viayna, FJ Candel, D Callejo-Velasco, R Ramos, J San-Roman, P Barreiro, et al. (+5)
657 [GO] 2022―Jan―20 POSA247 Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies during COVID-19 Pandemic: A Single-Arm, Before-and-After Study R Murteira, S Romano, I Teixeira, H Galante, S Sousa, A Teixeira Rodrigues
658 [GO] 2022―Jan―20 POSB248 Medication Management Practices for Non-Communicable Diseases during the Second Wave of the COVID-19 Pandemic: A Snapshot of the European Situation P Kardas, JFM van Boven, B Wettermark, E Menditto, H Pinnock, I Tsiligianni, T Agh
659 [GO] 2022―Jan―20 POSB396 Identification of Risk Factors Associated with ICU Admission in COVID-19 Patients I Kukreja, A Chopra, A Arora, V Verma, A Shukla
660 [GO] 2022―Jan―20 POSB13 Thirty-Day Readmission in US Hospitalized COVID-19 Patients E Mozaffari, S Liang, HM Stewart, M Thrun, P Hodgkins, R Haubrich
661 [GO] 2022―Jan―20 POSC44 Extra Regional COVID-19 Patients Transfers: A Retrospective Analysis of Distance, Time and Cost for Train, Helicopter and Fixed-Wing Ambulances A Girault, P Chauvin, P Cucharero Atienza, N Sirven, O Grimaud
662 [GO] 2022―Jan―20 POSC1 The Influence of Diabetic History in the Prognosis of Hospitalized COVID-19 Patients: A Prospective Observational Study A Issac, J Kochuparambil
663 [GO] 2022―Jan―20 POSB103 COVID-19 Positive Patients Hospital Management in the Italian Setting: The Economic Impact LB Ferrario, F Schettini, E Porazzi, M Dalla Bona, MB Pagani, T Dezi, et al. (+8)
664 [GO] 2022―Jan―20 POSC17 A TARGETED LITERATURE REVIEW TO COMPARE COVID-19 SYMPTOM DIARIES AND PATIENT-REPORTED CONCEPT K. Jarodia, K. Scippa, K. Rudell
665 [GO] 2022―Jan―20 POSA286 Early Experience with Health Technology Assessments for COVID-19 Treatments X Sitavu-Radu, T Tulika, R Rajani, S Vasileva
666 [GO] 2022―Jan―20 POSB360 Perception of COVID-19 Vaccination Among Chronic Patients: To Be or Not to Be Vaccinated? A Vives, L Armand, L Radoszycki, O Wilczynski
667 [GO] 2022―Jan―20 POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study B Jahn, G Sroczynski, M Bicher, C Rippinger, N Mühlberger, J Santamaria, et al. (+3)
668 [GO] 2022―Jan―20 POSC117 A Public Health and Budget Impact Analysis (BIA) of COVID-19 Vaccination in Austria M Traunfellner, F Meyer, E Walter
669 [GO] 2022―Jan―20 POSC407 Monitoring of Reported COVID-19 Vaccination Rates in Community Oncology Settings R Harrell, A Kwon, M Karhade, N Robert, N Wu, B Heller, et al. (+3)
670 [GO] 2022―Jan―20 P20 Evaluating Preferences and the Effect of Altruism on COVID-19 Vaccine Decisions: A Discrete Choice Experiment M Kelley, EF Drabo, CL Gong
671 [GO] 2022―Jan―20 POSB193 COVID-19 Vaccine Development Pipeline: 2021 R Ahlawat, R Singhal, A Rajput, R Goyal
672 [GO] 2022―Jan―20 POSB222 Can Gene Therapy Prices Remain the Same? What We Have Learned from the COVID-19 Vaccines K Sigurðardóttir, O Sola-Morales
673 [GO] 2022―Jan―20 POSA225 Comparing the US Drug Development, Pricing, Access, and Reimbursement Strategies for COVID-19 Vaccines as a Potential Model for Novel Oncology Therapies Y Lee, K Lee, H Park, M Neese, ZM Khan
674 [GO] 2022―Jan―20 POSB328 Barriers and Enablers for Adherence to Antiretroviral Therapy Among People Living with HIV/AIDS in the Era of COVID-19: A Qualitative Experience from a Low Middle-Income Country A Ahmed, J Dujaili, A Awaisu, FK Hashmi
675 [GO] 2022―Jan―20 POSC102 High-Flow Nasal Cannula in Patients with COVID-19: Is a Cost-Effective Alternative? JM Alves Junior, D Villagelin, FE Prota, A Chrispim, C Silva, E Yamanaka, et al. (+7)
676 [GO] 2022―Jan―20 POSC413 A Systematic Review of Real-World Clinical Practice Data in COVID-19: Non-Interventional Studies S Mishinova, J Gomon, A Kolbin, VV Strizheletsky, I Ivanov
677 [GO] 2022―Jan―20 P53 The Early Lessons of COVID-19: The Need for a Broader Health-Economic Perspective M Schöttler, S Van der Schans, M Postma, C Boersma
678 [GO] 2022―Jan―20 P23 Change in Healthcare Utilisation and Inpatient Mortality in Patients Hospitalised with Heart Failure during the Coronavirus Pandemic in England: A Retrospective Cross-Sectional Study Utilising HES D Jones, L Barham
679 [GO] 2022―Jan―20 POSB178 Geographical Inequalities in Coronavirus (SARS-COV-2) Mortality in Europe D Elmer, D Endrei, T Csákvári, N Németh, L Horváth, N Danku, et al. (+2)
680 [GO] 2022―Jan―20 POSB422 Machine Learning-Based Virtual Screening, Molecular Docking and Drug-Likeness to Discover New Inhibitors of the Glycoprotein Spike (S1) of SARS-CoV-2 AF Cobre, A Junkert, MM Fachi, B Böger, M Surek, A Wiens, et al. (+2)
681 [GO] 2022―Jan―20 POSA210 Decentralized Study Methods: A Summary of the Regulatory Landscape in the SARS-COV-2 Era and Beyond A Bevan, M Baltezegar
682 [GO] 2022―Jan―20 POSA310 Artificial Intelligence Applied on Administrative Big Data to Predict the Severity of SARS-COV-2 Infection B Iacolare, V Perrone, D Sangiorgi, A Ghigi, E Giacomini, C Nappi, et al. (+16)
683 [GO] 2022―Jan―20 P24 Telehealth Access and Use by the U.S. Medicare Population during the Pandemic T Swenson
684 [GO] 2022―Jan―20 POSA234 The Value of a Large Care Network in Delivering Continuity of Care to Clinically Extremely Vulnerable People During a Global Pandemic: A UK Case Study S Boeger, E Busink, G Dewsnap, K Basnayake, M Beaumont
685 [GO] 2021―Dez―11 The Effects of Severe Acute Respiratory Syndrome Coronavirus 2 on the Reported Mental Health Symptoms of Nonprofessional Carers: An Analysis Across Europe Luz María Peña-Longobardo, Juan Oliva-Moreno, Beatriz Rodríguez-Sánchez
686 [GO] 2021―Dez―08 Quantifying the Effect of Public Activity Intervention Policies on COVID-19 Pandemic Containment Using Epidemiologic Data From 145 Countries Jichao Sun, Yefeng Zheng, Wenhua Liang, Zifeng Yang, Zhiqi Zeng, Tiegang Li, et al. (+4)
687 [GO] 2021―Okt―16 Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review Oscar Lau, Nirma Khatri Vadlamudi
688 [GO] 2021―Sep―30 Cost-Effectiveness of Coronavirus Disease 2019 Policy Measures: A Systematic Review Sophie Vandepitte, Tijs Alleman, Ingmar Nopens, Jan Baetens, Samuel Coenen, Delphine De Smedt
689 [GO] 2021―Aug―05 Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories J. Jaime Caro, Jörgen Möller, Vatshalan Santhirapala, Harpreet Gill, Jessica Johnston, Kariem El-Boghdadly, et al. (+3)
690 [GO] 2021―Aug―05 Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios William F. Vásquez, Jennifer M. Trudeau
691 [GO] 2021―Jul―31 Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic Brittany R. Lapin, Wai Hong Wilson Tang, Ryan Honomichl, Olivia Hogue, Irene L. Katzan
692 [GO] 2021―Jun―04 PNS21 Protection Motivation Theory in Predicting Intention to Engage in Protective Behaviors Against NOVEL Coronavirus Diseases (COVID-19) G. Adunlin, H. Galadima, C. Cropp, J.C. Cagle
693 [GO] 2021―Jun―04 PMU1 Evolving Access Under COVID-19 J. Cook
694 [GO] 2021―Jun―04 PNS36 VALUE Based Procurement: A Tool to Make Better Purchasing Decisions after COVID-19 G. Prada, C. Brabata, D. Guarin, R. Iunes, R. Lenz, V. Zamora Mesia
695 [GO] 2021―Jun―04 PIN49 Developing a Predictive Algorithm to Identify the Key Factors Impacting on the Transmission and Fatalities from COVID-19 F. Kamgar, R. Hughes, S. Lucherini
696 [GO] 2021―Jun―04 PNS69 Burnout Syndrome Prevention In Nursing At Pandemic (Covid-19): A Literature Review F. Caballol-Avendaño, A. Flores-Hoyos, J. Guerra-Cruz, V. Merillu-González, F. Morales-Vizcarra, K. Reynaldos-Grandón
697 [GO] 2021―Jun―04 PCV40 Cardiovascular Outcomes Associated with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis H. Alkofide, R. Almesned, L. Alnoghaimshi, Z. Alkherb, G. Alhindi, G. Korayem
698 [GO] 2021―Jun―04 PIN52 Effectiveness in Reducing the Risk of Death and Severity of a SET of Measures Against COVID-19 : The Case of an Insured Population in the Colombian Caribbean F. Salcedo Mejía, L. Moyano, A. Lozano, N. Alvis Zakzuk, J.C. Fernandez Mercado, J. Paz Wilchez, N. Alvis Guzman
699 [GO] 2021―Jun―04 IN2 Characteristics of Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) across the Three Waves in the US: A Claims-Based Study Using a Large National Sample V. Divino
700 [GO] 2021―Jun―04 PIN81 Towards a Better Understanding of COVID-19 Among Young Adults Ages 18-24 Sands-Lincoln. M, H. Huang, G.P. Jackson, S. Wang
701 [GO] 2021―Jun―04 PNS13 Comparative Network Efficiency Analysis of Brazil Response to COVID-19 at State Level T. Nepomuceno, W.M. Silva, S.D.F. Gomes, T.F.O. Rodriguez
702 [GO] 2021―Jun―04 PIN56 Content Analysis of FDA Warning Letters for Fraudulent COVID-19 Claims Using the Economic, Clinical, Humanistic Outcomes (ECHO) MODEL J. Guo, J. Yang, J. Muzumdar, T. Park
703 [GO] 2021―Jun―04 PIN40 Risk Factors for Severe Outcomes in COVID-19 Confirmed or Suspected Beneficiaries Enrolled in Mississippi Medicaid Y. Rong, S. Ramachandran, E. Pittman, K. Bhattacharya, J.P. Bentley, B. Banahan, et al. (+2)
704 [GO] 2021―Jun―04 PMU29 Burden of COVID-19 Consequences: an Example of Post-viral Chronic Fatigue Syndrome D. Araja, U. Berkis, A. Lunga, M. Murovska
705 [GO] 2021―Jun―04 PIN67 Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods D. Sheinson, Y. Meng, D. Elsea
706 [GO] 2021―Jun―04 PIN58 The U.S. International Trade of Medical Products in the COVID-19 Era S.M. Preciado, K. Lotfi, E. Seoane-Vazquez, R. Rodriguez-Monguio, P. Brancazio
707 [GO] 2021―Jun―04 PRS24 Utilizing Blue Cross Blue Shield of Louisiana (BCBSLA) Risk of Hospitalization (ROH) AI Predictive Model to Help Louisiana Identify Patients at High Risk for a COVID-19 Hospital Admission J. Holloway, M. Cong, J. Ouyang, B. Vicidomina, S. Nigam
708 [GO] 2021―Jun―04 PCN238 COVID-19 Impact on Breast and Prostate Cancer Screening, Diagnosis, and Surgery: A Real-World Study from the Brazilian and Colombian Public Healthcare System Perspectives P.V.P. Lima, L. van der Werf, R. Ferreira, D. Kashiura, L. Ono, G. Julian, et al. (+2)
709 [GO] 2021―Jun―04 PNS14 Direct Medical Costs Related to COVID-19 in Colombia N. Alvis-Zakzuk, A. Florez-Tanus, D. Diaz-Jimenez, P. Chaparro-Narvaez, C. Castañeda-Orjuela, F. De La Hoz, et al. (+2)
710 [GO] 2021―Jun―04 PRS21 Quantifying the years of life lost due to COVID-19 in Colombia: preliminary estimates N. Alvis-Zakzuk, N. Alvis-Guzman, D. Diaz-Jimenez, C. Dueñas Castell, J. Rojas-Suarez, J.C. Fernandez Mercado, et al. (+3)
711 [GO] 2021―Jun―04 PIN32 A Systematic Literature Review of the Economic Burden of Hospitalized Adults with COVID-19 in Europe and Asia E. Achter, Y. Shen, R. Goldgrub, R. Kendall, D. Shah
712 [GO] 2021―Jun―04 PDB48 Increased Mortality of COVID-19 in Patients with Diabetes: A Retrospective Cohort Study in a Health PLAN in Brazil J. Busch, J.P. Reis Neto
713 [GO] 2021―Jun―04 PIN41 The Public Health Implications of Google Trends and News Coverage for COVID-19 in the Early Epidemic Stage: A Multinational Study in Eight Countries F. Huang, G. Feng, T. Liu, Q. Chen, T. Jian, Q. Zhong, et al. (+4)
714 [GO] 2021―Jun―04 PIN22 A Systematic Literature Review of the Economic Burden of Hospitalized Adults with COVID-19 in the USA Y. Shen, R. Goldgrub, E. Achter, R. Kendall, D. Shah
715 [GO] 2021―Jun―04 PIN42 Molecular Testing Dynamics Is Reactive to COVID-19 Incidence: Observations from the Colombian Experience A. Lozano, J. Zakzuk, F. Salcedo Mejía, L. Moyano, N. Alvis-Zakzuk, N.R. Alvis-Zakzuk, N. Alvis-Guzman
716 [GO] 2021―Jun―04 IN4 Non-Health Considerations in Economic Evaluations of COVID-19 Interventions: A Systemic Review M. Podolsky, D. Kim, P.J. Neumann
717 [GO] 2021―Jun―04 PIN44 COVID-19 Knowledge, and Mental Health IMPACT Assessment in Haiti Y. Gousse, T. Jean
718 [GO] 2021―Jun―04 PMH19 Evaluation of Symptoms of Depression Amongst People with Substance Use during COVID-19 Lockdown in India: A CROSS-Sectional Study P.B. Samaksha, R.K. Puvvada
719 [GO] 2021―Jun―04 PDG40 Assessing the Tuscany Region Response to COVID-19 Lockdown in NON-Hospital Supply of Antidiabetic Drugs: An Interrupted Time Series Analysis E. Guidotti, S. Manetti, M. Vainieri, F. Attanasio, N. Orsini
720 [GO] 2021―Jun―04 PRS17 Economic Impact of COVID-19 Lockdown on Households in Nigeria F. Fatoye, T. Gebrye, O.O. Arije, C. Fatoye, O. Onigbinde, C. Mbada
721 [GO] 2021―Jun―04 PIN77 Engagement in Preventive Behaviors Following Exposure to COVID-19 News on Social Media T. Park, I. Ju, J. Ohs, A. Hinsley, J. Muzumdar
722 [GO] 2021―Jun―04 PMU48 The IMPACT of COVID-19 on European Health Technology Assessments P. Wagner, J. Zlateva, A. van Engen, S. Plantör
723 [GO] 2021―Jun―04 PMU45 The Impact of COVID-19 on Patient Management across the EU and US J. Piercy, E.A. Holdsworth, J. Austin, M.J. Hughes, K. Khela, G. Taylor-Stokes, J. Hall
724 [GO] 2021―Jun―04 PNS67 Gaining Trust in the Use of Virtual Meetings for Health Technology Assessment during the COVID-19 Pandemic J. Dickson, M. Pierre, L. Lockhart, J. McCormack
725 [GO] 2021―Jun―04 PNS56 Survey of the Awareness of Pharmacists about Quarantine Measures during the COVID-19 Pandemic O. Semenov, O. Zaliska, N. Maksymovych, V. Huz, Z. Zabolotnya
726 [GO] 2021―Jun―04 PMU58 Americans' Health Priorities during the COVID-19 Pandemic J. Cook, M. Pittaoulis, K. Gilchrist, J. Alderfer, M. Sapia
727 [GO] 2021―Jun―04 PMH24 Demographic and Clinical Factors Associated with Post Traumatic Stress Disorder (PTSD) during the COVID-19 Pandemic B.L. Rosario, H. Huang, G.P. Jackson, B. Kolt, S. Wang
728 [GO] 2021―Jun―04 PIN8 Application of Innovative Pricing in Response to the COVID-19 Pandemic C. Akunne, B. Connelly, S. Bathija
729 [GO] 2021―Jun―04 PDB28 Innovative Application of a Mobile APP for Gestational Diabetes Health Education in the Era of the COVID-19 Pandemic and BIG DATA G. Feng, F. Huang, Q. Chen, Q. Zhong, T. Liu, D. Hao, et al. (+3)
730 [GO] 2021―Jun―04 PRS32 Management Of The Covid-19 Pandemic Around Public Health: Ethical Perspectives C. Alcayaga, V. Loor-Sánchez, N. Oyarce-Hormazábal, M.P. Riveros-Riveros, K. Reynaldos-Grandón
731 [GO] 2021―Jun―04 PNS25 Changing in Health Care Service Demand during the COVID-19 Pandemic in 2020: A Study Case of a Subsidized Health Care Company in the Caribbean Region of Colombia F. Salcedo Mejía, L. Moyano, A. Lozano, N. Alvis Zakzuk, J.C. Fernandez Mercado, J. Paz Wilchez, N. Alvis Guzman
732 [GO] 2021―Jun―04 PIN55 Strategies, Ministers of Health and New Regulations: Did We Win or Were We Won By the COVID-19 Pandemic in Brazil? R. Arcaro, C.R. Pereira da Veiga, C. Da Veiga
733 [GO] 2021―Jun―04 PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia J. Pesa, J.N. Liberman, M. Petrillo, C. Ruetsch
734 [GO] 2021―Jun―04 PMU5 IMPACT of Telehealth Utilization during the COVID-19 Pandemic on Health Care Resource Utilization P. Arora, J. Ha, D. Mehta
735 [GO] 2021―Jun―04 PUK19 DATA Quality Considerations for Determining the IMPACT of the COVID-19 Pandemic on Outpatient Visits and Procedures in the United States P. Brendel, R. Jain, A. Lien, D. Lee, J.B. Shelton, R. Fang, et al. (+4)
736 [GO] 2021―Jun―04 PMU63 Post-Lockdown Impact of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in the United States B. Halioua, J. Zetlaoui, A. Astruc, M. Harrizi, A. Bombezin--Domino, L. Radoszycki
737 [GO] 2021―Jun―04 PIN20 Predicting the IMPACT of Vaccination Strategies in the COVID-19 Pandemic Using a Susceptible-Exposed-Infectious-Removed (SEIR) MODEL W. Song, Y. Yi
738 [GO] 2021―Jun―04 PCN120 Clinical and Economic Consequences of Delayed Care Due to the COVID-19 Pandemic- Focus on Mammograms and Breast Cancer K. Infante, N. Eslami, S. Garfield
739 [GO] 2021―Jun―04 PIN47 COVID-19 Patient Severities in Japanese EMR M. Okada, S. Wada, M. Isshiki, S. Utsunomiya, T. Akiyama, K. Hamada, S. Demiya
740 [GO] 2021―Jun―04 PIN74 Health-Related Quality of Life (HRQoL) in COVID-19 Patients - a Systematic Literature Review N. Goli, N. Kayam, N. Kumar, D. Shah
741 [GO] 2021―Jun―04 PIN46 COVID-19 Patients Analysis Utilizing JAPAN and US Claims Databases S.W. Kim, T. Ishii, S. Takeno, Y. Kado, Y. Tamai, T. Akiyama, et al. (+2)
742 [GO] 2021―Jun―04 PIN64 Identifying COVID-19 Patients from Unstructured Notes: Performance of a Commercial Clinical Named Entity Recognition System V. Kumar, L. Rasouliyan, S. Long, M.B. Rao
743 [GO] 2021―Jun―04 IN1 Treatment Journey of COVID-19 Patients in Hospital Settings R. Moon, N. Rosenthal, H. Brown
744 [GO] 2021―Jun―04 IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States F. Sun, S. Jeyakumar, N. Smith
745 [GO] 2021―Jun―04 ML2 Supervised Machine Learning Predicts Mortality in COVID-19 Patients Using Electronic Health Records X. Marinaro, Z. Meng, X. Zhang, K. Lodaya, D.K. Hayashida, S. Munson, F. D'Souza
746 [GO] 2021―Jun―04 PIN1 Polypharmacy Among COVID-19 Patients: A Prisma-Based Systematic Review of Available Literature S. Iloanusi, O. Mgbere, E.J. Essien
747 [GO] 2021―Jun―04 PDG17 Adverse Drug Reactions Associated to Hydroxychloroquine and Remdesivir in COVID-19 Patients: Analysis of Reported ADR to the Portuguese Pharmacovigilance System R. Ivos, I. Ribeiro-Vaz, J. Polónia, A. Silva
748 [GO] 2021―Jun―04 PRS30 COVID-19 RAPID Antigen Test False Positives and False Negatives Reported to the FDA Manufacturer and User Facility Device Experience Database M. Zettler, A. Gajra, B. Feinberg
749 [GO] 2021―Jun―04 PIH22 Efficacy Of Telephone-Based Educational Intervention On Knowledge Transfer Of COVID-19 Related Health Topics To Elderly Citizens In Hong Kong: A Pilot Study M.Y. Fung, Y.H. Lee, Y.T.A. Lee, M.L. Wong, J.T.S. Li, V. Lee
750 [GO] 2021―Jun―04 PIN34 COVID-19 Related Knowledge, Attitude and Practices in a Southeastern City in Nigeria: A Cross-Sectional Survey N.J.R. Iloanusi, S. Iloanusi, O. Mgbere, A.I. Ajayi, E.J. Essien
751 [GO] 2021―Jun―04 PIN83 The COVID-19 Research Database: Building One of the Largest PRO Bono Real-World DATA Repositories A. Talwai, V. Wing, Y. Itzkovich, A. Galaznik, A. Chatterjee, R. Jain, J. LaBonte
752 [GO] 2021―Jun―04 PNS105 Patient Preferences and Feedback Regarding Daily Reporting of COVID-19 Symptoms Using Personal Smartphones for the Obvio-19 Study S. Dallabrida, H. Linke, P. Shah, M. Culbreth-Notaro
753 [GO] 2021―Jun―04 PIN54 Analysis of COVID-19 Treatment Drugs Availability in Ukraine O. Blavatska, I. Blavatskyi
754 [GO] 2021―Jun―04 PIN63 Choosing the Right COVID-19 Vaccine: A Multiple Stakeholder Multicriteria Decision Analysis For the Assessment of Available Vaccines in Latin America M.A. Espinoza, J. Guzman, J. Soto, G. Hernandez, D. Guarin, V. Boers Trilles, M. Martin De Bustamante
755 [GO] 2021―Jun―04 PIN5 Immunogenicity and Safety of the COVID-19 Vaccines Compared to Controls in Healthy Adults: A Systematic Review O. Lau, N. Vadlamudi
756 [GO] 2021―Jun―04 PIN35 Prevalence of COVID-19 vs. Seasonal Influenza: A Population-Based National Survey of US Adults K. Rajagopalan, B. Mahadik
757 [GO] 2021―Jun―04 PNS86 How US Clinical Trials Are Being Reimagined in a COVID-19 World C. Hildreth, K. Infante, N. Eslami, S. Garfield
758 [GO] 2021―Jun―04 PIN50 Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19: A Comparison of Two Methods S. Emerson, K. Johnston, A. Howarth, J. Schneider, M. Friesen, S. Szabo
759 [GO] 2021―Jun―04 PIN51 Role of Asymptomatic Carriers in the Transmission of COVID-19: A Review U. Abubakar, M. Hammad
760 [GO] 2021―Jun―04 PND48 Real World Data and COVID-19: Healthcare Impact in Emergency Care, Stroke Emergency Care and Stroke-Related Deaths in Chile L. Paez, R. Lenz, D. Paredes
761 [GO] 2021―Jun―04 PIN59 COVID-19: The Real-World Hospitalized Patient Experience L. Rasouliyan, V. Kumar, S. Long, M.B. Rao
762 [GO] 2021―Jun―04 PRS28 A Scoping Review of Consequences of Untreated Stroke: Economic Burden Due to COVID-19? K. Hernández, D. Paredes, R. Lenz
763 [GO] 2021―Jun―04 PMH18 Emotional Well-Being Among Pharmacy Students during the COVID Pandemic M. Zakeri, La Cruz A De, D. Wallace, S.D. Sadeghi, S.S. Sansgiry
764 [GO] 2021―Jun―04 MT1 Telehealth Utilization and Multiple Sclerosis Imaging Utilization in Four MS Centers during the COVID Pandemic: Real-world evidence from the MS-CQI improvement research collaborative. A. Chen, M. Molaei, A. Vaeth, K. Walsh, B. Oliver
765 [GO] 2021―Apr―19 Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic Jagpreet Chhatwal, Maarten J. Postma
766 [GO] 2021―Mrz―11 Societal Effects Are a Major Factor for the Uptake of the Coronavirus Disease 2019 (COVID-19) Digital Contact Tracing App in The Netherlands Niek Mouter, Marion Collewet, G. Ardine de Wit, Adrienne Rotteveel, Mattijs S. Lambooij, Roselinde Kessels
767 [GO] 2021―Mrz―10 Statistical Decision Properties of Imprecise Trials Assessing Coronavirus Disease 2019 (COVID-19) Drugs Charles F. Manski, Aleksey Tetenov
768 [GO] 2021―Mrz―09 Quality-Adjusted Life-Year Losses Averted With Every COVID-19 Infection Prevented in the United States Anirban Basu, Varun J. Gandhay
769 [GO] 2021―Mrz―06 Minimizing Population Health Loss in Times of Scarce Surgical Capacity During the Coronavirus Disease 2019 Crisis and Beyond: A Modeling Study Benjamin Gravesteijn, Eline Krijkamp, Jan Busschbach, Geert Geleijnse, Isabel Retel Helmrich, Sophie Bruinsma, et al. (+7)
770 [GO] 2021―Feb―21 Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies Jidi Zhao, Huajie Jin, Xun Li, Jianguo Jia, Chao Zhang, Huijuan Zhao, et al. (+9)
771 [GO] 2021―Feb―21 How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Adrian Towse, Kalipso Chalkidou, Isobel Firth, Hannah Kettler, Rachel Silverman
772 [GO] 2020―Dez―11 PIN166 Health-Related Quality of Life (HRQOL) Outcomes and Potential Interventions in Patients Diagnosed with COVID-19. M. Sehgal, V. Pandey
773 [GO] 2020―Dez―11 PMD34 RAPID Medtech Innovation Briefings for COVID-19 R. Owens, Y. Wang, K. Carter
774 [GO] 2020―Dez―11 PIN170 The NOVEL Coronavirus Disease (COVID-19): Impacts on TESTS and Hospitalizations Performance in a Health PLAN in Brazil J. Busch, J.P. Reis Neto
775 [GO] 2020―Dez―11 PUK14 ACUTE Renal Failure during COVID-19 and Its LONG-TERM IMPACT on Health System S. Boeger, J. Petrovic, E. Busink, C. Apel, F. Kircelli, R. Pohlmeier
776 [GO] 2020―Dez―11 PIN167 Patient-Reported Outcomes to Capture the Signs, Symptoms and Impacts of COVID-19 and the IMPACT of the Pandemic on People with and without Infection M. Reaney, K. Heuer, J. Turnbull, J. Paty
777 [GO] 2020―Dez―11 CO2 WHEN Could a Second Wave of COVID-19 Appear in Germany and How Strong Will IT be? a Simulation Analysis S. Walzer
778 [GO] 2020―Dez―11 PIN120 The IMPACT of LONG-TERM Exposure to PM2.5, PM10 and NO2 Air Pollutants on the Age-Adjusted Mortality RATE of COVID-19 Based on the Example of Poland. A. Musiałek, A. Nosowicz
779 [GO] 2020―Dez―11 PIN122 Racial Disparity in COVID-19 Burden at the US Epicenter M. Bhattacharyya, R. Bhattacharyya, L.E. Miller, A.L. Miller, C. Stewart, S. Rojanasarot
780 [GO] 2020―Dez―11 PIN78 County-level differences in COVID-19 cases and fatalities in Germany A. Batscheider, J.A. Gossmann, R.A. Greiner, E. Shlaen, B. Antoni, D. Böckmann, et al. (+2)
781 [GO] 2020―Dez―11 PIN81 Within Country Regional Inequalities of the Incidence of Coronavirus Disease 2019 (COVID-19) Caused By Sars-COV-2 VIRUS in Hungary I. Boncz, A. Sebestyén, J. Betlehem, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
782 [GO] 2020―Dez―11 PIN112 Geographical Inequalities of the Incidence of Coronavirus Disease 2019 (COVID-19) Caused By Sars-COV-2 VIRUS in the European Union I. Boncz, E. Dora, A. Sebestyén, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
783 [GO] 2020―Dez―11 CO1 Mapping The Landscape Of Covid-19 Clinical Trials In The US: Assessing The Opportunities And Gaps In Trial Designs, Interventions And Endpoints Z. Kocaata, I. Simankova, T. Wilke
784 [GO] 2020―Dez―11 PNS245 Do Patient Preferences Change in a Pandemic? Exploring Italian Patient Reported Experience DATA during the COVID-19 Crisis K. Jamieson Gilmore, S. De Rosis, S. Nuti
785 [GO] 2020―Dez―11 PIN124 Analysis of Race and Ethnicity of COVID-19 Deaths in the United States C. Xavier, R. Rasu
786 [GO] 2020―Dez―11 PIN114 Estimation of Quality-Adjusted Life YEARS (QALY) Losses Associated with COVID-19 Deaths in Ukraine V. Serediuk, O. Piniazhko, O. Topachevskyi, T. Dumenko, L. Kovtun
787 [GO] 2020―Dez―11 PIN117 Identification of Patients with COVID-19 Infection Prior to the New COVID-19 Diagnostic Code - a Premier Database Analysis. C. Holy, S. Shah, N. Elangovanraaj, D. Krishnan, S. Gupta, P. Trivedi, et al. (+4)
788 [GO] 2020―Dez―11 PRS41 Understanding the Clinical Burden of ACUTE Respiratory Distress Syndrome (ARDS) in a COVID-19 Era - a Targeted Search and Epidemiological MODEL D. Tomaras, S. Harricharan, G. Tremblay, F. Anna
789 [GO] 2020―Dez―11 PCN224 An Italian Experience: How the COVID-19 Era HAS Modified the Radiological Activity in a Cancer Hospital A. Rossi, A. Prochowski Iamurri, C. Cerchione, N. Gentili, V. Danesi, M. Altini, et al. (+2)
790 [GO] 2020―Dez―11 PNS10 Research in the COVID-19 Era: Accelerating the Shift in the Research Paradigm from Traditional Towards Digital/Virtual Solutions D. Stein, M. Baltezegar
791 [GO] 2020―Dez―11 PIN178 Impact of Selected Comorbidities on Healthcare Resource Utilization Among Hospitalized Patients with COVID-19 in a US Population Z. Icten, I. Livingstone, J. Menzin
792 [GO] 2020―Dez―11 PMH16 Productivity, Depression, and Measures to Reduce Social IMPACT: The Economic IMPACT of COVID-19 in Brazil R. Andrade, D. Sansone, D. Farah, R. Garcia, G. Tannus, M. Fonseca
793 [GO] 2020―Dez―11 PIN90 Characteristics of Patients Died Due to Coronavirus Disease 2019 (COVID-19) in Hungary I. Boncz, J. Betlehem, E. Dora, Z. Kívés, R. Vajda, B. Molics, et al. (+2)
794 [GO] 2020―Dez―11 PIN65 Socio-Economic Burden of COVID-19 in Russian Federation A. Kolbin, J. Gomon, Y. Balykina, D. Belousov, I. Ivanov
795 [GO] 2020―Dez―11 PIN75 Characteristics of Patients Diagnosed with COVID-19 in the US: A Descriptive Claims-Based Study from a National Perspective V. Divino, Y. Wang, C. Beggs, M. DeKoven
796 [GO] 2020―Dez―11 PIN87 Comparing Methodologies to Predict Incidence of COVID-19 in US Counties P. Coplan, S. Shah, A. Bhardwaj, A. Gurubaran, H. Dwarakanathan, G. Cafri, et al. (+5)
797 [GO] 2020―Dez―11 IN3 Impact of Government Measures on COVID-19 Incidence of Reported New Cases: An Analysis of 9 Countries S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
798 [GO] 2020―Dez―11 PIN17 Healthcare Resource Utilization and Cost in Patients with Inpatient Mortality Due to COVID-19 Infection C. Holy, S. Shah, N. Elangovanraaj, D. Krishnan, S. Gupta, P. Trivedi, et al. (+5)
799 [GO] 2020―Dez―11 PIN82 The Influence of Social Distancing on COVID-19 Infections in the U.S. P. Coplan, G. Cafri, R. Khanna, A.S. Chitnis, B. Nandi, H. Dwarakanathan, et al. (+5)
800 [GO] 2020―Dez―11 PIN68 COVID-19 Simulator: An Interactive Tool to Inform COVID-19 Intervention Policy Decisions in the United States J. Chhatwal, O. Dalgic, P. Mueller, M. Adee, Y. Xiao, M.A. Ladd, et al. (+2)
801 [GO] 2020―Dez―11 PMH29 To Assess the Psychological IMPACT of COVID-19 Lockdown Among Healthy Individuals in India. S. P.B., K. Undela, R.K. Puvvada, B. Gupta, K. Manohar Rao, S. Palaksha
802 [GO] 2020―Dez―11 PIN139 The Cost-Effectiveness of COVID-19 Lockdowns in the United States R. Becker
803 [GO] 2020―Dez―11 PIN85 The Application of Global Influenza Pandemic Mortality Progression and Vaccine Production Strategies As Analogues for COVID-19 Management and Understanding. C. Fidler
804 [GO] 2020―Dez―11 CO3 Effectiveness of Government Measures to Reduce COVID-19 Mortality across 5 Different Countries S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
805 [GO] 2020―Dez―11 PRS56 Cost-Effectiveness of Social Distancing to Reduce COVID-19 Mortality in the United States B. Bloudek, K. Migliaccio-Walle, P.J. Barrett, V. Nguyen, L. Bloudek
806 [GO] 2020―Dez―11 PNS173 Impact of COVID-19 on HTA Bodies and Pharmaceutical Company Pricing and Market Access Activities M. Thomas, P. Craddy, G. Foxon
807 [GO] 2020―Dez―11 PCN3 IMPACT of COVID-19 on Immunotherapy Utilization in Metastatic NON-SMALL Cell LUNG Cancer P. Chopra, Y. Zhai, M. Myers
808 [GO] 2020―Dez―11 PCN293 Understanding Real-World Experiences and Impacts of COVID-19 on Patients with Breast Cancer: A Social MEDIA Listening Analysis S. Halhol, M. Raluy-Callado, M. Oguz, A. Booth
809 [GO] 2020―Dez―11 PNS263 Pandemics and Access to Care: Use of Real-World DATA to Examine the IMPACT of COVID-19 on Pharmacy Visits in JAPAN M. LoPresti, T. Seo, N. Sato
810 [GO] 2020―Dez―11 PMU84 IMPACT of COVID-19 on Physician Engagement and Life Science Companies' Digital and Operational Strategy N. Eslami, B. Harris, V. Parris, P. Sharan, S. Butler, K. Infante, et al. (+3)
811 [GO] 2020―Dez―11 PMD42 The IMPACT of COVID-19 on Telemedicine in Ophthalmology: A Literature Review D. O'Boyle, F. Carones, K. Darcy, B.S. Malyugin, R. Rejdak, L. Moccaldi, F. Vidal Aroca
812 [GO] 2020―Dez―11 PRO103 The IMPACT of COVID-19 on the Future Pricing and Market Access of RARE Diseases and CELL-/GENE-Therapies C. Teale, A. Roldan-Gomendio, S. Heinz, C. Sayadian, N. Jimenez
813 [GO] 2020―Dez―11 PIN123 How Much Will the COVID-19 Outbreak Have Cost the German Health Care System in the First Months Since the Outbreak? S. Walzer, L. Vollmer, S. Krenberger
814 [GO] 2020―Dez―11 PSU20 Attitude of Hungarian Adults Towards Emergency Plans before COVID-19 Outbreak in Hungary A. Kovács, A. Oláh, A. Pakai, E. Inhoff, G. Far, K. Wirthné-Gyergyák, et al. (+2)
815 [GO] 2020―Dez―11 PIN173 Studying Fake News on Twitter during the COVID-19 Pandemia in France A. Gedik, P. Foulquié, S. Renner, A. Mebarki, N. Texier, S. Schück
816 [GO] 2020―Dez―11 PIN66 A Scoping Review of the Literature on the Multifactorial Health-Economics Burden Caused By the COVID-19 Pandemic L. Chillotti, N. Largeron, G. Olivera
817 [GO] 2020―Dez―11 PIN126 Russian Mandatory Medical Insurance System Response to COVID-19 Pandemic M. Avxentyeva, V. Omelianovskiy, I. Zhelezniakova
818 [GO] 2020―Dez―11 PIN133 Medical Human Resource NEEDS of Chinese Health Professionals during the COVID-19 Pandemic. W. Hao, Z. Zhuang, W.K. Ming
819 [GO] 2020―Dez―11 PIN152 How Much Does a Life Cost? Lessons from the COVID-19 Pandemic A. Estévez-Carrillo, M. Cerezales, C. Crespo
820 [GO] 2020―Dez―11 PMD33 Estimating Societal Costs Associated with Vision Loss and Delayed Cataract Surgery: The Potential IMPACT of the COVID-19 Pandemic. D. O'Boyle, R. Busutil, L. Moccaldi
821 [GO] 2020―Dez―11 PMU7 Efficiency-Based Protocols for BEDS Evacuation during the COVID-19 Pandemic T. Nepomuceno, W.M.D.N. Silva, L.G.D.O. Silva
822 [GO] 2020―Dez―11 PNS21 From Disease Burden to Healthcare Cost: Highlighting the Health Economics Aspects of the COVID-19 Pandemic K. Athanasakis, N. Nomikos, K. Souliotis, J. Kyriopoulos
823 [GO] 2020―Dez―11 PNS126 Simpli - a Capacity Simulator for Evaluating Measures to Reduce the Backlog of Hospital Services after the COVID-19 Pandemic C. Bandeiras, F. Oliveira, M. Mota, R. Moita Fidalgo, A. Oliveira, C. Franco, et al. (+4)
824 [GO] 2020―Dez―11 PUK21 The VALUE of a Sustainable and Resilient Technical Service Network and Its Importance in Times of the COVID-19 Pandemic C. Hornig, E. Busink, B. Lababidi, M. Luckau, T. Pohl, C. Mutz
825 [GO] 2020―Dez―11 SP3 Should I Choose Artificial Intelligence or Clinicians' Diagnosis? a Discrete Choice Experiment of Patients' Preference UNDER COVID-19 Pandemic in China T. Liu, W. Tsang, F. Huang, W.K. Ming
826 [GO] 2020―Dez―11 PIN49 Influenza Vaccination and Its IMPACT on the Availability Intensive Care Unit BEDS during the COVID-19 Pandemic in Colombia M. Pareja, S. Londono, M. Moreno
827 [GO] 2020―Dez―11 PCV78 Clinical Pharmacists Assistance during COVID-19 Pandemic in Patients with ACUTE Coronary Syndrome at a Tertiary Care Hospital in India. O. Gona, R. Madhan
828 [GO] 2020―Dez―11 PIN154 QALY Losses Attributable to COVID-19 Pandemic in Spain V. Hernando, M. Brosa
829 [GO] 2020―Dez―11 PMU85 IMPACT of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in Europe B. Halioua, J. Zetlaoui, A. Astruc, T. Lévy-Heidmann, D. Testa, A. Bombezin--Domino, L. Radoszycki
830 [GO] 2020―Dez―11 PMU109 IMPACT of the COVID-19 Pandemic on Patients with Immune-Mediated Inflammatory Diseases Taking a Biologic Therapy B. Halioua, J. Zetlaoui, A. Astruc, D. Testa, A. Bombezin--Domino, L. Radoszycki
831 [GO] 2020―Dez―11 PMH25 The IMPACT of the COVID-19 Pandemic on the Mental Health of US Adults: A CROSS-Sectional Study A. Morlock, R. Morlock, S. Holmstrom
832 [GO] 2020―Dez―11 PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis W. Padula, S. Malaviya, N. Reid, F. Chingcuanco, J. Ballreich, J. Tierce, G.C. Alexander
833 [GO] 2020―Dez―11 PCN216 An Innovative Organization MODEL to Face Risks Reduction Challenges in an Italian Cancer Center during the COVID-19 Pandemic: A Risk Reduction Estimation Study N. Gentili, A. Roncadori, I. Massa, C. Florescu, L. Bertoni, F. Galardi, et al. (+7)
834 [GO] 2020―Dez―11 PCN353 Oncology Treatments during COVID-19 Pandemic: IMPACT in a Health Care PLAN in Brazil J.P. Reis Neto, J. Busch
835 [GO] 2020―Dez―11 PNS116 Maintaining Routine Healthcare for Chronic Medical Conditions during the COVID-19 Pandemic: What WE CAN Learn from Australia Z.M. Thet Lwin, T.C. Higgins, K. Winn, K.H. Naing
836 [GO] 2020―Dez―11 PIN8 A MODEL for Estimation of Possible COVID-19 Patient Numbers in Turkey S. Öztopçu, E.B. Karahan, S. Ökçün, M. Kurnaz, G. Oğuzhan, Z. Caliskan, G. Kockaya
837 [GO] 2020―Dez―11 PDB45 Obesity: A Major Risk Factor for Adverse Outcomes Among Young COVID-19 Patients R. Kashambwa, Z. Drebert
838 [GO] 2020―Dez―11 PIN108 Using the Apriori Algorithm to Identify Risk Factors Associated with Survival and Mortality Among COVID-19 Patients A. Vashisht, C. Holy, S. Shah, N. Elangovanraaj, S. Johnston, P. Coplan
839 [GO] 2020―Dez―11 PIN171 A Real-World DATA Analysis of Mortality and Heart Arrhythmia Risk in Hospitalized COVID-19 Patients Treated with Hydroxychloroquine Z. Drebert, R. Kashambwa
840 [GO] 2020―Dez―11 PIN56 Cost of COVID-19 Patients Treatment in Turkey E.B. Karahan, S. Öztopçu, M. Kurnaz, S. Ökçün, Z. Caliskan, G. Oğuzhan, G. Kockaya
841 [GO] 2020―Dez―11 ML4 Application of Machine Learning Models to Evaluate COVID-19 Related ICU Utilization in a US Population Z. Icten, C. Chan, M. Munsell, J. Menzin
842 [GO] 2020―Dez―11 PNS198 Arogya Setu Mobile Application for COVID-19 Self-Assessment, Education and Participatory Disease Surveillance: Perception Among Medical and Technology University Students. J. Kochuparambil, A. Nidha
843 [GO] 2020―Dez―11 PUK20 Reimbursement Landscape in Europe As Hurdle or Accelerator of HOME Hemodialysis in COVID-19 Times E. Busink, J. Petrovic, D. Kendzia, S. Boeger, C. Apel
844 [GO] 2020―Dez―11 PIN79 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Population M. Costa, P. Net, D. Proshenska, F. Bianic, F. Guelfucci
845 [GO] 2020―Dez―11 PIN107 What Would be the Public Health Benefits of a COVID-19 Vaccine? Results from a Preliminary Assessment in the French Elderly Population P. Net, M. Costa, D. Proshenska, F. Bianic, F. Guelfucci
846 [GO] 2020―Dez―11 PNS206 Projecting the COVID-19 Weekly Deaths and Hospitalizations for Jefferson County, Kentucky P. Naiya
847 [GO] 2020―Dez―11 PIN3 Chloroquine and Hydroxychloroquine in COVID-19 with or without Azithromycin: A Systematic Review of in Vitro and Clinical Studies M. Jameleddine, N. Harzallah, H. Grati, M.C. Jebali, C. Hamouda
848 [GO] 2020―Dez―11 PMU82 Increasing Importance of Digital CME in a Post COVID-19 World N. Eslami, K. Infante, B. Harris, G. Erickson, C. Hoyvald, S. Garfield
849 [GO] 2020―Dez―11 PMU5 The Future of Market Access in a Post COVID-19 World - What Do WE Need to Do Differently? C. Teale, S. Morrison, R. Zeidman, R. Tolley, L. Flemingq
850 [GO] 2020―Dez―11 PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives K. Skaltsa, C. Ivanescu, M. Reaney
851 [GO] 2020―Dez―11 PIN110 Socioeconomic Factors Impacting COVID-19-Related Mortality in the United States E. Ridgway, N. Savant, G. Pauletti, J.A. Pieper, P. Juang
852 [GO] 2020―Dez―11 PMU59 The IMPACT of COVID-19: A Comparison of the Number of Regulatory and Health Technology Assessments between the First SIX Months of 2019 and 2020 M. Salvador, K.E. Young
853 [GO] 2020―Dez―11 PIN70 Knowledge Towards Universal Safety Precautions Among Healthcare Population in India during Initial Phase of COVID-19: A Web Based Survey J. Kochuparambil, A. Issac, S. George, N.K. Panicker
854 [GO] 2020―Dez―11 PRS81 Insights into the Coronavirus Disease Perceptions in Pakistan W. Ullah, H. Almansour, G. Victor, S. Hussain, A.J. Pienaar
855 [GO] 2020―Dez―11 CL4 Concerns, Quality of Life, Access to Care and Productivity of the General Population during the First 8 WEEKS of the Coronavirus Lockdown in Belgium and the Netherlands R. Michels, L.M.A. Goossens, R. Bruin, H. van Ballegooijen, M. Krol
856 [GO] 2020―Dez―11 PIN153 Lessons Learned from Economic Models of Influenza Vaccines and Applications to SARS-CoV-2 J. Benner, N. Adair, M. Friedman, J. Menzin, M. Sussman
857 [GO] 2020―Dez―11 PMU28 Multimodal Strategy to Control and Mitigate a Sars-COV-2 Epidemic Outbreak in the Emergency Service of Highly Complex Hospital in Santiago De Chile M. Galvez, J. Retamal, M. Chepo, K. Mondaca, C. Silva, N. Febré
858 [GO] 2020―Dez―11 PRS65 US Sars-COV-2 Geospatial Predictive Weather Mapping MODEL: Application of Machine Learned Bayesian Networks to Healthcare Decision Making J. Vanderpuye-Orgle, D. Erim, M. Maruszczak, S. Pandey, A. Shields, M. Keywood, et al. (+2)
859 [GO] 2020―Dez―11 PIN71 Comparison of Seasonality of Common Viral and Respiratory Diseases VS Emergence of Sars-COV-2 Infection D. Krishnan, C. Holy, S. Shah, N. Elangovanraaj, S. Gupta, P. Trivedi, et al. (+3)
860 [GO] 2020―Dez―11 PIN74 The Impact of Social Distancing on Sars-COV-2 Mortality: A US Analysis A. Gurubaran, C. Holy, S. Shah, B. Nandi, H. Dwarakanathan, A. Bhardwaj, et al. (+2)
861 [GO] 2020―Dez―11 PIN115 Understanding Sars-COV-2 Mortality: IMPACT of Population and Mobility Metrics S. Shah, B. Ray, C. Holy, M. Sakthivel, N. Elangovanraaj, D. Krishnan, et al. (+5)
862 [GO] 2020―Dez―11 PIN111 Predicting the Decline in Sars-COV-2 New Infections: A Modelling Analysis of US Counties H. Dwarakanathan, O. Kakade, A. Bhardwaj, C. Holy, A. Gurubaran, S. Shah, P. Coplan
863 [GO] 2020―Dez―11 PRS58 IMPACT of Sars-COV-2 on Provided Healthcare. Evidence from the Emergency Phase in Italy. R. Di Bidino, A. Cicchetti
864 [GO] 2020―Dez―11 CO4 An Evaluation of the Differences in Vaccine Approval and Procurement Processes between Healthcare Systems during a Pandemic A. Robert, J. Farrington, L. Longworth
865 [GO] 2020―Dez―11 PIN145 Online- Education in Times of Pandemic a Strategy That Allows Change in Times of Crisis, an Example in Chile. N. Febré, V. Nasabun Flores, M.V. Badilla, S. Contreras, T. Pavlov, L.R. Diaz-Diaz, P. Ivanovic
866 [GO] 2020―Dez―11 PR3 Patient-Reported Outcome Measures to Prioritize Surgical Lists during Pandemic Events S. De Rosis, D.A. Lungu, F. Pennucci, S. Nuti
867 [GO] 2020―Dez―11 PCV81 Virtual Anticoagulation Clinic Care a Telehealth MODEL to Deliver Continuity of Anticoagulation Care during the COVID 19 Pandemic: Insights from Southern India O. Gona, S.K. S, R. Madhan
868 [GO] 2020―Dez―10 Modeling Social Distancing Strategies to Prevent SARS-CoV-2 Spread in Israel: A Cost-Effectiveness Analysis Amir Shlomai, Ari Leshno, Ella H. Sklan, Moshe Leshno
869 [GO] 2020―Okt―13 The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19) C. Daniel Mullins, Michael F. Drummond
870 [GO] 2020―Okt―05 Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group Joy Leahy, Conor Hickey, David McConnell, Owen Cassidy, Lea Trela-Larsen, Michael Barry, et al. (+2)
871 [GO] 2020―Sep―06 Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations Dalia M Dawoud, Khaled Y Soliman
872 [GO] 2020―Sep―04 Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study Shelby Reed, Juan Marcos Gonzalez, F. Reed Johnson
873 [GO] 2020―Aug―27 Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the UK Darshan Zala, Iris Mosweu, Simone Critchlow, Renee Romeo, Paul McCrone
874 [GO] 2020―Jul―27 Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China Siyu Ma, David D. Kim, Joshua T. Cohen, Peter J. Neumann
875 [GO] 2020―Mai―21 The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease-2019 Treatments Available and Affordable Steven Forsythe, Joshua Cohen, Peter Neumann, Stefano M. Bertozzi, Anthony Kinghorn
 [1] 

875 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.018 sec